<?xml version="1.0" encoding="UTF-8"?>

<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="HIV.D"/>
  <text>
    <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p>This case-insensitive code system <code>http://worldhealthorganization.github.io/smart-hiv/CodeSystem/HIV.D</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style="white-space:nowrap">DE1<a name="HIV.D-DE1"> </a></td><td>Reason for visit</td><td><div><p>Whether visit was scheduled or unscheduled, clinical only, or for ARV drug pick-up</p>
</div></td></tr><tr><td style="white-space:nowrap">DE2<a name="HIV.D-DE2"> </a></td><td>First clinical visit</td><td><div><p>The client's first appointment for clinical care by a provider at the facility</p>
</div></td></tr><tr><td style="white-space:nowrap">DE3<a name="HIV.D-DE3"> </a></td><td>Clinical visit</td><td><div><p>Appointment for clinical care by a provider</p>
</div></td></tr><tr><td style="white-space:nowrap">DE4<a name="HIV.D-DE4"> </a></td><td>ART initiation</td><td><div><p>Appointment for initiation of ART</p>
</div></td></tr><tr><td style="white-space:nowrap">DE5<a name="HIV.D-DE5"> </a></td><td>ART drug pick up</td><td><div><p>Appointment for an antiretroviral drug pick up</p>
</div></td></tr><tr><td style="white-space:nowrap">DE6<a name="HIV.D-DE6"> </a></td><td>Issues and concerns</td><td><div><p>Visit to address issues and concerns</p>
</div></td></tr><tr><td style="white-space:nowrap">DE7<a name="HIV.D-DE7"> </a></td><td>Post-treatment follow-up visit for cervical precancer lesions or invasive cervical cancer</td><td><div><p>Appointment for a post-treatment follow-up visit for cervical precancer lesions or invasive cervical cancer</p>
</div></td></tr><tr><td style="white-space:nowrap">DE8<a name="HIV.D-DE8"> </a></td><td>Scheduled visit</td><td><div><p>Is this is a scheduled visit?</p>
</div></td></tr><tr><td style="white-space:nowrap">DE9<a name="HIV.D-DE9"> </a></td><td>Body temperature</td><td><div><p>Temperature of the client in Celsius</p>
</div></td></tr><tr><td style="white-space:nowrap">DE10<a name="HIV.D-DE10"> </a></td><td>Respiratory rate</td><td><div><p>The number of breaths per minute</p>
</div></td></tr><tr><td style="white-space:nowrap">DE11<a name="HIV.D-DE11"> </a></td><td>Heart rate</td><td><div><p>The number of heartbeats per minute</p>
</div></td></tr><tr><td style="white-space:nowrap">DE12<a name="HIV.D-DE12"> </a></td><td>Body height</td><td><div><p>The client's height in centimetres</p>
</div></td></tr><tr><td style="white-space:nowrap">DE13<a name="HIV.D-DE13"> </a></td><td>Body weight</td><td><div><p>The client's current weight in kilograms</p>
</div></td></tr><tr><td style="white-space:nowrap">DE14<a name="HIV.D-DE14"> </a></td><td>Systolic blood pressure</td><td><div><p>Systolic blood pressure (SBP) in mmHg</p>
</div></td></tr><tr><td style="white-space:nowrap">DE15<a name="HIV.D-DE15"> </a></td><td>Diastolic blood pressure</td><td><div><p>Diastolic blood pressure (DBP) in mmHg</p>
</div></td></tr><tr><td style="white-space:nowrap">DE16<a name="HIV.D-DE16"> </a></td><td>Blood pressure cannot be taken</td><td><div><p>If the client's blood pressure cannot be taken, this should be indicated here. Otherwise, blood pressure should be measured.</p>
</div></td></tr><tr><td style="white-space:nowrap">DE17<a name="HIV.D-DE17"> </a></td><td>Signs of serious illness</td><td><div><p>Signs that may indicate the client has a serious illness and needs triage or an emergency referral</p>
</div></td></tr><tr><td style="white-space:nowrap">DE18<a name="HIV.D-DE18"> </a></td><td>Fever of 39 C or greater</td><td><div><p>Client has a fever with a measured temperature of 102.2 F/39 C or greater</p>
</div></td></tr><tr><td style="white-space:nowrap">DE19<a name="HIV.D-DE19"> </a></td><td>Tachycardia</td><td><div><p>Heart rate above a rate per minute based on age</p>
</div></td></tr><tr><td style="white-space:nowrap">DE20<a name="HIV.D-DE20"> </a></td><td>Tachypnea</td><td><div><p>Respiratory rate above a number of breaths per minute based on age</p>
</div></td></tr><tr><td style="white-space:nowrap">DE21<a name="HIV.D-DE21"> </a></td><td>Unable to walk unaided</td><td><div><p>Client is not able to walk without help</p>
</div></td></tr><tr><td style="white-space:nowrap">DE22<a name="HIV.D-DE22"> </a></td><td>Lethargy</td><td><div><p>Client is exhibiting lethargy as a sign of serious illness</p>
</div></td></tr><tr><td style="white-space:nowrap">DE23<a name="HIV.D-DE23"> </a></td><td>Unconsciousness</td><td><div><p>Client is currently unconscious</p>
</div></td></tr><tr><td style="white-space:nowrap">DE24<a name="HIV.D-DE24"> </a></td><td>Convulsions</td><td><div><p>Client is convulsing</p>
</div></td></tr><tr><td style="white-space:nowrap">DE25<a name="HIV.D-DE25"> </a></td><td>Unable to drink</td><td><div><p>Child is not able to drink</p>
</div></td></tr><tr><td style="white-space:nowrap">DE26<a name="HIV.D-DE26"> </a></td><td>Unable to breastfeed</td><td><div><p>Infant or child is not able to breastfeed</p>
</div></td></tr><tr><td style="white-space:nowrap">DE27<a name="HIV.D-DE27"> </a></td><td>Repeated vomiting</td><td><div><p>Client is repeatedly vomiting</p>
</div></td></tr><tr><td style="white-space:nowrap">DE28<a name="HIV.D-DE28"> </a></td><td>Headache</td><td><div><p>Client is exhibiting a headache</p>
</div></td></tr><tr><td style="white-space:nowrap">DE29<a name="HIV.D-DE29"> </a></td><td>Other sign of serious illness</td><td><div><p>Client is exhibiting another sign of a serious illness</p>
</div></td></tr><tr><td style="white-space:nowrap">DE30<a name="HIV.D-DE30"> </a></td><td>Other sign of serious illness (specify)</td><td><div><p>Client is exhibiting another sign of a serious illness (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE31<a name="HIV.D-DE31"> </a></td><td>Currently pregnant</td><td><div><p>Client is currently pregnant</p>
</div></td></tr><tr><td style="white-space:nowrap">DE32<a name="HIV.D-DE32"> </a></td><td>Breastfeeding</td><td><div><p>Client is giving infant breast milk</p>
</div></td></tr><tr><td style="white-space:nowrap">DE33<a name="HIV.D-DE33"> </a></td><td>Number of pregnancies (gravida)</td><td><div><p>Total number of times the woman has been pregnant (gravida)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE34<a name="HIV.D-DE34"> </a></td><td>Number of miscarriages and/or abortions</td><td><div><p>Total number of pregnancies lost/ended due to miscarriages and/or abortions before 22 weeks/5 months</p>
</div></td></tr><tr><td style="white-space:nowrap">DE35<a name="HIV.D-DE35"> </a></td><td>Number of live births</td><td><div><p>Total number of live births after 22 weeks</p>
</div></td></tr><tr><td style="white-space:nowrap">DE36<a name="HIV.D-DE36"> </a></td><td>Parity</td><td><div><p>Calculated parity is the total number of live and stillbirths</p>
</div></td></tr><tr><td style="white-space:nowrap">DE37<a name="HIV.D-DE37"> </a></td><td>Serodiscordant partner</td><td><div><p>Client's HIV status is different from a current partner's HIV status</p>
</div></td></tr><tr><td style="white-space:nowrap">DE38<a name="HIV.D-DE38"> </a></td><td>On ART</td><td><div><p>Client is currently taking ART</p>
</div></td></tr><tr><td style="white-space:nowrap">DE39<a name="HIV.D-DE39"> </a></td><td>ART start date</td><td><div><p>The date on which the client started or restarted ART</p>
</div></td></tr><tr><td style="white-space:nowrap">DE40<a name="HIV.D-DE40"> </a></td><td>Stopped ART</td><td><div><p>Client stopped taking ART</p>
</div></td></tr><tr><td style="white-space:nowrap">DE41<a name="HIV.D-DE41"> </a></td><td>Date ART stopped</td><td><div><p>Date on which client stopped ART</p>
</div></td></tr><tr><td style="white-space:nowrap">DE42<a name="HIV.D-DE42"> </a></td><td>Established on ART</td><td><div><p>Is the client successfully established on ART?</p>
</div></td></tr><tr><td style="white-space:nowrap">DE43<a name="HIV.D-DE43"> </a></td><td>ART start type</td><td><div><p>Whether the client is ART naive or is restarting ART</p>
</div></td></tr><tr><td style="white-space:nowrap">DE44<a name="HIV.D-DE44"> </a></td><td>First-time user of ART</td><td><div><p>Client is ART naive, having never taken ART to treat HIV before</p>
</div></td></tr><tr><td style="white-space:nowrap">DE45<a name="HIV.D-DE45"> </a></td><td>Restarting ART</td><td><div><p>Client is restarting ART after stopping treatment for any reason</p>
</div></td></tr><tr><td style="white-space:nowrap">DE46<a name="HIV.D-DE46"> </a></td><td>Date of initiation on ART</td><td><div><p>The date on which the client was first initiated on ART</p>
</div></td></tr><tr><td style="white-space:nowrap">DE47<a name="HIV.D-DE47"> </a></td><td>Time on ART</td><td><div><p>Time the client has been on ART since starting or restarting it in years and months</p>
</div></td></tr><tr><td style="white-space:nowrap">DE48<a name="HIV.D-DE48"> </a></td><td>Date(s) ART restarted</td><td><div><p>Date(s) client restarted ART after stopping (intentionally interrupting) for any number of reasons (see &quot;Reason ART stopped&quot;)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE49<a name="HIV.D-DE49"> </a></td><td>ART cohort</td><td><div><p>Month and year client originally started ART (documented) at a health facility in the system. The cohort is a group of patients who started ART in the same month (or quarter) and year, whose status is followed over time, using the ART register.</p>
</div></td></tr><tr><td style="white-space:nowrap">DE50<a name="HIV.D-DE50"> </a></td><td>Transfer in for HIV care</td><td><div><p>Client is transferring in with records or known ART drugs and ART start date</p>
</div></td></tr><tr><td style="white-space:nowrap">DE51<a name="HIV.D-DE51"> </a></td><td>Date of transfer in</td><td><div><p>Date client presented at facility (with transfer/referral slip) from another facility (and on ART) within the system</p>
</div></td></tr><tr><td style="white-space:nowrap">DE52<a name="HIV.D-DE52"> </a></td><td>Facility transferred from</td><td><div><p>Name of health facility client was transferred from</p>
</div></td></tr><tr><td style="white-space:nowrap">DE53<a name="HIV.D-DE53"> </a></td><td>Date enrolled in HIV care</td><td><div><p>Date client first enrols in HIV care at the facility. Begins when a person with a confirmed HIV diagnosis presents to a facility where HIV care is provided and a medical record, patient card, file or chart is opened for the first time. This could be at an HIV care/ART, MNCH or TB clinic.</p>
</div></td></tr><tr><td style="white-space:nowrap">DE54<a name="HIV.D-DE54"> </a></td><td>Age at enrolment</td><td><div><p>Client's age when the client was enrolled in ART care</p>
</div></td></tr><tr><td style="white-space:nowrap">DE55<a name="HIV.D-DE55"> </a></td><td>Facility where client first enrolled in HIV care</td><td><div><p>Facility where the client first enrolled in HIV care</p>
</div></td></tr><tr><td style="white-space:nowrap">DE56<a name="HIV.D-DE56"> </a></td><td>Antiretroviral (ARV) drugs received prior to enrolment</td><td><div><p>Whether or not the client received ARV drugs prior to enrolling into HIV care</p>
</div></td></tr><tr><td style="white-space:nowrap">DE57<a name="HIV.D-DE57"> </a></td><td>No prior ARVs</td><td><div><p>Client received no prior ARVs</p>
</div></td></tr><tr><td style="white-space:nowrap">DE58<a name="HIV.D-DE58"> </a></td><td>Received ARVs prior without records/documentation</td><td><div><p>Client received ARVs prior without records/documentation</p>
</div></td></tr><tr><td style="white-space:nowrap">DE59<a name="HIV.D-DE59"> </a></td><td>Received ARVs during pregnancy or breastfeeding</td><td><div><p>Client received ARVs during pregnancy or breastfeeding</p>
</div></td></tr><tr><td style="white-space:nowrap">DE60<a name="HIV.D-DE60"> </a></td><td>Received ARVs for PEP or PrEP</td><td><div><p>Client received ARVs for post-exposure prophylaxis (PEP) or PrEP</p>
</div></td></tr><tr><td style="white-space:nowrap">DE61<a name="HIV.D-DE61"> </a></td><td>ARV prophylaxis for an HIV-exposed infant</td><td><div><p>Client received ARV prophylaxis for an HIV-exposed infant</p>
</div></td></tr><tr><td style="white-space:nowrap">DE62<a name="HIV.D-DE62"> </a></td><td>Date ARV drugs received prior to enrolment</td><td><div><p>Date ARV drugs were started prior to enrolment into HIV care/ART</p>
</div></td></tr><tr><td style="white-space:nowrap">DE63<a name="HIV.D-DE63"> </a></td><td>Location ARV drugs received prior to enrolment</td><td><div><p>Health facility (or other location) where ARV drugs were received prior to enrolment into HIV care/ART</p>
</div></td></tr><tr><td style="white-space:nowrap">DE64<a name="HIV.D-DE64"> </a></td><td>ARV drug regimen received prior to enrolment</td><td><div><p>ARV drug regimen received prior to enrolment into HIV care/ART</p>
</div></td></tr><tr><td style="white-space:nowrap">DE65<a name="HIV.D-DE65"> </a></td><td>Existing chronic health conditions</td><td><div><p>Does the client have any current chronic health conditions or problems?</p>
</div></td></tr><tr><td style="white-space:nowrap">DE66<a name="HIV.D-DE66"> </a></td><td>No chronic or past health conditions</td><td><div><p>Client does not have chronic diseases or any past health conditions</p>
</div></td></tr><tr><td style="white-space:nowrap">DE67<a name="HIV.D-DE67"> </a></td><td>Don't know</td><td><div><p>Client does not know whether she has any chronic diseases or past health conditions</p>
</div></td></tr><tr><td style="white-space:nowrap">DE68<a name="HIV.D-DE68"> </a></td><td>Diabetes other or unspecified</td><td><div><p>Client has diabetes of other or unspecified type</p>
</div></td></tr><tr><td style="white-space:nowrap">DE69<a name="HIV.D-DE69"> </a></td><td>Diabetes pre-existing type 1</td><td><div><p>Client has pre-existing type 1 diabetes mellitus</p>
</div></td></tr><tr><td style="white-space:nowrap">DE70<a name="HIV.D-DE70"> </a></td><td>Diabetes pre-existing type 2</td><td><div><p>Client has pre-existing type 2 diabetes mellitus</p>
</div></td></tr><tr><td style="white-space:nowrap">DE71<a name="HIV.D-DE71"> </a></td><td>Hypertension</td><td><div><p>High blood pressure</p>
</div></td></tr><tr><td style="white-space:nowrap">DE72<a name="HIV.D-DE72"> </a></td><td>Other</td><td><div><p>Other health conditions not included in the list</p>
</div></td></tr><tr><td style="white-space:nowrap">DE73<a name="HIV.D-DE73"> </a></td><td>Other (specify)</td><td><div><p>Other health conditions not included in the list (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE74<a name="HIV.D-DE74"> </a></td><td>Original first-line ART regimen</td><td><div><p>Original full, first-line ARV drug regimen patient started on at this facility</p>
</div></td></tr><tr><td style="white-space:nowrap">DE75<a name="HIV.D-DE75"> </a></td><td>Current ART regimen</td><td><div><p>The current ART regimen the client is taking</p>
</div></td></tr><tr><td style="white-space:nowrap">DE76<a name="HIV.D-DE76"> </a></td><td>Current ART regimen start date</td><td><div><p>The date on which the client started taking the current ART regimen</p>
</div></td></tr><tr><td style="white-space:nowrap">DE77<a name="HIV.D-DE77"> </a></td><td>Preferred first-line ART regimen</td><td><div><p>The preferred first-line ART regimen for the client according to WHO (or national) guidelines</p>
</div></td></tr><tr><td style="white-space:nowrap">DE78<a name="HIV.D-DE78"> </a></td><td>Alternative first-line ART regimen</td><td><div><p>The alternative first-line ART regimen for the client according to WHO (or national) guidelines</p>
</div></td></tr><tr><td style="white-space:nowrap">DE79<a name="HIV.D-DE79"> </a></td><td>First-line ART regimen under special circumstances</td><td><div><p>The first-line ART regimen for the client under special circumstances according to WHO (or national) guidelines</p>
</div></td></tr><tr><td style="white-space:nowrap">DE80<a name="HIV.D-DE80"> </a></td><td>Preferred second-line ART regimen</td><td><div><p>The preferred second-line ART regimen for the client according to WHO (or national) guidelines</p>
</div></td></tr><tr><td style="white-space:nowrap">DE81<a name="HIV.D-DE81"> </a></td><td>Alternative second-line ART regimen</td><td><div><p>The alternative second-line ART regimen for the client according to WHO (or national) guidelines</p>
</div></td></tr><tr><td style="white-space:nowrap">DE82<a name="HIV.D-DE82"> </a></td><td>Optimal regimen for transition</td><td><div><p>The optimal regimen for transition to DTG-based regimens for children established on ART</p>
</div></td></tr><tr><td style="white-space:nowrap">DE83<a name="HIV.D-DE83"> </a></td><td>Current ART regimen (first-, second-, or third-line)</td><td><div><p>ART regimen for treating clients living with HIV, based on national guidance</p>
</div></td></tr><tr><td style="white-space:nowrap">DE84<a name="HIV.D-DE84"> </a></td><td>First-line ART regimen for adults and adolescents</td><td><div><p>First-line ART regimen for adults and adolescents living with HIV</p>
</div></td></tr><tr><td style="white-space:nowrap">DE85<a name="HIV.D-DE85"> </a></td><td>First-line ART regimen for children</td><td><div><p>First-line ART regimen for children living with HIV</p>
</div></td></tr><tr><td style="white-space:nowrap">DE86<a name="HIV.D-DE86"> </a></td><td>First-line ART regimen for neonates</td><td><div><p>First-line ART regimen for neonates living with HIV</p>
</div></td></tr><tr><td style="white-space:nowrap">DE87<a name="HIV.D-DE87"> </a></td><td>Second-line ART regimen for adults and adolescents</td><td><div><p>Second-line ART regimen for adults and adolescents living with HIV</p>
</div></td></tr><tr><td style="white-space:nowrap">DE88<a name="HIV.D-DE88"> </a></td><td>Second-line ART regimen for children</td><td><div><p>Second-line ART regimen for children living with HIV</p>
</div></td></tr><tr><td style="white-space:nowrap">DE89<a name="HIV.D-DE89"> </a></td><td>Third-line ART regimen</td><td><div><p>Third-line ART regimen for people living with HIV (Not defined by WHO. National programmes should develop policies for third-line ART)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE90<a name="HIV.D-DE90"> </a></td><td>ART regimen</td><td><div><p>List of ART regimens</p>
</div></td></tr><tr><td style="white-space:nowrap">DE91<a name="HIV.D-DE91"> </a></td><td>ABC + 3TC + ATV/r</td><td><div><p>Regimen containing abacavir, lamivudine, and atazanavir/ritonavir</p>
</div></td></tr><tr><td style="white-space:nowrap">DE92<a name="HIV.D-DE92"> </a></td><td>ABC + 3TC + DTG</td><td><div><p>Regimen containing abacavir, lamivudine, and dolutegravir</p>
</div></td></tr><tr><td style="white-space:nowrap">DE93<a name="HIV.D-DE93"> </a></td><td>ABC + 3TC + EFV</td><td><div><p>Regimen containing abacavir, lamivudine, and efavarinez</p>
</div></td></tr><tr><td style="white-space:nowrap">DE94<a name="HIV.D-DE94"> </a></td><td>ABC + 3TC + LPV/r</td><td><div><p>Regimen containing abacavir, lamivudine, and lopinavir/ritonavir</p>
</div></td></tr><tr><td style="white-space:nowrap">DE95<a name="HIV.D-DE95"> </a></td><td>ABC + 3TC + NVP</td><td><div><p>Regimen containing abacavir, lamivudine, and nevirapine</p>
</div></td></tr><tr><td style="white-space:nowrap">DE96<a name="HIV.D-DE96"> </a></td><td>ABC + 3TC + RAL</td><td><div><p>Regimen containing abacavir, lamivudine, and raltegravir</p>
</div></td></tr><tr><td style="white-space:nowrap">DE97<a name="HIV.D-DE97"> </a></td><td>AZT + 3TC + ATV/r</td><td><div><p>Regimen containing zidovudine, lamivudine, and atazanavir/ritonavir</p>
</div></td></tr><tr><td style="white-space:nowrap">DE98<a name="HIV.D-DE98"> </a></td><td>AZT + 3TC + DRV/r</td><td><div><p>Regimen containing zidovudine, lamivudine, and darunavir/ritonavir</p>
</div></td></tr><tr><td style="white-space:nowrap">DE99<a name="HIV.D-DE99"> </a></td><td>AZT + 3TC + DTG</td><td><div><p>Regimen containing zidovudine, lamivudine, and dolutegravir</p>
</div></td></tr><tr><td style="white-space:nowrap">DE100<a name="HIV.D-DE100"> </a></td><td>AZT + 3TC + EFV</td><td><div><p>Regimen containing zidovudine, lamivudine, and efavirenz</p>
</div></td></tr><tr><td style="white-space:nowrap">DE101<a name="HIV.D-DE101"> </a></td><td>AZT + 3TC + EFV 600 mg</td><td><div><p>Regimen containing zidovudine, lamivudine, and efavirenz 600 mg</p>
</div></td></tr><tr><td style="white-space:nowrap">DE102<a name="HIV.D-DE102"> </a></td><td>AZT + 3TC + LPV/r</td><td><div><p>Regimen containing zidovudine, lamivudine, and lopinavir/ritonavir</p>
</div></td></tr><tr><td style="white-space:nowrap">DE103<a name="HIV.D-DE103"> </a></td><td>AZT + 3TC + NVP</td><td><div><p>Regimen containing zidovudine, lamivudine, and nevirapine</p>
</div></td></tr><tr><td style="white-space:nowrap">DE104<a name="HIV.D-DE104"> </a></td><td>AZT + 3TC + RAL</td><td><div><p>Regimen containing zidovudine, lamivudine, and raltegravir</p>
</div></td></tr><tr><td style="white-space:nowrap">DE105<a name="HIV.D-DE105"> </a></td><td>TAF + 3TC + DTG</td><td><div><p>Regimen containing tenofovir alafenamide, lamivudine, and dolutegravir</p>
</div></td></tr><tr><td style="white-space:nowrap">DE106<a name="HIV.D-DE106"> </a></td><td>TAF + FTC + DTG</td><td><div><p>Regimen containing tenofovir alafenamide, emtricitabine, and dolutegravir</p>
</div></td></tr><tr><td style="white-space:nowrap">DE107<a name="HIV.D-DE107"> </a></td><td>TDF + 3TC + ATV/r</td><td><div><p>Regimen containing tenofovir disoproxil fumarate, lamivudine, and atazanavir/ritonavir</p>
</div></td></tr><tr><td style="white-space:nowrap">DE108<a name="HIV.D-DE108"> </a></td><td>TDF + 3TC + DRV/r</td><td><div><p>Regimen containing tenofovir disoproxil fumarate, lamivudine, and darunavir/ritonavir</p>
</div></td></tr><tr><td style="white-space:nowrap">DE109<a name="HIV.D-DE109"> </a></td><td>TDF + 3TC + DTG</td><td><div><p>Regimen containing tenofovir disoproxil fumarate, lamivudine, and dolutegravir</p>
</div></td></tr><tr><td style="white-space:nowrap">DE110<a name="HIV.D-DE110"> </a></td><td>TDF + 3TC + EFV</td><td><div><p>Regimen containing tenofovir disoproxil fumarate, lamivudine, and efavirenz</p>
</div></td></tr><tr><td style="white-space:nowrap">DE111<a name="HIV.D-DE111"> </a></td><td>TDF + 3TC + EFV 400 mg</td><td><div><p>Regimen containing tenofovir disoproxil fumarate, lamivudine, and efavirenz (400 mg)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE112<a name="HIV.D-DE112"> </a></td><td>TDF + 3TC + EFV 600 mg</td><td><div><p>Regimen containing tenofovir disoproxil fumarate, lamivudine, and efavirenz (600 mg)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE113<a name="HIV.D-DE113"> </a></td><td>TDF + 3TC + LPV/r</td><td><div><p>Regimen containing tenofovir disoproxil fumarate, lamivudine, and lopinavir/ritonavir</p>
</div></td></tr><tr><td style="white-space:nowrap">DE114<a name="HIV.D-DE114"> </a></td><td>TDF + 3TC + NVP</td><td><div><p>Regimen containing tenofovir disoproxil fumarate, lamivudine, and nevirapine</p>
</div></td></tr><tr><td style="white-space:nowrap">DE115<a name="HIV.D-DE115"> </a></td><td>TDF + 3TC + PI/r</td><td><div><p>Regimen containing tenofovir disoproxil fumarate, lamivudine, and a boosted protease inhibitor</p>
</div></td></tr><tr><td style="white-space:nowrap">DE116<a name="HIV.D-DE116"> </a></td><td>TDF + 3TC + RAL</td><td><div><p>Regimen containing tenofovir disoproxil fumarate, lamivudine, and raltegravir</p>
</div></td></tr><tr><td style="white-space:nowrap">DE117<a name="HIV.D-DE117"> </a></td><td>TDF + FTC + ATV/r</td><td><div><p>Regimen containing tenofovir disoproxil fumarate, emtricitabine, and atazanavir/ritonavir</p>
</div></td></tr><tr><td style="white-space:nowrap">DE118<a name="HIV.D-DE118"> </a></td><td>TDF + FTC + DRV/r</td><td><div><p>Regimen containing tenofovir disoproxil fumarate, emtricitabine, and darunavir/ritonavir</p>
</div></td></tr><tr><td style="white-space:nowrap">DE119<a name="HIV.D-DE119"> </a></td><td>TDF + FTC + DTG</td><td><div><p>Regimen containing tenofovir disoproxil fumarate, emtricitabine, and dolutegravir</p>
</div></td></tr><tr><td style="white-space:nowrap">DE120<a name="HIV.D-DE120"> </a></td><td>TDF + FTC + EFV</td><td><div><p>Regimen containing tenofovir disoproxil fumarate, emtricitabine, and efavirenz</p>
</div></td></tr><tr><td style="white-space:nowrap">DE121<a name="HIV.D-DE121"> </a></td><td>TDF + FTC + EFV 600 mg</td><td><div><p>Regimen containing tenofovir disoproxil fumarate, emtricitabine, and efavirenz (600 mg)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE122<a name="HIV.D-DE122"> </a></td><td>TDF + FTC + LPV/r</td><td><div><p>Regimen containing tenofovir disoproxil fumarate, emtricitabine, and lopinavir/ritonavir</p>
</div></td></tr><tr><td style="white-space:nowrap">DE123<a name="HIV.D-DE123"> </a></td><td>TDF + FTC + NVP</td><td><div><p>Regimen containing tenofovir disoproxil fumarate, emtricitabine, and nevirapine</p>
</div></td></tr><tr><td style="white-space:nowrap">DE124<a name="HIV.D-DE124"> </a></td><td>TDF + FTC + PI/r</td><td><div><p>Regimen containing tenofovir disoproxil fumarate, emtricitabine, and a boosted protease inhibitor</p>
</div></td></tr><tr><td style="white-space:nowrap">DE125<a name="HIV.D-DE125"> </a></td><td>TDF + FTC + RAL</td><td><div><p>Regimen containing tenofovir disoproxil fumarate, emtricitabine, and raltegravir</p>
</div></td></tr><tr><td style="white-space:nowrap">DE126<a name="HIV.D-DE126"> </a></td><td>Other</td><td><div><p>Other regimen based upon WHO recommendations</p>
</div></td></tr><tr><td style="white-space:nowrap">DE127<a name="HIV.D-DE127"> </a></td><td>Other (specify)</td><td><div><p>Other regimen based upon WHO recommendations (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE128<a name="HIV.D-DE128"> </a></td><td>ART regimen composition</td><td><div><p>Drug composition of client's current ART regimen</p>
</div></td></tr><tr><td style="white-space:nowrap">DE129<a name="HIV.D-DE129"> </a></td><td>ABC</td><td><div><p>Treated with abacavir (ABC)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE130<a name="HIV.D-DE130"> </a></td><td>FTC</td><td><div><p>Treated with emtricitabine (FTC)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE131<a name="HIV.D-DE131"> </a></td><td>3TC</td><td><div><p>Treated with lamivudine (3TC)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE132<a name="HIV.D-DE132"> </a></td><td>AZT</td><td><div><p>Treated with zidovudine (AZT)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE133<a name="HIV.D-DE133"> </a></td><td>DDI</td><td><div><p>Treated with didanosine (DDI)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE134<a name="HIV.D-DE134"> </a></td><td>D4T</td><td><div><p>Treated with stavudine (D4T)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE135<a name="HIV.D-DE135"> </a></td><td>TDF</td><td><div><p>Treated with tenofovir (TDF)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE136<a name="HIV.D-DE136"> </a></td><td>EFV</td><td><div><p>Treated with efavirenz (EFV)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE137<a name="HIV.D-DE137"> </a></td><td>ETV</td><td><div><p>Treated with etravirine (ETV)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE138<a name="HIV.D-DE138"> </a></td><td>NVP</td><td><div><p>Treated with nevirapine (NVP)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE139<a name="HIV.D-DE139"> </a></td><td>RIL</td><td><div><p>Treated with rilpivirine (RIL)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE140<a name="HIV.D-DE140"> </a></td><td>ATV/r</td><td><div><p>Treated with atazanavir/ritonavir (ATV/r)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE141<a name="HIV.D-DE141"> </a></td><td>LPV/r</td><td><div><p>Treated with lopinavir/ritonavir (LPV/r)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE142<a name="HIV.D-DE142"> </a></td><td>DRV/r</td><td><div><p>Treated with darunavir/ritonavir (DRV/r)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE143<a name="HIV.D-DE143"> </a></td><td>RTV</td><td><div><p>Treated with ritonavir (RTV)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE144<a name="HIV.D-DE144"> </a></td><td>DTG</td><td><div><p>Treated with dolutegravir (DTG)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE145<a name="HIV.D-DE145"> </a></td><td>RAL</td><td><div><p>Treated with raltegravir (RAL)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE146<a name="HIV.D-DE146"> </a></td><td>ART regimen drug class</td><td><div><p>Drug class of current ART regimen</p>
</div></td></tr><tr><td style="white-space:nowrap">DE147<a name="HIV.D-DE147"> </a></td><td>NRTI</td><td><div><p>Treated with nucleoside reverse transcriptase inhibitors (NRTIs)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE148<a name="HIV.D-DE148"> </a></td><td>NtRTI</td><td><div><p>Treated with nucleotide reverse-transcriptase inhibitors (NtRTIs)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE149<a name="HIV.D-DE149"> </a></td><td>NNRTI</td><td><div><p>Treated with non-nucleoside reverse transcriptase inhibitors (NNRTIs)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE150<a name="HIV.D-DE150"> </a></td><td>PI</td><td><div><p>Treated with protease inhibitors (PIs)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE151<a name="HIV.D-DE151"> </a></td><td>INSTI</td><td><div><p>Treated with integrase strand transfer inhibitors (INSTIs)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE152<a name="HIV.D-DE152"> </a></td><td>Prevention services offered and referrals</td><td><div><p>Offer or refer for prevention services</p>
</div></td></tr><tr><td style="white-space:nowrap">DE153<a name="HIV.D-DE153"> </a></td><td>Offer male and female condoms and condom-compatible lubricants</td><td><div><p>Offer male and female condoms and condom-compatible lubricants</p>
</div></td></tr><tr><td style="white-space:nowrap">DE154<a name="HIV.D-DE154"> </a></td><td>Harm reduction for people who inject drugs</td><td><div><p>Offer or refer people who inject drugs to harm reduction services (needle and syringe programmes, opioid substitution therapy, other drug-dependence treatment and opioid overdose prevention and management)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE155<a name="HIV.D-DE155"> </a></td><td>Behavioural interventions to support risk reduction</td><td><div><p>Offer or refer to services for behavioural interventions to support risk reduction, particularly for people with HIV and members of key populations</p>
</div></td></tr><tr><td style="white-space:nowrap">DE156<a name="HIV.D-DE156"> </a></td><td>Sexual and reproductive health integrated services</td><td><div><p>Offer or refer to sexual and reproductive health services</p>
</div></td></tr><tr><td style="white-space:nowrap">DE157<a name="HIV.D-DE157"> </a></td><td>Contraception and family planning</td><td><div><p>Offer contraception and family planning services</p>
</div></td></tr><tr><td style="white-space:nowrap">DE158<a name="HIV.D-DE158"> </a></td><td>Check pregnancy status</td><td><div><p>Check woman's pregnancy status</p>
</div></td></tr><tr><td style="white-space:nowrap">DE159<a name="HIV.D-DE159"> </a></td><td>Prevention of mother-to-child transmission</td><td><div><p>Offer prevention of mother-to-child transmission services (counselling)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE160<a name="HIV.D-DE160"> </a></td><td>STI testing and treatment</td><td><div><p>Offer STI testing and treatment services</p>
</div></td></tr><tr><td style="white-space:nowrap">DE161<a name="HIV.D-DE161"> </a></td><td>HBsAg test date</td><td><div><p>Date client was tested for hepatitis B virus (HBV)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE162<a name="HIV.D-DE162"> </a></td><td>HBsAg test result</td><td><div><p>Hepatitis B virus test result (HBsAg)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE163<a name="HIV.D-DE163"> </a></td><td>Positive</td><td><div><p>HBsAg test result was positive</p>
</div></td></tr><tr><td style="white-space:nowrap">DE164<a name="HIV.D-DE164"> </a></td><td>Negative</td><td><div><p>HBsAg test result was negative</p>
</div></td></tr><tr><td style="white-space:nowrap">DE165<a name="HIV.D-DE165"> </a></td><td>Indeterminate</td><td><div><p>HBsAg test result was indeterminate</p>
</div></td></tr><tr><td style="white-space:nowrap">DE166<a name="HIV.D-DE166"> </a></td><td>Date HBV test result returned to client</td><td><div><p>Date HBV test result (HBsAG) was returned to client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE167<a name="HIV.D-DE167"> </a></td><td>HBV treatment (TDF) start date</td><td><div><p>Date when client started treatment (TDF) for hepatitis B virus (HBV)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE168<a name="HIV.D-DE168"> </a></td><td>HBV treatment regimen prescribed</td><td><div><p>Hepatitis B virus treatment regimen prescribed</p>
</div></td></tr><tr><td style="white-space:nowrap">DE169<a name="HIV.D-DE169"> </a></td><td>HCV test date</td><td><div><p>Date client was tested for hepatitis C virus (HCV antibody, HCV RNA or HCV core antigen)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE170<a name="HIV.D-DE170"> </a></td><td>HCV test result</td><td><div><p>Hepatitis C virus test result (HCV antibody, HCV RNA or HCV core antigen)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE171<a name="HIV.D-DE171"> </a></td><td>Positive</td><td><div><p>HCV test result was positive</p>
</div></td></tr><tr><td style="white-space:nowrap">DE172<a name="HIV.D-DE172"> </a></td><td>Negative</td><td><div><p>HCV test result was negative</p>
</div></td></tr><tr><td style="white-space:nowrap">DE173<a name="HIV.D-DE173"> </a></td><td>Indeterminate</td><td><div><p>HCV test result was indeterminate</p>
</div></td></tr><tr><td style="white-space:nowrap">DE174<a name="HIV.D-DE174"> </a></td><td>Date HCV test result returned to client</td><td><div><p>Date HCV test result was returned to client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE175<a name="HIV.D-DE175"> </a></td><td>HCV treatment start date</td><td><div><p>Date when client started treatment for hepatitis C virus (HCV)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE176<a name="HIV.D-DE176"> </a></td><td>HCV treatment completion date</td><td><div><p>Date when client completed treatment for hepatitis C virus (HCV)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE177<a name="HIV.D-DE177"> </a></td><td>HCV treatment regimen prescribed</td><td><div><p>Hepatitis C virus treatment regimen prescribed</p>
</div></td></tr><tr><td style="white-space:nowrap">DE178<a name="HIV.D-DE178"> </a></td><td>HCV viral load test date</td><td><div><p>Hepatitis C viral load test date</p>
</div></td></tr><tr><td style="white-space:nowrap">DE179<a name="HIV.D-DE179"> </a></td><td>HCV viral load test result</td><td><div><p>Hepatitis C viral load test result (qualitative)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE180<a name="HIV.D-DE180"> </a></td><td>Detected</td><td><div><p>HCV was detected</p>
</div></td></tr><tr><td style="white-space:nowrap">DE181<a name="HIV.D-DE181"> </a></td><td>Not detected</td><td><div><p>HCV was not detected</p>
</div></td></tr><tr><td style="white-space:nowrap">DE182<a name="HIV.D-DE182"> </a></td><td>HCV medicine type</td><td><div><p>Type of medicine client is prescribed</p>
</div></td></tr><tr><td style="white-space:nowrap">DE183<a name="HIV.D-DE183"> </a></td><td>Interferon</td><td><div><p>Client is prescribed interferon</p>
</div></td></tr><tr><td style="white-space:nowrap">DE184<a name="HIV.D-DE184"> </a></td><td>Direct acting antivirals</td><td><div><p>Client is prescribed direct acting antivirals</p>
</div></td></tr><tr><td style="white-space:nowrap">DE185<a name="HIV.D-DE185"> </a></td><td>Currently on TDF-based ART</td><td><div><p>Client is currently on TDF-based ART regimen</p>
</div></td></tr><tr><td style="white-space:nowrap">DE186<a name="HIV.D-DE186"> </a></td><td>HIV clinical stage</td><td><div><p>WHO clinical stage of client based on signs and symptoms. WHO clinical staging is a way to categorize HIV disease severity based on new or recurrent clinical events. There are 4 WHO clinical stages that range from mild symptoms (WHO clinical stage 1) to severe symptoms (WHO clinical stage 4).</p>
</div></td></tr><tr><td style="white-space:nowrap">DE187<a name="HIV.D-DE187"> </a></td><td>WHO HIV clinical stage 1</td><td><div><p>Client is currently assessed to be at a clinical stage 1, based on clinical assessment and diagnostics</p>
</div></td></tr><tr><td style="white-space:nowrap">DE188<a name="HIV.D-DE188"> </a></td><td>WHO HIV clinical stage 2</td><td><div><p>Client is currently assessed to be at a clinical stage 2, based on clinical assessment and diagnostics</p>
</div></td></tr><tr><td style="white-space:nowrap">DE189<a name="HIV.D-DE189"> </a></td><td>WHO HIV clinical stage 3</td><td><div><p>Client is currently assessed to be at a clinical stage 3, based on clinical assessment and diagnostics</p>
</div></td></tr><tr><td style="white-space:nowrap">DE190<a name="HIV.D-DE190"> </a></td><td>WHO HIV clinical stage 4</td><td><div><p>Client is currently assessed to be at a clinical stage 4, based on clinical assessment and diagnostics</p>
</div></td></tr><tr><td style="white-space:nowrap">DE191<a name="HIV.D-DE191"> </a></td><td>Number of missed doses</td><td><div><p>Number of doses of antiretroviral therapy (ART) the client missed since the last visit, used for monitoring adherence</p>
</div></td></tr><tr><td style="white-space:nowrap">DE192<a name="HIV.D-DE192"> </a></td><td>Received viral load test result</td><td><div><p>Client received results from viral load test</p>
</div></td></tr><tr><td style="white-space:nowrap">DE193<a name="HIV.D-DE193"> </a></td><td>Date viral load test results received by client</td><td><div><p>The date on which the client received results from viral load test</p>
</div></td></tr><tr><td style="white-space:nowrap">DE194<a name="HIV.D-DE194"> </a></td><td>Date of viral load sample collection</td><td><div><p>Date and time when the sample was collected to test the client's HIV viral load</p>
</div></td></tr><tr><td style="white-space:nowrap">DE195<a name="HIV.D-DE195"> </a></td><td>Date of scheduled review of viral load test results</td><td><div><p>Expected date when client's viral load test results will be returned and reviewed</p>
</div></td></tr><tr><td style="white-space:nowrap">DE196<a name="HIV.D-DE196"> </a></td><td>Date of ART interruption</td><td><div><p>Date of client's ART interruption (ART stop or missed drug pick-up)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE197<a name="HIV.D-DE197"> </a></td><td>Reason(s) for adherence problem</td><td><div><p>Reason why client was not adherent</p>
</div></td></tr><tr><td style="white-space:nowrap">DE198<a name="HIV.D-DE198"> </a></td><td>Forgot</td><td><div><p>Client reported not being adherent because they forgot</p>
</div></td></tr><tr><td style="white-space:nowrap">DE199<a name="HIV.D-DE199"> </a></td><td>Toxicity/side effects</td><td><div><p>Client reported not being adherent because of toxicity/side effects</p>
</div></td></tr><tr><td style="white-space:nowrap">DE200<a name="HIV.D-DE200"> </a></td><td>Busy</td><td><div><p>Client reported not being adherent because they were busy</p>
</div></td></tr><tr><td style="white-space:nowrap">DE201<a name="HIV.D-DE201"> </a></td><td>Change of routine</td><td><div><p>Client reported not being adherent because of a change of routine</p>
</div></td></tr><tr><td style="white-space:nowrap">DE202<a name="HIV.D-DE202"> </a></td><td>Travel cost</td><td><div><p>Client reported not being adherent because of travel cost</p>
</div></td></tr><tr><td style="white-space:nowrap">DE203<a name="HIV.D-DE203"> </a></td><td>Distance to clinic</td><td><div><p>Client reported not being adherent because of distance to clinic</p>
</div></td></tr><tr><td style="white-space:nowrap">DE204<a name="HIV.D-DE204"> </a></td><td>Client lost/ran out of pills</td><td><div><p>Client reported not being adherent because client lost/ran out of pills</p>
</div></td></tr><tr><td style="white-space:nowrap">DE205<a name="HIV.D-DE205"> </a></td><td>Stock-out</td><td><div><p>Client reported not being adherent because of a stock-out</p>
</div></td></tr><tr><td style="white-space:nowrap">DE206<a name="HIV.D-DE206"> </a></td><td>Too ill</td><td><div><p>Client reported not being adherent because of being too ill</p>
</div></td></tr><tr><td style="white-space:nowrap">DE207<a name="HIV.D-DE207"> </a></td><td>Pill burden</td><td><div><p>Client reported not being adherent because of the pill burden</p>
</div></td></tr><tr><td style="white-space:nowrap">DE208<a name="HIV.D-DE208"> </a></td><td>Felt well</td><td><div><p>Client reported not being adherent because they felt well</p>
</div></td></tr><tr><td style="white-space:nowrap">DE209<a name="HIV.D-DE209"> </a></td><td>Depression</td><td><div><p>Client reported not being adherent because of depression</p>
</div></td></tr><tr><td style="white-space:nowrap">DE210<a name="HIV.D-DE210"> </a></td><td>Alcohol use</td><td><div><p>Client reported not being adherent because of alcohol use</p>
</div></td></tr><tr><td style="white-space:nowrap">DE211<a name="HIV.D-DE211"> </a></td><td>Substance use</td><td><div><p>Client reported not being adherent because of substance use (i.e. drugs)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE212<a name="HIV.D-DE212"> </a></td><td>Stigma/disclosure concerns</td><td><div><p>Client reported not being adherent because of stigma/disclosure concerns</p>
</div></td></tr><tr><td style="white-space:nowrap">DE213<a name="HIV.D-DE213"> </a></td><td>Lack of food</td><td><div><p>Client reported not being adherent because of a lack of food</p>
</div></td></tr><tr><td style="white-space:nowrap">DE214<a name="HIV.D-DE214"> </a></td><td>Poor palatability</td><td><div><p>Client reported not being adherent because of poor palatability</p>
</div></td></tr><tr><td style="white-space:nowrap">DE215<a name="HIV.D-DE215"> </a></td><td>Other reason for nonadherence</td><td><div><p>Client reported not being adherent because of other reason for nonadherence</p>
</div></td></tr><tr><td style="white-space:nowrap">DE216<a name="HIV.D-DE216"> </a></td><td>Other reason for nonadherence (specify)</td><td><div><p>Client reported not being adherent because of other reason for nonadherence (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE217<a name="HIV.D-DE217"> </a></td><td>Reason ART stopped</td><td><div><p>Reason client intentionally stopped ART</p>
</div></td></tr><tr><td style="white-space:nowrap">DE218<a name="HIV.D-DE218"> </a></td><td>Toxicity/side effects</td><td><div><p>Client stopped ART because of toxicity/side effects</p>
</div></td></tr><tr><td style="white-space:nowrap">DE219<a name="HIV.D-DE219"> </a></td><td>Severe illness, hospitalization</td><td><div><p>Client stopped ART because of severe illness, hospitalization</p>
</div></td></tr><tr><td style="white-space:nowrap">DE220<a name="HIV.D-DE220"> </a></td><td>Drugs out of stock</td><td><div><p>Client stopped ART because drugs were out of stock</p>
</div></td></tr><tr><td style="white-space:nowrap">DE221<a name="HIV.D-DE221"> </a></td><td>Client lacks finances</td><td><div><p>Client stopped ART because of lack of finances</p>
</div></td></tr><tr><td style="white-space:nowrap">DE222<a name="HIV.D-DE222"> </a></td><td>Excluded HIV infection in infant</td><td><div><p>Client stopped ART because HIV infection in infant was excluded</p>
</div></td></tr><tr><td style="white-space:nowrap">DE223<a name="HIV.D-DE223"> </a></td><td>Other reason for stopping ART</td><td><div><p>Client stopped ART because of other reason</p>
</div></td></tr><tr><td style="white-space:nowrap">DE224<a name="HIV.D-DE224"> </a></td><td>Other reason for stopping ART (specify)</td><td><div><p>Client stopped ART because of other reason (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE225<a name="HIV.D-DE225"> </a></td><td>Treatment failure</td><td><div><p>ART treatment failure</p>
</div></td></tr><tr><td style="white-space:nowrap">DE226<a name="HIV.D-DE226"> </a></td><td>Clinical failure</td><td><div><p>New or recurrent clinical event indicating severe immunodeficiency in adults or advanced or severe immunodeficiency in children</p>
</div></td></tr><tr><td style="white-space:nowrap">DE227<a name="HIV.D-DE227"> </a></td><td>Immunological failure</td><td><div><p>CD4 count at or below 250 cells/mm3 following clinical failure</p>
</div></td></tr><tr><td style="white-space:nowrap">DE228<a name="HIV.D-DE228"> </a></td><td>Virological failure</td><td><div><p>The inability to achieve or maintain viral suppression below a certain threshold indicated by viral load above 1000 copies/mL based on two consecutive viral load measurements in 3 months, with adherence support following the first viral load test</p>
</div></td></tr><tr><td style="white-space:nowrap">DE229<a name="HIV.D-DE229"> </a></td><td>General care activities recommended</td><td><div><p>General care activities to be performed during the care visit</p>
</div></td></tr><tr><td style="white-space:nowrap">DE230<a name="HIV.D-DE230"> </a></td><td>Determine WHO clinical stage</td><td><div><p>Determine WHO clinical stage based on past and current HIV-related conditions</p>
</div></td></tr><tr><td style="white-space:nowrap">DE231<a name="HIV.D-DE231"> </a></td><td>Determine if advanced disease</td><td><div><p>Determine if client is in an advanced stage of HIV, as a special package of services may be provided</p>
</div></td></tr><tr><td style="white-space:nowrap">DE232<a name="HIV.D-DE232"> </a></td><td>Prepare for ART</td><td><div><p>Prepare client new to ART</p>
</div></td></tr><tr><td style="white-space:nowrap">DE233<a name="HIV.D-DE233"> </a></td><td>Prepare, assess and support adherence</td><td><div><p>Prepare, assess and support adherence</p>
</div></td></tr><tr><td style="white-space:nowrap">DE234<a name="HIV.D-DE234"> </a></td><td>Manage current medications</td><td><div><p>Manage current medications being taken by the client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE235<a name="HIV.D-DE235"> </a></td><td>Check pregnancy status</td><td><div><p>Check woman's pregnancy status</p>
</div></td></tr><tr><td style="white-space:nowrap">DE236<a name="HIV.D-DE236"> </a></td><td>Provide family planning and contraception</td><td><div><p>Provide family planning and contraception counselling</p>
</div></td></tr><tr><td style="white-space:nowrap">DE237<a name="HIV.D-DE237"> </a></td><td>Support disclosure and partner notification</td><td><div><p>Support disclosure and partner notification</p>
</div></td></tr><tr><td style="white-space:nowrap">DE238<a name="HIV.D-DE238"> </a></td><td>Counsel on risk reduction and prevention</td><td><div><p>Counsel on risk reduction and combination HIV prevention approaches</p>
</div></td></tr><tr><td style="white-space:nowrap">DE239<a name="HIV.D-DE239"> </a></td><td>Assess, prevent and manage noncommunicable diseases</td><td><div><p>Assess, prevent and manage noncommunicable diseases</p>
</div></td></tr><tr><td style="white-space:nowrap">DE240<a name="HIV.D-DE240"> </a></td><td>Screen for and manage mental health problems</td><td><div><p>Screen for and manage mental health problems</p>
</div></td></tr><tr><td style="white-space:nowrap">DE241<a name="HIV.D-DE241"> </a></td><td>Screen for and manage and substance use issues</td><td><div><p>Screen for and manage and substance use issues</p>
</div></td></tr><tr><td style="white-space:nowrap">DE242<a name="HIV.D-DE242"> </a></td><td>Provide psychosocial counselling and support</td><td><div><p>Provide psychosocial counselling and support</p>
</div></td></tr><tr><td style="white-space:nowrap">DE243<a name="HIV.D-DE243"> </a></td><td>Manage pain and symptoms</td><td><div><p>Manage pain and symptoms client is experiencing</p>
</div></td></tr><tr><td style="white-space:nowrap">DE244<a name="HIV.D-DE244"> </a></td><td>Conduct a nutritional assessment and counsel on nutrition</td><td><div><p>Conduct a nutritional assessment and counsel on nutrition</p>
</div></td></tr><tr><td style="white-space:nowrap">DE245<a name="HIV.D-DE245"> </a></td><td>Conduct a growth and development assessment</td><td><div><p>Conduct a growth and development assessment</p>
</div></td></tr><tr><td style="white-space:nowrap">DE246<a name="HIV.D-DE246"> </a></td><td>Provide support on infant and child feeding</td><td><div><p>Provide support on infant and child feeding to mother or care giver</p>
</div></td></tr><tr><td style="white-space:nowrap">DE247<a name="HIV.D-DE247"> </a></td><td>Preventing and treating coinfections</td><td><div><p>Coinfection prevention and treatment activities performed during the care visit</p>
</div></td></tr><tr><td style="white-space:nowrap">DE248<a name="HIV.D-DE248"> </a></td><td>Provide co-trimoxazole preventive therapy (CPT)</td><td><div><p>Provide co-trimoxazole prophylaxis for clients new to ART or identified as taking it</p>
</div></td></tr><tr><td style="white-space:nowrap">DE249<a name="HIV.D-DE249"> </a></td><td>Intensified TB case finding and linkage to TB treatment</td><td><div><p>Offer or refer for intensified TB case finding and linkage to TB treatment</p>
</div></td></tr><tr><td style="white-space:nowrap">DE250<a name="HIV.D-DE250"> </a></td><td>Provide isoniazid preventive therapy</td><td><div><p>Provide isoniazid preventive therapy</p>
</div></td></tr><tr><td style="white-space:nowrap">DE251<a name="HIV.D-DE251"> </a></td><td>Screen for cryptococcal infection and fungal prophylaxis</td><td><div><p>Screen for cryptococcal infection and fungal prophylaxis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE252<a name="HIV.D-DE252"> </a></td><td>Screen for hepatitis B</td><td><div><p>Screen for hepatitis B virus</p>
</div></td></tr><tr><td style="white-space:nowrap">DE253<a name="HIV.D-DE253"> </a></td><td>Screen for hepatitis C</td><td><div><p>Screen for hepatitis C virus</p>
</div></td></tr><tr><td style="white-space:nowrap">DE254<a name="HIV.D-DE254"> </a></td><td>Prevent malaria</td><td><div><p>Prevent malaria including with insecticide-treated bed-nets and prophylaxis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE255<a name="HIV.D-DE255"> </a></td><td>Screen for STIs</td><td><div><p>Screen for STIs</p>
</div></td></tr><tr><td style="white-space:nowrap">DE256<a name="HIV.D-DE256"> </a></td><td>Prevent and screen for cervical cancer</td><td><div><p>Prevent and screen for cervical cancer</p>
</div></td></tr><tr><td style="white-space:nowrap">DE257<a name="HIV.D-DE257"> </a></td><td>Anal cancer screening (for men who have sex with men)</td><td><div><p>Offer anal cancer screening (for men who have sex with men)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE258<a name="HIV.D-DE258"> </a></td><td>Assessment and provision of vaccinations</td><td><div><p>Assessment and provision of vaccinations, such as for people from key populations, pregnant women and infants; and, where appropriate, tetanus vaccination for adolescent boys and men receiving VMMC</p>
</div></td></tr><tr><td style="white-space:nowrap">DE259<a name="HIV.D-DE259"> </a></td><td>Risk factors, comorbidities and coinfections signs and symptoms</td><td><div><p>Signs and symptoms of opportunistic infections or other comorbidities experienced by client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE260<a name="HIV.D-DE260"> </a></td><td>Oral candidiasis</td><td><div><p>Client's comorbidities or coinfections or symptoms of these include oral candidiasis (after the first 6-8 weeks of life)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE261<a name="HIV.D-DE261"> </a></td><td>Vaginal candidiasis</td><td><div><p>Client's comorbidities or coinfections or symptoms of these include vaginal candidiasis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE262<a name="HIV.D-DE262"> </a></td><td>Cough</td><td><div><p>Client's comorbidities or coinfections or symptoms of these include cough</p>
</div></td></tr><tr><td style="white-space:nowrap">DE263<a name="HIV.D-DE263"> </a></td><td>Prolonged fever</td><td><div><p>Client's comorbidities or coinfections or symptoms of these include prolonged fever</p>
</div></td></tr><tr><td style="white-space:nowrap">DE264<a name="HIV.D-DE264"> </a></td><td>Night sweats</td><td><div><p>Client's comorbidities or coinfections or symptoms of these include night sweats</p>
</div></td></tr><tr><td style="white-space:nowrap">DE265<a name="HIV.D-DE265"> </a></td><td>Weight loss</td><td><div><p>Client's comorbidities or coinfections or symptoms of these include weight loss</p>
</div></td></tr><tr><td style="white-space:nowrap">DE266<a name="HIV.D-DE266"> </a></td><td>Difficulty breathing</td><td><div><p>Client's comorbidities or coinfections or symptoms of these include difficulty breathing</p>
</div></td></tr><tr><td style="white-space:nowrap">DE267<a name="HIV.D-DE267"> </a></td><td>Pneumonia</td><td><div><p>Client's comorbidities or coinfections or symptoms of these include pneumonia</p>
</div></td></tr><tr><td style="white-space:nowrap">DE268<a name="HIV.D-DE268"> </a></td><td>Urethral discharge</td><td><div><p>Client's comorbidities or coinfections or symptoms of these include urethral discharge</p>
</div></td></tr><tr><td style="white-space:nowrap">DE269<a name="HIV.D-DE269"> </a></td><td>Syphilis</td><td><div><p>Client's comorbidities or coinfections or symptoms of these include syphilis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE270<a name="HIV.D-DE270"> </a></td><td>Pelvic inflammatory disease</td><td><div><p>Client's comorbidities or coinfections or symptoms of these include pelvic inflammatory disease</p>
</div></td></tr><tr><td style="white-space:nowrap">DE271<a name="HIV.D-DE271"> </a></td><td>Ulcers - skin</td><td><div><p>Client's comorbidities or coinfections or symptoms of these include ulcers - skin</p>
</div></td></tr><tr><td style="white-space:nowrap">DE272<a name="HIV.D-DE272"> </a></td><td>Ulcers - mouth or other</td><td><div><p>Client's comorbidities or coinfections or symptoms of these include ulcers - mouth or other</p>
</div></td></tr><tr><td style="white-space:nowrap">DE273<a name="HIV.D-DE273"> </a></td><td>Ulcers - male genital</td><td><div><p>Client's comorbidities or coinfections or symptoms of these include ulcers - male genital</p>
</div></td></tr><tr><td style="white-space:nowrap">DE274<a name="HIV.D-DE274"> </a></td><td>Vaginal discharge</td><td><div><p>Client's comorbidities or coinfections or symptoms of these include vaginal discharge</p>
</div></td></tr><tr><td style="white-space:nowrap">DE275<a name="HIV.D-DE275"> </a></td><td>Malaria</td><td><div><p>Client's comorbidities or coinfections or symptoms of these include malaria</p>
</div></td></tr><tr><td style="white-space:nowrap">DE276<a name="HIV.D-DE276"> </a></td><td>Chronic obstructive pulmonary disease</td><td><div><p>Client's comorbidities or coinfections or symptoms of these include chronic obstructive pulmonary disease</p>
</div></td></tr><tr><td style="white-space:nowrap">DE277<a name="HIV.D-DE277"> </a></td><td>Hypertension</td><td><div><p>Client's comorbidities or coinfections or symptoms of these include hypertension</p>
</div></td></tr><tr><td style="white-space:nowrap">DE278<a name="HIV.D-DE278"> </a></td><td>Diabetes</td><td><div><p>Client's comorbidities or coinfections or symptoms of these include diabetes</p>
</div></td></tr><tr><td style="white-space:nowrap">DE279<a name="HIV.D-DE279"> </a></td><td>Gestational diabetes</td><td><div><p>Client's comorbidities or coinfections or symptoms of these include gestational diabetes</p>
</div></td></tr><tr><td style="white-space:nowrap">DE280<a name="HIV.D-DE280"> </a></td><td>Mental health disorders</td><td><div><p>Client's comorbidities or coinfections or symptoms of these include mental health disorders (including depression, dementia, encephalitis, seizures)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE281<a name="HIV.D-DE281"> </a></td><td>Diarrhoea or abdominal pain</td><td><div><p>Client's comorbidities or coinfections or symptoms of these include diarrhoea or abdominal pain</p>
</div></td></tr><tr><td style="white-space:nowrap">DE282<a name="HIV.D-DE282"> </a></td><td>Presumptive TB</td><td><div><p>Client's comorbidities or coinfections or symptoms of these include presumptive TB</p>
</div></td></tr><tr><td style="white-space:nowrap">DE283<a name="HIV.D-DE283"> </a></td><td>Severe or complicated malnutrition</td><td><div><p>Client's comorbidities or coinfections or symptoms of these include severe or complicated malnutrition</p>
</div></td></tr><tr><td style="white-space:nowrap">DE284<a name="HIV.D-DE284"> </a></td><td>Poor growth or development</td><td><div><p>Client's comorbidities or coinfections or symptoms of these include poor growth or development</p>
</div></td></tr><tr><td style="white-space:nowrap">DE285<a name="HIV.D-DE285"> </a></td><td>Oedema</td><td><div><p>Client's comorbidities or coinfections or symptoms of these include oedema</p>
</div></td></tr><tr><td style="white-space:nowrap">DE286<a name="HIV.D-DE286"> </a></td><td>Previously treated for TB</td><td><div><p>Client has previously been treated for tuberculosis (TB)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE287<a name="HIV.D-DE287"> </a></td><td>Other</td><td><div><p>Other comorbidities or coinfection signs or symptoms</p>
</div></td></tr><tr><td style="white-space:nowrap">DE288<a name="HIV.D-DE288"> </a></td><td>Other (specify)</td><td><div><p>Other comorbidities or coinfection signs or symptoms (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE289<a name="HIV.D-DE289"> </a></td><td>WHO HIV clinical stage condition or symptom</td><td><div><p>New or recurrent clinical events used to categorize HIV disease severity based at baseline and follow up</p>
</div></td></tr><tr><td style="white-space:nowrap">DE290<a name="HIV.D-DE290"> </a></td><td>Asymptomatic</td><td><div><p>No HIV-related symptoms reported and no clinical signs on examination</p>
</div></td></tr><tr><td style="white-space:nowrap">DE291<a name="HIV.D-DE291"> </a></td><td>Persistent generalized lymphadenopathy</td><td><div><p>Persistent enlarged lymph nodes &gt;1 cm at two or more non-contiguous sites (excluding inguinal) without known cause</p>
</div></td></tr><tr><td style="white-space:nowrap">DE292<a name="HIV.D-DE292"> </a></td><td>Moderate unexplained weight loss</td><td><div><p>Moderate unexplained weight loss (&lt;10% of presumed or measured body weight)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE293<a name="HIV.D-DE293"> </a></td><td>Recurrent respiratory tract infections</td><td><div><p>Client's symptoms include recurrent respiratory tract infections including sinusitis, tonsillitis, otitis media or pharyngitis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE294<a name="HIV.D-DE294"> </a></td><td>Unexplained persistent hepatosplenomegaly</td><td><div><p>Client's symptoms include unexplained persistent hepatosplenomegaly</p>
</div></td></tr><tr><td style="white-space:nowrap">DE295<a name="HIV.D-DE295"> </a></td><td>Herpes zoster</td><td><div><p>Client's symptoms include herpes zoster</p>
</div></td></tr><tr><td style="white-space:nowrap">DE296<a name="HIV.D-DE296"> </a></td><td>Angular cheilitis</td><td><div><p>Client's symptoms include angular cheilitis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE297<a name="HIV.D-DE297"> </a></td><td>Linear gingival erythema</td><td><div><p>Client's symptoms include linear gingival erythema</p>
</div></td></tr><tr><td style="white-space:nowrap">DE298<a name="HIV.D-DE298"> </a></td><td>Recurrent oral ulceration</td><td><div><p>Client's symptoms include recurrent oral ulceration</p>
</div></td></tr><tr><td style="white-space:nowrap">DE299<a name="HIV.D-DE299"> </a></td><td>Papular pruritic eruption</td><td><div><p>Client's symptoms include papular pruritic eruption</p>
</div></td></tr><tr><td style="white-space:nowrap">DE300<a name="HIV.D-DE300"> </a></td><td>Fungal nail infections</td><td><div><p>Client's symptoms include fungal nail infections</p>
</div></td></tr><tr><td style="white-space:nowrap">DE301<a name="HIV.D-DE301"> </a></td><td>Seborrhoeic dermatitis</td><td><div><p>Client's symptoms include seborrhoeic dermatitis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE302<a name="HIV.D-DE302"> </a></td><td>Extensive wart virus infection</td><td><div><p>Client's symptoms include extensive wart virus infection</p>
</div></td></tr><tr><td style="white-space:nowrap">DE303<a name="HIV.D-DE303"> </a></td><td>Extensive molluscum contagiosum</td><td><div><p>Client's symptoms include extensive molluscum contagiosum</p>
</div></td></tr><tr><td style="white-space:nowrap">DE304<a name="HIV.D-DE304"> </a></td><td>Unexplained persistent parotid enlargement</td><td><div><p>Client's symptoms include unexplained persistent parotid enlargement</p>
</div></td></tr><tr><td style="white-space:nowrap">DE305<a name="HIV.D-DE305"> </a></td><td>Unexplained severe weight loss in adults</td><td><div><p>Unexplained severe weight loss (&gt;10% of presumed or measured body weight)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE306<a name="HIV.D-DE306"> </a></td><td>Unexplained moderate malnutrition not adequately responding to standard therapy</td><td><div><p>Defined as weight-for-height &lt; - 2 z-score or mid-upper arm circumference 115 mm to &lt;125 mm. For children younger than five years of age: stunting is defined as severe acute malnutrition - either weight for height &lt; -3 z-score or mid-upper arm circumference &lt;115 mm or the presence of oedema.</p>
</div></td></tr><tr><td style="white-space:nowrap">DE307<a name="HIV.D-DE307"> </a></td><td>Unexplained chronic diarrhoea for longer than 1 month</td><td><div><p>Client's symptoms include unexplained chronic diarrhoea for longer than 1 month</p>
</div></td></tr><tr><td style="white-space:nowrap">DE308<a name="HIV.D-DE308"> </a></td><td>Unexplained persistent diarrhoea (14 days or more)</td><td><div><p>Client's symptoms include unexplained persistent diarrhoea (14 days or more)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE309<a name="HIV.D-DE309"> </a></td><td>Unexplained persistent fever (above 37.5 C, intermittent or constant, for longer than one 1 month)</td><td><div><p>Client's symptoms include unexplained persistent fever (above 37.5 C, intermittent or constant, for longer than one 1 month)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE310<a name="HIV.D-DE310"> </a></td><td>Persistent oral candidiasis</td><td><div><p>Client's symptoms include persistent oral candidiasis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE311<a name="HIV.D-DE311"> </a></td><td>Oral hairy leukoplakia</td><td><div><p>Client has fine white small linear or corrugated lesions on lateral borders of the tongue that do not scrape off</p>
</div></td></tr><tr><td style="white-space:nowrap">DE312<a name="HIV.D-DE312"> </a></td><td>Pulmonary TB</td><td><div><p>Client's symptoms include pulmonary TB</p>
</div></td></tr><tr><td style="white-space:nowrap">DE313<a name="HIV.D-DE313"> </a></td><td>Lymph node TB</td><td><div><p>Client's symptoms include lymph node TB</p>
</div></td></tr><tr><td style="white-space:nowrap">DE314<a name="HIV.D-DE314"> </a></td><td>Severe bacterial infections (such as pneumonia, empyema, pyomyositis, bone or joint infection, meningitis, bacteraemia)</td><td><div><p>Client's symptoms include severe bacterial infections (such as pneumonia, empyema, pyomyositis, bone or joint infection, meningitis, bacteraemia)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE315<a name="HIV.D-DE315"> </a></td><td>Severe recurrent bacterial pneumonia</td><td><div><p>Client's symptoms include severe recurrent bacterial pneumonia</p>
</div></td></tr><tr><td style="white-space:nowrap">DE316<a name="HIV.D-DE316"> </a></td><td>Acute necrotizing ulcerative stomatitis</td><td><div><p>Client's symptoms include acute necrotizing ulcerative stomatitis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE317<a name="HIV.D-DE317"> </a></td><td>Acute necrotizing ulcerative gingivitis</td><td><div><p>Client's symptoms include acute necrotizing ulcerative gingivitis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE318<a name="HIV.D-DE318"> </a></td><td>Acute necrotizing ulcerative periodontitis</td><td><div><p>Client's symptoms include acute necrotizing ulcerative periodontitis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE319<a name="HIV.D-DE319"> </a></td><td>Unexplained anaemia (&lt;8 g/dL)</td><td><div><p>Client's symptoms include unexplained anaemia (&lt;8 g/dL)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE320<a name="HIV.D-DE320"> </a></td><td>Neutropaenia (&lt;0.5 x 10^9/L)</td><td><div><p>Client's symptoms include neutropaenia (&lt;0.5 x 10^9/L)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE321<a name="HIV.D-DE321"> </a></td><td>Chronic thrombocytopaenia (&lt;50 x 10^9/L)</td><td><div><p>Client's symptoms include chronic thrombocytopaenia (&lt;50 x 10^9/L)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE322<a name="HIV.D-DE322"> </a></td><td>Symptomatic lymphoid interstitial pneumonitis</td><td><div><p>Client's symptoms include symptomatic lymphoid interstitial pneumonitis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE323<a name="HIV.D-DE323"> </a></td><td>Chronic HIV-associated lung disease, including bronchiectasis</td><td><div><p>Client's symptoms include chronic HIV-associated lung disease, including bronchiectasis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE324<a name="HIV.D-DE324"> </a></td><td>HIV wasting syndrome</td><td><div><p>Unexplained involuntary weight loss (&gt;10% baseline body weight), with obvious wasting or body mass index &lt;18.5; PLUS EITHER unexplained chronic reported for longer than one month; OR reports of fever or night sweats for more than one month without other cause and lack of response to antibiotics or antimalarial agents; malaria must be excluded in malarious areas.</p>
</div></td></tr><tr><td style="white-space:nowrap">DE325<a name="HIV.D-DE325"> </a></td><td>Unexplained severe wasting not responding to standard therapy</td><td><div><p>Client has unexplained severe wasting not responding to standard therapy . For under 5 years old, defined as weight-for-height &lt; -3 z-score</p>
</div></td></tr><tr><td style="white-space:nowrap">DE326<a name="HIV.D-DE326"> </a></td><td>Unexplained stunting not responding to standard therapy</td><td><div><p>Client has unexplained stunting not responding to standard therapy . For under 5 years old, defined as length-for- age/height-for-age &lt; -2 z-score</p>
</div></td></tr><tr><td style="white-space:nowrap">DE327<a name="HIV.D-DE327"> </a></td><td>Unexplained severe malnutrition not responding to standard therapy</td><td><div><p>Client has unexplained severe malnutrition not responding to standard therapy . For under 5 years old, weight for height &lt; -3 z-score or mid-upper arm circumference &lt;115 mm or the presence of oedema</p>
</div></td></tr><tr><td style="white-space:nowrap">DE328<a name="HIV.D-DE328"> </a></td><td>Pneumocystis (jirovecii) pneumonia</td><td><div><p>Client's symptoms include pneumocystis (jirovecii) pneumonia</p>
</div></td></tr><tr><td style="white-space:nowrap">DE329<a name="HIV.D-DE329"> </a></td><td>Recurrent severe bacterial pneumonia</td><td><div><p>Client's symptoms include recurrent severe bacterial pneumonia</p>
</div></td></tr><tr><td style="white-space:nowrap">DE330<a name="HIV.D-DE330"> </a></td><td>Recurrent severe bacterial infections (such as empyema, pyomyositis, bone or joint infection, meningitis, but excluding pneumonia)</td><td><div><p>Client's symptoms include recurrent severe bacterial infections (such as empyema, pyomyositis, bone or joint infection, meningitis, but excluding pneumonia)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE331<a name="HIV.D-DE331"> </a></td><td>Empyema</td><td><div><p>Client's symptoms include recurrent empyema</p>
</div></td></tr><tr><td style="white-space:nowrap">DE332<a name="HIV.D-DE332"> </a></td><td>Pyomyositis</td><td><div><p>Client's symptoms include recurrent pyomyositis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE333<a name="HIV.D-DE333"> </a></td><td>Bone or joint infection</td><td><div><p>Client's symptoms include recurrent bone or joint infections</p>
</div></td></tr><tr><td style="white-space:nowrap">DE334<a name="HIV.D-DE334"> </a></td><td>Meningitis</td><td><div><p>Client's symptoms include recurrent meningitis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE335<a name="HIV.D-DE335"> </a></td><td>Chronic herpes simplex infection (orolabial or cutaneous of more than 1 month duration or visceral at any site)</td><td><div><p>Client's symptoms include chronic herpes simplex infection (orolabial or cutaneous of more than 1 month duration or visceral at any site)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE336<a name="HIV.D-DE336"> </a></td><td>Chronic herpes simplex infection (orolabial, genital or anorectal of more than 1 month in duration or visceral at any site)</td><td><div><p>Client's symptoms include chronic herpes simplex infection (orolabial, genital or anorectal of more than one month in duration or visceral at any site)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE337<a name="HIV.D-DE337"> </a></td><td>Oesophageal candidiasis (or candidiasis of trachea, bronchi or lungs)</td><td><div><p>Client's symptoms include oesophageal candidiasis (or candidiasis of trachea, bronchi or lungs)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE338<a name="HIV.D-DE338"> </a></td><td>Extrapulmonary TB</td><td><div><p>Client's symptoms include extrapulmonary tuberculosis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE339<a name="HIV.D-DE339"> </a></td><td>Kaposi sarcoma</td><td><div><p>Client's symptoms include Kaposi sarcoma</p>
</div></td></tr><tr><td style="white-space:nowrap">DE340<a name="HIV.D-DE340"> </a></td><td>Cytomegalovirus infection (retinitis or infection of other organs)</td><td><div><p>Client's symptoms include cytomegalovirus infection (retinitis or infection of other organs)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE341<a name="HIV.D-DE341"> </a></td><td>Central nervous system toxoplasmosis</td><td><div><p>Client's symptoms include central nervous system toxoplasmosis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE342<a name="HIV.D-DE342"> </a></td><td>HIV encephalopathy</td><td><div><p>Client's symptoms include HIV encephalopathy</p>
</div></td></tr><tr><td style="white-space:nowrap">DE343<a name="HIV.D-DE343"> </a></td><td>Extrapulmonary cryptococcosis, including meningitis</td><td><div><p>Client's symptoms include extrapulmonary cryptococcosis, including meningitis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE344<a name="HIV.D-DE344"> </a></td><td>Disseminated nontuberculous mycobacterial infection</td><td><div><p>Client's symptoms include disseminated nontuberculous mycobacterial infection</p>
</div></td></tr><tr><td style="white-space:nowrap">DE345<a name="HIV.D-DE345"> </a></td><td>Progressive multifocal leukoencephalopathy</td><td><div><p>Client's symptoms include progressive multifocal leukoencephalopathy</p>
</div></td></tr><tr><td style="white-space:nowrap">DE346<a name="HIV.D-DE346"> </a></td><td>Chronic cryptosporidiosis</td><td><div><p>Client's symptoms include chronic cryptosporidiosis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE347<a name="HIV.D-DE347"> </a></td><td>Chronic cryptosporidiosis (with diarrhoea)</td><td><div><p>Client's symptoms include chronic cryptosporidiosis (with diarrhoea)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE348<a name="HIV.D-DE348"> </a></td><td>Chronic isosporiasis</td><td><div><p>Client's symptoms include chronic isosporiasis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE349<a name="HIV.D-DE349"> </a></td><td>Disseminated mycosis (extrapulmonary histoplasmosis, coccidioidomycosis)</td><td><div><p>Client's symptoms include disseminated mycosis (extrapulmonary histoplasmosis, coccidioidomycosis)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE350<a name="HIV.D-DE350"> </a></td><td>Disseminated endemic mycosis (extrapulmonary histoplasmosis, coccidioidomycosis, penicilliosis)</td><td><div><p>Client's symptoms include disseminated endemic mycosis (extrapulmonary histoplasmosis, coccidioidomycosis, penicilliosis)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE351<a name="HIV.D-DE351"> </a></td><td>Cerebral lymphoma</td><td><div><p>Client's symptoms include cerebral lymphoma</p>
</div></td></tr><tr><td style="white-space:nowrap">DE352<a name="HIV.D-DE352"> </a></td><td>B-cell non-Hodgkin lymphoma</td><td><div><p>Client's symptoms include b-cell non-Hodgkin lymphoma</p>
</div></td></tr><tr><td style="white-space:nowrap">DE353<a name="HIV.D-DE353"> </a></td><td>HIV-associated nephropathy or cardiomyopathy</td><td><div><p>Client's symptoms include HIV- associated nephropathy or cardiomyopathy</p>
</div></td></tr><tr><td style="white-space:nowrap">DE354<a name="HIV.D-DE354"> </a></td><td>Recurrent septicaemia (including nontyphoidal Salmonella)</td><td><div><p>Client's symptoms include recurrent bacteraemia (septicaemia) (including nontyphoidal salmonella)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE355<a name="HIV.D-DE355"> </a></td><td>Invasive cervical carcinoma</td><td><div><p>Client's symptoms include invasive cervical carcinoma</p>
</div></td></tr><tr><td style="white-space:nowrap">DE356<a name="HIV.D-DE356"> </a></td><td>Atypical disseminated leishmaniasis</td><td><div><p>Client's symptoms include atypical disseminated leishmaniasis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE357<a name="HIV.D-DE357"> </a></td><td>Neutropenia</td><td><div><p>Client's symptoms include neutropenia, an abnormally low count of a type of white blood cell (neutrophils)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE358<a name="HIV.D-DE358"> </a></td><td>Clinical stage at start of ART</td><td><div><p>WHO clinical stage of client based on signs and symptoms at start of ART</p>
</div></td></tr><tr><td style="white-space:nowrap">DE359<a name="HIV.D-DE359"> </a></td><td>WHO clinical stage 1</td><td><div><p>Client is assessed to be at a clinical stage of 1 at the time of starting ART, based on clinical assessment and diagnostics</p>
</div></td></tr><tr><td style="white-space:nowrap">DE360<a name="HIV.D-DE360"> </a></td><td>WHO clinical stage 2</td><td><div><p>Client is assessed to be at a clinical stage of 2 at the time of starting ART, based on clinical assessment and diagnostics</p>
</div></td></tr><tr><td style="white-space:nowrap">DE361<a name="HIV.D-DE361"> </a></td><td>WHO clinical stage 3</td><td><div><p>Client is assessed to be at a clinical stage of 3 at the time of starting ART, based on clinical assessment and diagnostics</p>
</div></td></tr><tr><td style="white-space:nowrap">DE362<a name="HIV.D-DE362"> </a></td><td>WHO clinical stage 4</td><td><div><p>Client is assessed to be at a clinical stage of 4 at the time of starting ART, based on clinical assessment and diagnostics</p>
</div></td></tr><tr><td style="white-space:nowrap">DE363<a name="HIV.D-DE363"> </a></td><td>Date of clinical status change</td><td><div><p>Date on which the client's WHO HIV clinical stage changed, including the date when the client's stage is first determined</p>
</div></td></tr><tr><td style="white-space:nowrap">DE364<a name="HIV.D-DE364"> </a></td><td>CD4 count</td><td><div><p>CD4 cell count in cells/mm^3</p>
</div></td></tr><tr><td style="white-space:nowrap">DE365<a name="HIV.D-DE365"> </a></td><td>CD4 cell percentage</td><td><div><p>CD4 cell percentage</p>
</div></td></tr><tr><td style="white-space:nowrap">DE366<a name="HIV.D-DE366"> </a></td><td>Date of CD4 count test</td><td><div><p>Date and time when CD4 count test was conducted</p>
</div></td></tr><tr><td style="white-space:nowrap">DE367<a name="HIV.D-DE367"> </a></td><td>Baseline CD4 count</td><td><div><p>CD4 result from first CD4 test performed (such as at treatment initiation), also may be called CD4 at ART initiation or at ART start</p>
</div></td></tr><tr><td style="white-space:nowrap">DE368<a name="HIV.D-DE368"> </a></td><td>Date of baseline CD4 count test</td><td><div><p>Date and time when baseline CD4 count test was conducted</p>
</div></td></tr><tr><td style="white-space:nowrap">DE369<a name="HIV.D-DE369"> </a></td><td>Late ART initiation</td><td><div><p>Client had late ART initiation. That is, the client's first CD4 count from baseline CD4 test performed (such as at treatment initiation) was a count of &lt;200 cells/mm3</p>
</div></td></tr><tr><td style="white-space:nowrap">DE370<a name="HIV.D-DE370"> </a></td><td>Reasons for delayed ART initiation</td><td><div><p>Reason why ART was not initiated at diagnosis or within 7 days of diagnosis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE371<a name="HIV.D-DE371"> </a></td><td>Patient self-reported as not ready/willing</td><td><div><p>Client did not initiate ART at diagnosis or within 7 days of diagnosis because client self-reported as not ready/willing</p>
</div></td></tr><tr><td style="white-space:nowrap">DE372<a name="HIV.D-DE372"> </a></td><td>Not completed education, support and preparation for ART</td><td><div><p>Client did not initiate ART at diagnosis or within 7 days of diagnosis because client had not completed education, support and preparation for ART</p>
</div></td></tr><tr><td style="white-space:nowrap">DE373<a name="HIV.D-DE373"> </a></td><td>Fear of disclosure</td><td><div><p>Client did not initiate ART at diagnosis or within 7 days of diagnosis because of client's fear of disclosure</p>
</div></td></tr><tr><td style="white-space:nowrap">DE374<a name="HIV.D-DE374"> </a></td><td>Patient lacks finances</td><td><div><p>Client did not initiate ART at diagnosis or within 7 days of diagnosis because client lacks finances</p>
</div></td></tr><tr><td style="white-space:nowrap">DE375<a name="HIV.D-DE375"> </a></td><td>Initiated on TB treatment</td><td><div><p>Client did not initiate ART at diagnosis or within 7 days of diagnosis because client initiated on TB treatment</p>
</div></td></tr><tr><td style="white-space:nowrap">DE376<a name="HIV.D-DE376"> </a></td><td>Patient initiated on treatment for TB meningitis</td><td><div><p>Client did not initiate ART at diagnosis or within 7 days of diagnosis because client initiated on treatment for TB meningitis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE377<a name="HIV.D-DE377"> </a></td><td>Patient diagnosed with cryptococcal meningitis</td><td><div><p>Client did not initiate ART at diagnosis or within 7 days of diagnosis because client diagnosed with cryptococcal meningitis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE378<a name="HIV.D-DE378"> </a></td><td>Patient diagnosed with histoplasmosis</td><td><div><p>Client did not initiate ART at diagnosis or within 7 days of diagnosis because client diagnosed with histoplasmosis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE379<a name="HIV.D-DE379"> </a></td><td>Patient critically/severely ill</td><td><div><p>Client did not initiate ART at diagnosis or within 7 days of diagnosis because client critically/severely ill</p>
</div></td></tr><tr><td style="white-space:nowrap">DE380<a name="HIV.D-DE380"> </a></td><td>Other</td><td><div><p>Client did not initiate ART at diagnosis or within 7 days of diagnosis because of other reason</p>
</div></td></tr><tr><td style="white-space:nowrap">DE381<a name="HIV.D-DE381"> </a></td><td>Other (specify)</td><td><div><p>Client did not initiate ART at diagnosis or within 7 days of diagnosis because of other reason (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE382<a name="HIV.D-DE382"> </a></td><td>ART initiated within 7 days of diagnosis</td><td><div><p>Client initiated ART within 7 days of diagnosis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE383<a name="HIV.D-DE383"> </a></td><td>Time to start ART</td><td><div><p>Time from HIV diagnosis to when client started ART</p>
</div></td></tr><tr><td style="white-space:nowrap">DE384<a name="HIV.D-DE384"> </a></td><td>Within 7 days of HIV diagnosis</td><td><div><p>Client started ART within 7 days</p>
</div></td></tr><tr><td style="white-space:nowrap">DE385<a name="HIV.D-DE385"> </a></td><td>Within 30 days of HIV diagnosis</td><td><div><p>Client started ART within 30 days of ART initiation (but over 7 days)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE386<a name="HIV.D-DE386"> </a></td><td>Within 90 days of HIV diagnosis</td><td><div><p>Client started ART within 90 days of ART initiation (but over 30 days)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE387<a name="HIV.D-DE387"> </a></td><td>Viral load test result</td><td><div><p>Result from the viral load test in number of copies/mL</p>
</div></td></tr><tr><td style="white-space:nowrap">DE388<a name="HIV.D-DE388"> </a></td><td>Virally suppressed</td><td><div><p>The client is virally suppressed for HIV, based on the client's most recent viral load test result being less than 1000 copies/mL</p>
</div></td></tr><tr><td style="white-space:nowrap">DE389<a name="HIV.D-DE389"> </a></td><td>Date viral load test results received</td><td><div><p>Date the viral load test result was received from the lab or completed in the facility</p>
</div></td></tr><tr><td style="white-space:nowrap">DE390<a name="HIV.D-DE390"> </a></td><td>Viral load suppression date</td><td><div><p>Date on which the client tested as becoming virally suppressed, as indicated by a viral load test result under 1000 copies/mL</p>
</div></td></tr><tr><td style="white-space:nowrap">DE391<a name="HIV.D-DE391"> </a></td><td>Reason for HIV viral load test</td><td><div><p>Whether the viral load is being tested for routine monitoring on a set schedule or for targeted monitoring for suspected treatment failure</p>
</div></td></tr><tr><td style="white-space:nowrap">DE392<a name="HIV.D-DE392"> </a></td><td>Routine viral load test</td><td><div><p>Routine refers to viral load tests obtained at standard intervals following ART initiation to monitor viral load response to ART</p>
</div></td></tr><tr><td style="white-space:nowrap">DE393<a name="HIV.D-DE393"> </a></td><td>Targeted viral load monitoring</td><td><div><p>Targeted refers to viral load tests obtained based on a specific clinical indication (such as concern about disease progression or failure to respond to ART)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE394<a name="HIV.D-DE394"> </a></td><td>Initial viral load test</td><td><div><p>The first viral load test of the client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE395<a name="HIV.D-DE395"> </a></td><td>Follow-up viral load test after receiving enhanced adherence counselling</td><td><div><p>A follow-up viral load test within 3-6 months after enhanced adherence counselling after client received a high viral load test result</p>
</div></td></tr><tr><td style="white-space:nowrap">DE396<a name="HIV.D-DE396"> </a></td><td>Hepatitis B test required</td><td><div><p>Hepatitis B test is required</p>
</div></td></tr><tr><td style="white-space:nowrap">DE397<a name="HIV.D-DE397"> </a></td><td>Hepatitis C test recommended</td><td><div><p>Hepatitis C test is recommended or should be considered</p>
</div></td></tr><tr><td style="white-space:nowrap">DE398<a name="HIV.D-DE398"> </a></td><td>Syphilis test required</td><td><div><p>Syphilis test is required</p>
</div></td></tr><tr><td style="white-space:nowrap">DE399<a name="HIV.D-DE399"> </a></td><td>Monitoring examinations</td><td><div><p>Name of examinations, test and results for any relevant investigations carried out for client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE400<a name="HIV.D-DE400"> </a></td><td>Haemoglobin (Hb)</td><td><div><p>Provider ordered a Haemoglobin (Hb) test, number in g/dL test</p>
</div></td></tr><tr><td style="white-space:nowrap">DE401<a name="HIV.D-DE401"> </a></td><td>Pregnancy test</td><td><div><p>Provider ordered a pregnancy test for client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE402<a name="HIV.D-DE402"> </a></td><td>Syphilis test</td><td><div><p>Provider ordered a syphilis test</p>
</div></td></tr><tr><td style="white-space:nowrap">DE403<a name="HIV.D-DE403"> </a></td><td>Chest X-ray (CXR)</td><td><div><p>Provider ordered a chest X-ray (CXR)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE404<a name="HIV.D-DE404"> </a></td><td>Sputum or culture for TB</td><td><div><p>Provider ordered sputum or culture for TB</p>
</div></td></tr><tr><td style="white-space:nowrap">DE405<a name="HIV.D-DE405"> </a></td><td>HBsAg test (HBV)</td><td><div><p>Provider ordered an HBsAg test (HBV) test</p>
</div></td></tr><tr><td style="white-space:nowrap">DE406<a name="HIV.D-DE406"> </a></td><td>HIV viral load test ordered</td><td><div><p>Provider ordered an HIV viral load test</p>
</div></td></tr><tr><td style="white-space:nowrap">DE407<a name="HIV.D-DE407"> </a></td><td>HIV viral load test scheduled</td><td><div><p>Scheduled an HIV viral load test with client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE408<a name="HIV.D-DE408"> </a></td><td>CD4 count ordered</td><td><div><p>Provider ordered a CD4 cell count</p>
</div></td></tr><tr><td style="white-space:nowrap">DE409<a name="HIV.D-DE409"> </a></td><td>CD4 count test scheduled</td><td><div><p>Scheduled a CD4 test with client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE410<a name="HIV.D-DE410"> </a></td><td>Cryptococcal antigen test</td><td><div><p>Provider ordered a cryptococcal antigen test</p>
</div></td></tr><tr><td style="white-space:nowrap">DE411<a name="HIV.D-DE411"> </a></td><td>Histoplasmosis antigen test</td><td><div><p>Provider ordered a histoplasmosis antigen test</p>
</div></td></tr><tr><td style="white-space:nowrap">DE412<a name="HIV.D-DE412"> </a></td><td>Cervical cancer screening scheduled</td><td><div><p>Scheduled cervical cancer screening with client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE413<a name="HIV.D-DE413"> </a></td><td>Date of scheduled monitoring examination</td><td><div><p>Date of scheduled monitoring examination</p>
</div></td></tr><tr><td style="white-space:nowrap">DE414<a name="HIV.D-DE414"> </a></td><td>Hepatitis C test ordered</td><td><div><p>Hepatitis C test has been ordered</p>
</div></td></tr><tr><td style="white-space:nowrap">DE415<a name="HIV.D-DE415"> </a></td><td>Syphilis test ordered</td><td><div><p>Syphilis test has been ordered</p>
</div></td></tr><tr><td style="white-space:nowrap">DE416<a name="HIV.D-DE416"> </a></td><td>Received viral load test results</td><td><div><p>Client received results from viral load test</p>
</div></td></tr><tr><td style="white-space:nowrap">DE417<a name="HIV.D-DE417"> </a></td><td>Date viral load test results received by client</td><td><div><p>The date on which the client received results from a viral load test</p>
</div></td></tr><tr><td style="white-space:nowrap">DE418<a name="HIV.D-DE418"> </a></td><td>Reason for ARV drug regimen substitution</td><td><div><p>Reason why a substitution was made to the antiretroviral (ARV) drug regimen</p>
</div></td></tr><tr><td style="white-space:nowrap">DE419<a name="HIV.D-DE419"> </a></td><td>Toxicity/side effects</td><td><div><p>A substitution was made to the regimen because of toxicity/side effects</p>
</div></td></tr><tr><td style="white-space:nowrap">DE420<a name="HIV.D-DE420"> </a></td><td>Drug-drug interaction</td><td><div><p>A substitution was made to the regimen because of a drug-drug interaction</p>
</div></td></tr><tr><td style="white-space:nowrap">DE421<a name="HIV.D-DE421"> </a></td><td>Pregnancy</td><td><div><p>A substitution was made to the regimen because of pregnancy</p>
</div></td></tr><tr><td style="white-space:nowrap">DE422<a name="HIV.D-DE422"> </a></td><td>New TB</td><td><div><p>A substitution was made to the regimen because of new tuberculosis (TB)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE423<a name="HIV.D-DE423"> </a></td><td>New drug available</td><td><div><p>A substitution was made to the regimen because a new drug was available</p>
</div></td></tr><tr><td style="white-space:nowrap">DE424<a name="HIV.D-DE424"> </a></td><td>Drug out of stock</td><td><div><p>A substitution was made to the regimen because drug was out of stock</p>
</div></td></tr><tr><td style="white-space:nowrap">DE425<a name="HIV.D-DE425"> </a></td><td>Other reason for regimen substitution</td><td><div><p>A substitution was made for another reason</p>
</div></td></tr><tr><td style="white-space:nowrap">DE426<a name="HIV.D-DE426"> </a></td><td>Other reason for regimen substitution (specify)</td><td><div><p>A substitution was made for another reason (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE427<a name="HIV.D-DE427"> </a></td><td>Switch to second-line ART regimen recommended</td><td><div><p>A switch to second-line ART regimen is recommended</p>
</div></td></tr><tr><td style="white-space:nowrap">DE428<a name="HIV.D-DE428"> </a></td><td>Switch to third-line ART regimen recommended</td><td><div><p>A switch to third-line ART regimen is recommended</p>
</div></td></tr><tr><td style="white-space:nowrap">DE429<a name="HIV.D-DE429"> </a></td><td>Regimen switch made</td><td><div><p>Provider has made a regimen switch</p>
</div></td></tr><tr><td style="white-space:nowrap">DE430<a name="HIV.D-DE430"> </a></td><td>Reason for regimen switch</td><td><div><p>Reason why a switch to a second- or third-line regimen was made</p>
</div></td></tr><tr><td style="white-space:nowrap">DE431<a name="HIV.D-DE431"> </a></td><td>Clinical treatment failure</td><td><div><p>A switch was made to the regimen because of clinical treatment failure</p>
</div></td></tr><tr><td style="white-space:nowrap">DE432<a name="HIV.D-DE432"> </a></td><td>Immunological failure</td><td><div><p>A switch was made to the regimen because of immunological failure</p>
</div></td></tr><tr><td style="white-space:nowrap">DE433<a name="HIV.D-DE433"> </a></td><td>Virological failure</td><td><div><p>A switch was made to the regimen because of virological failure</p>
</div></td></tr><tr><td style="white-space:nowrap">DE434<a name="HIV.D-DE434"> </a></td><td>Other</td><td><div><p>A switch was made to the regimen for another reason</p>
</div></td></tr><tr><td style="white-space:nowrap">DE435<a name="HIV.D-DE435"> </a></td><td>Other (specify)</td><td><div><p>A switch was made to the regimen for another reason (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE436<a name="HIV.D-DE436"> </a></td><td>Regimen substitution recommended</td><td><div><p>A drug substitution is recommended</p>
</div></td></tr><tr><td style="white-space:nowrap">DE437<a name="HIV.D-DE437"> </a></td><td>Dose adjustment recommended</td><td><div><p>A dosage change is recommended</p>
</div></td></tr><tr><td style="white-space:nowrap">DE438<a name="HIV.D-DE438"> </a></td><td>Regimen substitution made</td><td><div><p>Provider has made a regimen substitution</p>
</div></td></tr><tr><td style="white-space:nowrap">DE439<a name="HIV.D-DE439"> </a></td><td>Co-trimoxazole prophylaxis start date</td><td><div><p>Date co-trimoxazole prophylaxis prescribed to client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE440<a name="HIV.D-DE440"> </a></td><td>Co-trimoxazole prophylaxis completion date</td><td><div><p>Completion date of co-trimoxazole prophylaxis prescribed to client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE441<a name="HIV.D-DE441"> </a></td><td>Co-trimoxazole prophylaxis dosage</td><td><div><p>Dose of co-trimoxazole prophylaxis prescribed to client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE442<a name="HIV.D-DE442"> </a></td><td>Co-trimoxazole prophylaxis number of days prescribed</td><td><div><p>Number of days of co-trimoxazole prophylaxis prescribed to client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE443<a name="HIV.D-DE443"> </a></td><td>Suspicion of treatment failure or interruption</td><td><div><p>Client has been on ART, but has stopped taking it or a treatment failure is suspected</p>
</div></td></tr><tr><td style="white-space:nowrap">DE444<a name="HIV.D-DE444"> </a></td><td>ART regimen prescribed</td><td><div><p>INCLUDE VALUE SETS OF REGIMENS</p>
</div></td></tr><tr><td style="white-space:nowrap">DE445<a name="HIV.D-DE445"> </a></td><td>Antiretroviral toxicity</td><td><div><p>Client is experiencing antiretroviral drug (ARV) toxicity</p>
</div></td></tr><tr><td style="white-space:nowrap">DE446<a name="HIV.D-DE446"> </a></td><td>Coinfection status at ART start</td><td><div><p>Clients status of coinfections at the time when ART was initiated</p>
</div></td></tr><tr><td style="white-space:nowrap">DE447<a name="HIV.D-DE447"> </a></td><td>Hepatitis B</td><td><div><p>Client was hepatitis B positive at the start of ART</p>
</div></td></tr><tr><td style="white-space:nowrap">DE448<a name="HIV.D-DE448"> </a></td><td>Hepatitis C</td><td><div><p>Client was hepatitis C positive at the start of ART</p>
</div></td></tr><tr><td style="white-space:nowrap">DE449<a name="HIV.D-DE449"> </a></td><td>Pregnant and breastfeeding status at ART start</td><td><div><p>ART status of women to prevent mother-to-child transmission</p>
</div></td></tr><tr><td style="white-space:nowrap">DE450<a name="HIV.D-DE450"> </a></td><td>Pregnant at ART start</td><td><div><p>Client was pregnant when ART was initiated</p>
</div></td></tr><tr><td style="white-space:nowrap">DE451<a name="HIV.D-DE451"> </a></td><td>Postpartum at ART start</td><td><div><p>Client was postpartum when ART was initiated</p>
</div></td></tr><tr><td style="white-space:nowrap">DE452<a name="HIV.D-DE452"> </a></td><td>ART start at labour and delivery</td><td><div><p>Client initiated ART at labour and delivery</p>
</div></td></tr><tr><td style="white-space:nowrap">DE453<a name="HIV.D-DE453"> </a></td><td>Breastfeeding at ART start</td><td><div><p>Client was breastfeeding when ART was initiated</p>
</div></td></tr><tr><td style="white-space:nowrap">DE454<a name="HIV.D-DE454"> </a></td><td>Delivery date of infant</td><td><div><p>Date of delivery/birth of infant if breastfeeding at ART start</p>
</div></td></tr><tr><td style="white-space:nowrap">DE455<a name="HIV.D-DE455"> </a></td><td>Serodiscordant partner at ART start</td><td><div><p>Client living with HIV was in an ongoing sexual relationship with an HIV-negative partner when ART was started</p>
</div></td></tr><tr><td style="white-space:nowrap">DE456<a name="HIV.D-DE456"> </a></td><td>Regimen start date</td><td><div><p>The date on which the client started taking the current ART regimen</p>
</div></td></tr><tr><td style="white-space:nowrap">DE457<a name="HIV.D-DE457"> </a></td><td>Medications prescribed</td><td><div><p>Name or regimen code of all other medications prescribed during the visit</p>
</div></td></tr><tr><td style="white-space:nowrap">DE458<a name="HIV.D-DE458"> </a></td><td>Date medications prescribed</td><td><div><p>Date the medications were prescribed</p>
</div></td></tr><tr><td style="white-space:nowrap">DE459<a name="HIV.D-DE459"> </a></td><td>Dose of medications prescribed</td><td><div><p>Number of doses (quantity taken at a single point in time) of drugs prescribed/dispensed</p>
</div></td></tr><tr><td style="white-space:nowrap">DE460<a name="HIV.D-DE460"> </a></td><td>Number of days medications prescribed</td><td><div><p>Number of days supply of each medication or regimen prescribed during the visit</p>
</div></td></tr><tr><td style="white-space:nowrap">DE461<a name="HIV.D-DE461"> </a></td><td>Medications dispensed</td><td><div><p>Any other medications that were dispensed to client, including preventive treatment</p>
</div></td></tr><tr><td style="white-space:nowrap">DE462<a name="HIV.D-DE462"> </a></td><td>Number of days of medications dispensed</td><td><div><p>Number of days supply of each medication or regimen dispensed during the visit</p>
</div></td></tr><tr><td style="white-space:nowrap">DE463<a name="HIV.D-DE463"> </a></td><td>Dosage</td><td><div><p>Prescribed dosage of the medication</p>
</div></td></tr><tr><td style="white-space:nowrap">DE464<a name="HIV.D-DE464"> </a></td><td>Frequency</td><td><div><p>Prescribed frequency for taking the medication</p>
</div></td></tr><tr><td style="white-space:nowrap">DE465<a name="HIV.D-DE465"> </a></td><td>Adherence counselling provided</td><td><div><p>Counselling was carried out during visit</p>
</div></td></tr><tr><td style="white-space:nowrap">DE466<a name="HIV.D-DE466"> </a></td><td>Type of treatment-limiting toxicity</td><td><div><p>Type of treatment-limiting toxicity experienced by client. Treatment-limiting toxicity is defined as a serious adverse drug reaction that results in drug discontinuation or substitution. In addition, any reaction that leads to treatment interruption or requires changing the drug or regimen because of an adverse drug reaction is also considered a serious adverse drug reaction.</p>
</div></td></tr><tr><td style="white-space:nowrap">DE467<a name="HIV.D-DE467"> </a></td><td>Gastrointestinal</td><td><div><p>Treatment-limiting toxicity due to GI issues (nausea, diarrhoea, abdominal pain, vomiting)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE468<a name="HIV.D-DE468"> </a></td><td>Skin issues</td><td><div><p>Treatment-limiting toxicity due to skin issues (rash, hypersensitivity reaction)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE469<a name="HIV.D-DE469"> </a></td><td>Peripheral neuropathy</td><td><div><p>Treatment-limiting toxicity due to peripheral neuropathy (burning/numbness/ tingling)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE470<a name="HIV.D-DE470"> </a></td><td>Central nervous system symptoms</td><td><div><p>Treatment-limiting toxicity due to central nervous system symptoms (dizzy, anxiety, nightmare, depression, seizures)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE471<a name="HIV.D-DE471"> </a></td><td>Weight gain</td><td><div><p>Treatment-limiting toxicity due to weight gain</p>
</div></td></tr><tr><td style="white-space:nowrap">DE472<a name="HIV.D-DE472"> </a></td><td>Hepatic dysfunction</td><td><div><p>Treatment-limiting toxicity due to hepatic dysfunction (jaundice)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE473<a name="HIV.D-DE473"> </a></td><td>Haematological disorders</td><td><div><p>Treatment-limiting toxicity due to haematological (anaemia, neutropenia) disorders</p>
</div></td></tr><tr><td style="white-space:nowrap">DE474<a name="HIV.D-DE474"> </a></td><td>Fatigue</td><td><div><p>Treatment-limiting toxicity due to fatigue</p>
</div></td></tr><tr><td style="white-space:nowrap">DE475<a name="HIV.D-DE475"> </a></td><td>Headache</td><td><div><p>Treatment-limiting toxicity due to headache</p>
</div></td></tr><tr><td style="white-space:nowrap">DE476<a name="HIV.D-DE476"> </a></td><td>Bone dysfunction</td><td><div><p>Treatment-limiting toxicity due to bone dysfunction (fractures, osteopenia)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE477<a name="HIV.D-DE477"> </a></td><td>Metabolic symptoms</td><td><div><p>Treatment-limiting toxicity due to metabolic symptoms (body fat changes, hyperglycaemia, dyslipidaemia)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE478<a name="HIV.D-DE478"> </a></td><td>Kidney dysfunction</td><td><div><p>Treatment-limiting toxicity due to kidney dysfunction (nephrolithiasis, renal insufficiency)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE479<a name="HIV.D-DE479"> </a></td><td>Unexpected adverse drug reaction</td><td><div><p>Client experienced an unexpected adverse drug reaction</p>
</div></td></tr><tr><td style="white-space:nowrap">DE480<a name="HIV.D-DE480"> </a></td><td>Unexpected adverse drug reaction (specify)</td><td><div><p>Specify the type of unexpected adverse drug reaction the client experienced</p>
</div></td></tr><tr><td style="white-space:nowrap">DE481<a name="HIV.D-DE481"> </a></td><td>Date(s) of substitution within first-line regimen</td><td><div><p>Date on which ARV drug regimen (one or more drugs) for client was changed within the first-line regimen (substitution)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE482<a name="HIV.D-DE482"> </a></td><td>Reason(s) for substitution within first-line regimen</td><td><div><p>Reason(s) why one ore more drugs in client's first-line ARV drug regimen was changed (substituted)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE483<a name="HIV.D-DE483"> </a></td><td>New antiretroviral regimen after substitution within first-line regimen</td><td><div><p>New antiretroviral (ARV) drugs after client changed regimen within the first-line regimen</p>
</div></td></tr><tr><td style="white-space:nowrap">DE484<a name="HIV.D-DE484"> </a></td><td>Date of switch to second-line regimen</td><td><div><p>Date client was changed from a first-line to second-line ARV drug regimen (switch)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE485<a name="HIV.D-DE485"> </a></td><td>New regimen after switch to second-line regimen</td><td><div><p>New ART regimen after switch to second-line ART regimen</p>
</div></td></tr><tr><td style="white-space:nowrap">DE486<a name="HIV.D-DE486"> </a></td><td>Reason for switch to second-line regimen</td><td><div><p>Reason why client was switched from first- to second-line ARV drug regimen (see &quot;Reason for regimen switch&quot; for levels)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE487<a name="HIV.D-DE487"> </a></td><td>Date(s) of substitution within second-line regimen</td><td><div><p>Date on which ARV drug regimen for client was changed within the second-line regimen (substitution)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE488<a name="HIV.D-DE488"> </a></td><td>Reason(s) for substitution within second-line regimen</td><td><div><p>Reason(s) why client changed drug regimen (within the second-line)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE489<a name="HIV.D-DE489"> </a></td><td>New regimen(s) after substitution within second-line regimen</td><td><div><p>New ARV drugs after client changed regimen within the second- line regimen</p>
</div></td></tr><tr><td style="white-space:nowrap">DE490<a name="HIV.D-DE490"> </a></td><td>Date of switch to third-line regimen</td><td><div><p>Date client was changed from a second- to third-line ARV drug regimen (switch)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE491<a name="HIV.D-DE491"> </a></td><td>New regimen after switch to third-line regimen</td><td><div><p>New ART regimen after switch to third-line ART regimen</p>
</div></td></tr><tr><td style="white-space:nowrap">DE492<a name="HIV.D-DE492"> </a></td><td>Reason for switch to third-line regimen</td><td><div><p>Reason why client was switched from second- to third-line ARV drug regimen (see &quot;Reason for regimen switch&quot; for levels)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE493<a name="HIV.D-DE493"> </a></td><td>Date(s) of substitution within third-line regimen</td><td><div><p>Date on which ARV drug regimen for client was changed within the third-line (substitution)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE494<a name="HIV.D-DE494"> </a></td><td>Reason(s) for substitution within third-line regimen</td><td><div><p>Reason(s) why client changed drug regimen (within the third-line)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE495<a name="HIV.D-DE495"> </a></td><td>New regimen(s) after substitution within third-line regimen</td><td><div><p>New ARV drugs after client changed regimen within the third-line regimen</p>
</div></td></tr><tr><td style="white-space:nowrap">DE496<a name="HIV.D-DE496"> </a></td><td>Enhanced adherence counselling provided</td><td><div><p>Enhanced adherence counselling was provided to the client during the visit</p>
</div></td></tr><tr><td style="white-space:nowrap">DE497<a name="HIV.D-DE497"> </a></td><td>First enhanced adherence counselling session completed</td><td><div><p>A first enhanced adherence counselling was provided to the client during the visit</p>
</div></td></tr><tr><td style="white-space:nowrap">DE498<a name="HIV.D-DE498"> </a></td><td>Date of first enhanced adherence counselling session completed</td><td><div><p>The date on which the first enhanced adherence counselling was provided to the client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE499<a name="HIV.D-DE499"> </a></td><td>Second enhanced adherence counselling session completed</td><td><div><p>A second enhanced adherence counselling was provided to the client during the visit</p>
</div></td></tr><tr><td style="white-space:nowrap">DE500<a name="HIV.D-DE500"> </a></td><td>Date of second enhanced adherence counselling session completed</td><td><div><p>The date on which the second enhanced adherence counselling was provided to the client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE501<a name="HIV.D-DE501"> </a></td><td>Third enhanced adherence counselling session completed</td><td><div><p>A third enhanced adherence counselling was provided to the client during the visit</p>
</div></td></tr><tr><td style="white-space:nowrap">DE502<a name="HIV.D-DE502"> </a></td><td>Date of third enhanced adherence counselling session completed</td><td><div><p>The date on which the third enhanced adherence counselling was provided to the client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE503<a name="HIV.D-DE503"> </a></td><td>Name of treatment supporter</td><td><div><p>Full name of person providing support to client for adherence, care, treatment and other needs (e.g. ARV pick-up if ill)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE504<a name="HIV.D-DE504"> </a></td><td>Address of treatment supporter</td><td><div><p>Full address or description of home of treatment supporter</p>
</div></td></tr><tr><td style="white-space:nowrap">DE505<a name="HIV.D-DE505"> </a></td><td>Telephone number of treatment supporter</td><td><div><p>Telephone number if available, or else telephone number of neighbour/friend</p>
</div></td></tr><tr><td style="white-space:nowrap">DE506<a name="HIV.D-DE506"> </a></td><td>Home-based care provider</td><td><div><p>Name of individual or organization that provides home-based care to client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE507<a name="HIV.D-DE507"> </a></td><td>Counselling provided on diagnoses</td><td><div><p>Counselling provided on diagnoses</p>
</div></td></tr><tr><td style="white-space:nowrap">DE508<a name="HIV.D-DE508"> </a></td><td>Hepatitis B positive counselling conducted</td><td><div><p>Whether counselling was provided to a client who has been diagnosed with hepatitis B</p>
</div></td></tr><tr><td style="white-space:nowrap">DE509<a name="HIV.D-DE509"> </a></td><td>Hepatitis C positive counselling conducted</td><td><div><p>Whether counselling was provided to a client who has been diagnosed with hepatitis C</p>
</div></td></tr><tr><td style="white-space:nowrap">DE510<a name="HIV.D-DE510"> </a></td><td>Syphilis counselling and treatment</td><td><div><p>Whether counselling and treatment was provided to a client who has been diagnosed with syphilis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE511<a name="HIV.D-DE511"> </a></td><td>Syphilis counselling, treatment and further testing</td><td><div><p>Whether counselling and treatment was provided to a client who has been diagnosed with syphilis. Additional testing (RPR test) recommended.</p>
</div></td></tr><tr><td style="white-space:nowrap">DE512<a name="HIV.D-DE512"> </a></td><td>Accepted partner services</td><td><div><p>Client accepted offer for partner services</p>
</div></td></tr><tr><td style="white-space:nowrap">DE513<a name="HIV.D-DE513"> </a></td><td>HIV testing for partners and biological children</td><td><div><p>Offer voluntary testing for all partners and biological children of positive cases (includes partner services and index case testing), as well as partners and social contacts of people from key populations, where appropriate</p>
</div></td></tr><tr><td style="white-space:nowrap">DE514<a name="HIV.D-DE514"> </a></td><td>HIV status of family member</td><td><div><p>HIV status of each family member at time of patient's enrolment, including partner (for mothers)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE515<a name="HIV.D-DE515"> </a></td><td>Unique ID of family member</td><td><div><p>Unique ID number of each family member if enrolled in HIV care according to national guidelines (see unique ID number)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE516<a name="HIV.D-DE516"> </a></td><td>Date of death of family member</td><td><div><p>Date of death for each family member as appropriate</p>
</div></td></tr><tr><td style="white-space:nowrap">DE517<a name="HIV.D-DE517"> </a></td><td>Offered voluntary partner services</td><td><div><p>Whether the client was offered voluntary partner services or family services</p>
</div></td></tr><tr><td style="white-space:nowrap">DE518<a name="HIV.D-DE518"> </a></td><td>Provided support for disclosure and partner services</td><td><div><p>Offer or refer for support for disclosure and partner services</p>
</div></td></tr><tr><td style="white-space:nowrap">DE519<a name="HIV.D-DE519"> </a></td><td>Other support services</td><td><div><p>Offer or refer for other support services</p>
</div></td></tr><tr><td style="white-space:nowrap">DE520<a name="HIV.D-DE520"> </a></td><td>Mental health services</td><td><div><p>Offer or refer for mental health services</p>
</div></td></tr><tr><td style="white-space:nowrap">DE521<a name="HIV.D-DE521"> </a></td><td>Psychosocial counselling, support and treatment adherence counselling</td><td><div><p>Offer or refer for psychosocial counselling, support and treatment adherence counselling</p>
</div></td></tr><tr><td style="white-space:nowrap">DE522<a name="HIV.D-DE522"> </a></td><td>Legal and social services</td><td><div><p>Offer or refer for legal and social services</p>
</div></td></tr><tr><td style="white-space:nowrap">DE523<a name="HIV.D-DE523"> </a></td><td>Services for responding to violence against women</td><td><div><p>Offer or refer for services for responding to violence against women, including first-line support and psychosocial support, post-rape care and other support services including shelters, legal services and women and child protection services</p>
</div></td></tr><tr><td style="white-space:nowrap">DE524<a name="HIV.D-DE524"> </a></td><td>Date/time of follow-up appointment</td><td><div><p>Date the client is to return for monitoring, re-supply or any other reason</p>
</div></td></tr><tr><td style="white-space:nowrap">DE525<a name="HIV.D-DE525"> </a></td><td>Type of follow-up appointment</td><td><div><p>Whether the visit will be clinical only, ARV drug pick-up or other. Client may have multiple follow-ups scheduled.</p>
</div></td></tr><tr><td style="white-space:nowrap">DE526<a name="HIV.D-DE526"> </a></td><td>Clinical visit</td><td><div><p>Appointment for clinical care by a provider</p>
</div></td></tr><tr><td style="white-space:nowrap">DE527<a name="HIV.D-DE527"> </a></td><td>Antiretroviral drug pick up</td><td><div><p>Appointment for a drug pick up</p>
</div></td></tr><tr><td style="white-space:nowrap">DE528<a name="HIV.D-DE528"> </a></td><td>Post-treatment follow-up visit for cervical precancer lesions or invasive cervical cancer</td><td><div><p>Appointment for a post-treatment follow-up visit for cervical precancer lesions or invasive cervical cancer</p>
</div></td></tr><tr><td style="white-space:nowrap">DE529<a name="HIV.D-DE529"> </a></td><td>Other</td><td><div><p>Other reason for the follow-up appointment</p>
</div></td></tr><tr><td style="white-space:nowrap">DE530<a name="HIV.D-DE530"> </a></td><td>Other (specify)</td><td><div><p>Other reason for the follow-up appointment (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE531<a name="HIV.D-DE531"> </a></td><td>Follow-up test recommended date</td><td><div><p>A test or screening recommended for the client's care plan at a future date</p>
</div></td></tr><tr><td style="white-space:nowrap">DE532<a name="HIV.D-DE532"> </a></td><td>Reason blood pressure reading not done</td><td><div><p>Reason why test was not performed</p>
</div></td></tr><tr><td style="white-space:nowrap">DE533<a name="HIV.D-DE533"> </a></td><td>BP cuff (sphygmomanometer) not available</td><td><div><p>Blood pressure cuff is not available</p>
</div></td></tr><tr><td style="white-space:nowrap">DE534<a name="HIV.D-DE534"> </a></td><td>BP cuff (sphygmomanometer) is broken</td><td><div><p>Blood pressure cuff is broken</p>
</div></td></tr><tr><td style="white-space:nowrap">DE535<a name="HIV.D-DE535"> </a></td><td>Other</td><td><div><p>Other reason blood pressure can not be taken</p>
</div></td></tr><tr><td style="white-space:nowrap">DE536<a name="HIV.D-DE536"> </a></td><td>Other (specify)</td><td><div><p>Other reason blood pressure can not be taken (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE537<a name="HIV.D-DE537"> </a></td><td>Current medications</td><td><div><p>List of all of the medications the client is currently taking</p>
</div></td></tr><tr><td style="white-space:nowrap">DE538<a name="HIV.D-DE538"> </a></td><td>No medications</td><td><div><p>The client is currently not on any medications</p>
</div></td></tr><tr><td style="white-space:nowrap">DE539<a name="HIV.D-DE539"> </a></td><td>Don't know of any current medications</td><td><div><p>The client does not know if she is on any medications</p>
</div></td></tr><tr><td style="white-space:nowrap">DE540<a name="HIV.D-DE540"> </a></td><td>Analgesic</td><td><div><p>Analgesic medication (painkiller)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE541<a name="HIV.D-DE541"> </a></td><td>Antacids</td><td><div><p>Antacids</p>
</div></td></tr><tr><td style="white-space:nowrap">DE542<a name="HIV.D-DE542"> </a></td><td>Antibiotics (broad-spectrum)</td><td><div><p>Client is currently taking broad-spectrum antibiotics</p>
</div></td></tr><tr><td style="white-space:nowrap">DE543<a name="HIV.D-DE543"> </a></td><td>Anticonvulsive</td><td><div><p>Anticonvulsive medication</p>
</div></td></tr><tr><td style="white-space:nowrap">DE544<a name="HIV.D-DE544"> </a></td><td>Antidiabetic</td><td><div><p>Antidiabetic medication</p>
</div></td></tr><tr><td style="white-space:nowrap">DE545<a name="HIV.D-DE545"> </a></td><td>Antifungals</td><td><div><p>Client is currently taking antifungals</p>
</div></td></tr><tr><td style="white-space:nowrap">DE546<a name="HIV.D-DE546"> </a></td><td>Antihelmintic</td><td><div><p>Antihelmintic or antiparasitic medication</p>
</div></td></tr><tr><td style="white-space:nowrap">DE547<a name="HIV.D-DE547"> </a></td><td>Antihypertensive</td><td><div><p>Antihypertensive medication</p>
</div></td></tr><tr><td style="white-space:nowrap">DE548<a name="HIV.D-DE548"> </a></td><td>Antimalarials</td><td><div><p>Antimalarial medication</p>
</div></td></tr><tr><td style="white-space:nowrap">DE549<a name="HIV.D-DE549"> </a></td><td>Antiretrovirals (ARVs)</td><td><div><p>Antiretrovirals (ARVs)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE550<a name="HIV.D-DE550"> </a></td><td>Antiparasitics</td><td><div><p>Client is currently taking antiparasitics</p>
</div></td></tr><tr><td style="white-space:nowrap">DE551<a name="HIV.D-DE551"> </a></td><td>Antivirals</td><td><div><p>Antiviral medication</p>
</div></td></tr><tr><td style="white-space:nowrap">DE552<a name="HIV.D-DE552"> </a></td><td>Buprenorphine</td><td><div><p>Opioid substitution to treat opioid dependence</p>
</div></td></tr><tr><td style="white-space:nowrap">DE553<a name="HIV.D-DE553"> </a></td><td>Co-trimoxazole preventive therapy (CPT)</td><td><div><p>Combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections</p>
</div></td></tr><tr><td style="white-space:nowrap">DE554<a name="HIV.D-DE554"> </a></td><td>Hormonal family planning method</td><td><div><p>Hormonal family planning method</p>
</div></td></tr><tr><td style="white-space:nowrap">DE555<a name="HIV.D-DE555"> </a></td><td>Methadone</td><td><div><p>Opioid substitution to treat opioid dependence</p>
</div></td></tr><tr><td style="white-space:nowrap">DE556<a name="HIV.D-DE556"> </a></td><td>PrEP to prevent HIV</td><td><div><p>Pre-exposure prophylaxis (PrEP) medication for preventing the acquisition of HIV</p>
</div></td></tr><tr><td style="white-space:nowrap">DE557<a name="HIV.D-DE557"> </a></td><td>Other antibiotics</td><td><div><p>Other antibiotics not listed above</p>
</div></td></tr><tr><td style="white-space:nowrap">DE558<a name="HIV.D-DE558"> </a></td><td>Other medications</td><td><div><p>Other medications or supplements that are not listed above</p>
</div></td></tr><tr><td style="white-space:nowrap">DE559<a name="HIV.D-DE559"> </a></td><td>Other medications (specify)</td><td><div><p>Other medications or supplements that are not listed above (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE560<a name="HIV.D-DE560"> </a></td><td>Allergies</td><td><div><p>Does the client have any allergies?</p>
</div></td></tr><tr><td style="white-space:nowrap">DE561<a name="HIV.D-DE561"> </a></td><td>No known allergies</td><td><div><p>Client does not have any known allergies</p>
</div></td></tr><tr><td style="white-space:nowrap">DE562<a name="HIV.D-DE562"> </a></td><td>Don't know of any allergies</td><td><div><p>Client does not know whether or not she has allergies</p>
</div></td></tr><tr><td style="white-space:nowrap">DE563<a name="HIV.D-DE563"> </a></td><td>Albendazole</td><td><div><p>Allergy to albendazole</p>
</div></td></tr><tr><td style="white-space:nowrap">DE564<a name="HIV.D-DE564"> </a></td><td>Malaria medication (sulfadoxine-pyrimethamine)</td><td><div><p>Allergy to malaria medication (sulfadoxine-pyrimethamine)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE565<a name="HIV.D-DE565"> </a></td><td>Penicillin</td><td><div><p>Allergy to penicillin</p>
</div></td></tr><tr><td style="white-space:nowrap">DE566<a name="HIV.D-DE566"> </a></td><td>Tenofovir disoproxil fumarate (TDF)</td><td><div><p>Allergy to pre-exposure prophylaxis (PrEP) tenofovir disoproxil fumarate (TDF)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE567<a name="HIV.D-DE567"> </a></td><td>Other allergies</td><td><div><p>Client has other allergies not listed here</p>
</div></td></tr><tr><td style="white-space:nowrap">DE568<a name="HIV.D-DE568"> </a></td><td>Other allergies (specify)</td><td><div><p>Client has other allergies not listed here (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE569<a name="HIV.D-DE569"> </a></td><td>Family planning method used</td><td><div><p>Method the client reports currently using at intake</p>
</div></td></tr><tr><td style="white-space:nowrap">DE570<a name="HIV.D-DE570"> </a></td><td>Copper-bearing intrauterine device (Cu-IUD)</td><td><div><p>A copper-bearing intrauterine device is being used as a family planning method</p>
</div></td></tr><tr><td style="white-space:nowrap">DE571<a name="HIV.D-DE571"> </a></td><td>Levonorgestrel intrauterine device (LNG-IUD)</td><td><div><p>A levonorgestrel intrauterine device (hormone-releasing intrauterine contraceptive device) is being used as a family planning method</p>
</div></td></tr><tr><td style="white-space:nowrap">DE572<a name="HIV.D-DE572"> </a></td><td>Etonogestrel (ETG) one-rod implant</td><td><div><p>An etonogestrel one-rod implant is being used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE573<a name="HIV.D-DE573"> </a></td><td>Levonorgestrel (LNG) two-rod implant</td><td><div><p>A levonorgestrel two-rod implant is being used as a family planning method</p>
</div></td></tr><tr><td style="white-space:nowrap">DE574<a name="HIV.D-DE574"> </a></td><td>DMPA-IM</td><td><div><p>Injectable depot medroxyprogesterone acetate (DMPA), administered intramuscularly, is being used as a family planning method</p>
</div></td></tr><tr><td style="white-space:nowrap">DE575<a name="HIV.D-DE575"> </a></td><td>DMPA-SC</td><td><div><p>Injectable depot medroxyprogesterone acetate (DMPA), administered subcutaneously is being used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE576<a name="HIV.D-DE576"> </a></td><td>NET-EN norethisterone enanthate</td><td><div><p>Injectable norethisterone enanthate (NET-EN) is being used as a family planning method</p>
</div></td></tr><tr><td style="white-space:nowrap">DE577<a name="HIV.D-DE577"> </a></td><td>Progestogen-only pills (POP)</td><td><div><p>Progestogen-only pills (POP) are being used as a family planning method</p>
</div></td></tr><tr><td style="white-space:nowrap">DE578<a name="HIV.D-DE578"> </a></td><td>Combined oral contraceptives (COCs)</td><td><div><p>Combined oral contraceptives (COCs) pills are being used as a family planning method</p>
</div></td></tr><tr><td style="white-space:nowrap">DE579<a name="HIV.D-DE579"> </a></td><td>Combined contraceptive patch</td><td><div><p>Transdermal combined contraceptive patch is being used as a family planning method</p>
</div></td></tr><tr><td style="white-space:nowrap">DE580<a name="HIV.D-DE580"> </a></td><td>Combined contraceptive vaginal ring (CVR)</td><td><div><p>Combined contraceptive vaginal ring (CVR) is being used as a family planning method</p>
</div></td></tr><tr><td style="white-space:nowrap">DE581<a name="HIV.D-DE581"> </a></td><td>Progesterone-releasing vaginal ring (PVR)</td><td><div><p>Progesterone-releasing vaginal ring (PVR) is being used as a family planning method</p>
</div></td></tr><tr><td style="white-space:nowrap">DE582<a name="HIV.D-DE582"> </a></td><td>Lactational amenorrhea method (LAM)</td><td><div><p>Lactational amenorrhea method (LAM) is being used as a family planning method</p>
</div></td></tr><tr><td style="white-space:nowrap">DE583<a name="HIV.D-DE583"> </a></td><td>Emergency contraceptive pills (ECPs)</td><td><div><p>Client uses emergency contraceptive pills (ECPs)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE584<a name="HIV.D-DE584"> </a></td><td>Fertility awareness-based methods (FAB)</td><td><div><p>Client uses fertility awareness-based methods (FAB)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE585<a name="HIV.D-DE585"> </a></td><td>Male condoms</td><td><div><p>Male condoms are being used as a family planning method</p>
</div></td></tr><tr><td style="white-space:nowrap">DE586<a name="HIV.D-DE586"> </a></td><td>Female condoms</td><td><div><p>Female condoms are being used as a family planning method</p>
</div></td></tr><tr><td style="white-space:nowrap">DE587<a name="HIV.D-DE587"> </a></td><td>Withdrawal</td><td><div><p>Client uses withdrawal method</p>
</div></td></tr><tr><td style="white-space:nowrap">DE588<a name="HIV.D-DE588"> </a></td><td>Female relying on male method</td><td><div><p>The female client is relying on her male partner for contraceptive methods (e.g. male condoms, male sterilization, withdrawal)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE589<a name="HIV.D-DE589"> </a></td><td>Male relying on female method</td><td><div><p>The male client is relying on his female partner for contraceptive methods</p>
</div></td></tr><tr><td style="white-space:nowrap">DE590<a name="HIV.D-DE590"> </a></td><td>Male sterilization</td><td><div><p>Male surgical sterilization (a vasectomy) is the family planning method used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE591<a name="HIV.D-DE591"> </a></td><td>Female sterilization</td><td><div><p>Female surgical sterilization procedure is the family planning method used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE592<a name="HIV.D-DE592"> </a></td><td>No method</td><td><div><p>Client is not using any family planning methods</p>
</div></td></tr><tr><td style="white-space:nowrap">DE593<a name="HIV.D-DE593"> </a></td><td>Medication status</td><td><div><p>Current state of the client's taking of the medication</p>
</div></td></tr><tr><td style="white-space:nowrap">DE594<a name="HIV.D-DE594"> </a></td><td>Currently taking</td><td><div><p>The medication is still being taken (active)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE595<a name="HIV.D-DE595"> </a></td><td>Completed</td><td><div><p>The medication is no longer being taken</p>
</div></td></tr><tr><td style="white-space:nowrap">DE596<a name="HIV.D-DE596"> </a></td><td>Entered in error</td><td><div><p>Entered in error</p>
</div></td></tr><tr><td style="white-space:nowrap">DE597<a name="HIV.D-DE597"> </a></td><td>Intended</td><td><div><p>The medication may be taken at some time in the future</p>
</div></td></tr><tr><td style="white-space:nowrap">DE598<a name="HIV.D-DE598"> </a></td><td>Stopped</td><td><div><p>Actions implied by the statement have been permanently halted, before all of them occurred. This should not be used if the statement was entered in error.</p>
</div></td></tr><tr><td style="white-space:nowrap">DE599<a name="HIV.D-DE599"> </a></td><td>On hold</td><td><div><p>The client has temporarily stopped taking the medication, but is expected to continue again later. May also be called &quot;suspended&quot;.</p>
</div></td></tr><tr><td style="white-space:nowrap">DE600<a name="HIV.D-DE600"> </a></td><td>Unknown</td><td><div><p>The state of the medication use is not currently known</p>
</div></td></tr><tr><td style="white-space:nowrap">DE601<a name="HIV.D-DE601"> </a></td><td>Did not take</td><td><div><p>The client did not take the medication</p>
</div></td></tr><tr><td style="white-space:nowrap">DE602<a name="HIV.D-DE602"> </a></td><td>Hepatitis B negative counselling conducted</td><td><div><p>Hepatitis B negative counselling conducted</p>
</div></td></tr><tr><td style="white-space:nowrap">DE603<a name="HIV.D-DE603"> </a></td><td>Vaccine brand</td><td><div><p>The brand or trade name used to refer to the vaccine received</p>
</div></td></tr><tr><td style="white-space:nowrap">DE604<a name="HIV.D-DE604"> </a></td><td>Vaccine type</td><td><div><p>Type of vaccine received (such as IPV, OPV)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE605<a name="HIV.D-DE605"> </a></td><td>Date and time of vaccination</td><td><div><p>Represents the visit/encounter date, which is the date and time when the vaccine was administered to the client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE606<a name="HIV.D-DE606"> </a></td><td>Vaccination location</td><td><div><p>The service delivery location where the vaccine adminstration occurred</p>
</div></td></tr><tr><td style="white-space:nowrap">DE607<a name="HIV.D-DE607"> </a></td><td>Dose number</td><td><div><p>Vaccine dose number within series</p>
</div></td></tr><tr><td style="white-space:nowrap">DE608<a name="HIV.D-DE608"> </a></td><td>Dose quantity</td><td><div><p>The quantity of vaccine product that was administered</p>
</div></td></tr><tr><td style="white-space:nowrap">DE609<a name="HIV.D-DE609"> </a></td><td>Total doses in series</td><td><div><p>The recommended number of vaccine doses for immunity according to national protocol</p>
</div></td></tr><tr><td style="white-space:nowrap">DE610<a name="HIV.D-DE610"> </a></td><td>Disease targeted</td><td><div><p>Vaccine preventable disease being targeted by vaccine administered</p>
</div></td></tr><tr><td style="white-space:nowrap">DE611<a name="HIV.D-DE611"> </a></td><td>Hepatitis A</td><td><div><p>The client is receiving vaccination to prevent against hepatitis A</p>
</div></td></tr><tr><td style="white-space:nowrap">DE612<a name="HIV.D-DE612"> </a></td><td>Hepatitis B</td><td><div><p>The client is receiving vaccination to prevent against hepatitis B</p>
</div></td></tr><tr><td style="white-space:nowrap">DE613<a name="HIV.D-DE613"> </a></td><td>Tetanus</td><td><div><p>The client is receiving vaccination to prevent against tetanus</p>
</div></td></tr><tr><td style="white-space:nowrap">DE614<a name="HIV.D-DE614"> </a></td><td>COVID-19</td><td><div><p>The client is receiving vaccination to prevent against COVID-19 due to SARS-CoV-2</p>
</div></td></tr><tr><td style="white-space:nowrap">DE615<a name="HIV.D-DE615"> </a></td><td>Influenza due to influenza B virus</td><td><div><p>The client is receiving vaccination to prevent against influenza due to influenza B virus</p>
</div></td></tr><tr><td style="white-space:nowrap">DE616<a name="HIV.D-DE616"> </a></td><td>Tuberculosis</td><td><div><p>The client is receiving vaccination to prevent against tuberculosis (e.g. BCG vaccine)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE617<a name="HIV.D-DE617"> </a></td><td>Acute poliomyelitis</td><td><div><p>The client is receiving vaccination to prevent against acute poliomyelitis (polio)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE618<a name="HIV.D-DE618"> </a></td><td>Measles</td><td><div><p>The client is receiving vaccination to prevent against measles</p>
</div></td></tr><tr><td style="white-space:nowrap">DE619<a name="HIV.D-DE619"> </a></td><td>Diptheria</td><td><div><p>The client is receiving vaccination to prevent against diptheria</p>
</div></td></tr><tr><td style="white-space:nowrap">DE620<a name="HIV.D-DE620"> </a></td><td>Rabies</td><td><div><p>The client is receiving vaccination to prevent against rabies</p>
</div></td></tr><tr><td style="white-space:nowrap">DE621<a name="HIV.D-DE621"> </a></td><td>Cholera</td><td><div><p>The client is receiving vaccination to prevent against cholera</p>
</div></td></tr><tr><td style="white-space:nowrap">DE622<a name="HIV.D-DE622"> </a></td><td>Mumps</td><td><div><p>The client is receiving vaccination to prevent against mumps</p>
</div></td></tr><tr><td style="white-space:nowrap">DE623<a name="HIV.D-DE623"> </a></td><td>HPV infection</td><td><div><p>The client is receiving vaccination to prevent against human papilloma virus (HPV) infection</p>
</div></td></tr><tr><td style="white-space:nowrap">DE624<a name="HIV.D-DE624"> </a></td><td>Haemophilus influenzae type B</td><td><div><p>The client is receiving vaccination to prevent against Haemophilus influenzae type B (Hib)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE625<a name="HIV.D-DE625"> </a></td><td>Varicella</td><td><div><p>The client is receiving vaccination to prevent against varicella</p>
</div></td></tr><tr><td style="white-space:nowrap">DE626<a name="HIV.D-DE626"> </a></td><td>Dengue</td><td><div><p>The client is receiving vaccination to prevent against dengue</p>
</div></td></tr><tr><td style="white-space:nowrap">DE627<a name="HIV.D-DE627"> </a></td><td>Yellow fever</td><td><div><p>The client is receiving vaccination to prevent against yellow fever</p>
</div></td></tr><tr><td style="white-space:nowrap">DE628<a name="HIV.D-DE628"> </a></td><td>Japanese Encephalitis</td><td><div><p>The client is receiving vaccination to prevent against Japanese encephalitis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE629<a name="HIV.D-DE629"> </a></td><td>Rubella</td><td><div><p>The client is receiving vaccination to prevent against rubella</p>
</div></td></tr><tr><td style="white-space:nowrap">DE630<a name="HIV.D-DE630"> </a></td><td>Pertussis</td><td><div><p>The client is receiving vaccination to prevent against pertussis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE631<a name="HIV.D-DE631"> </a></td><td>Enteritis due to rotavirus</td><td><div><p>The client is receiving vaccination to prevent against enteritis due to rotavirus</p>
</div></td></tr><tr><td style="white-space:nowrap">DE632<a name="HIV.D-DE632"> </a></td><td>Pneumococcal disease</td><td><div><p>The client is receiving vaccination to prevent against pneumococcal disease</p>
</div></td></tr><tr><td style="white-space:nowrap">DE633<a name="HIV.D-DE633"> </a></td><td>Meningococcal disease</td><td><div><p>The client is receiving vaccination to prevent against meningococcal disease</p>
</div></td></tr><tr><td style="white-space:nowrap">DE634<a name="HIV.D-DE634"> </a></td><td>Tick-borne encephalitis</td><td><div><p>The client is receiving vaccination to prevent against tick-borne encephalitis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE635<a name="HIV.D-DE635"> </a></td><td>Typhoid</td><td><div><p>The client is receiving vaccination to prevent against typhoid</p>
</div></td></tr><tr><td style="white-space:nowrap">DE636<a name="HIV.D-DE636"> </a></td><td>Reason immunization was not provided</td><td><div><p>Reason the vaccine dose was not given</p>
</div></td></tr><tr><td style="white-space:nowrap">DE637<a name="HIV.D-DE637"> </a></td><td>Stock-out</td><td><div><p>Stock-out of vaccine</p>
</div></td></tr><tr><td style="white-space:nowrap">DE638<a name="HIV.D-DE638"> </a></td><td>Client is ill</td><td><div><p>Client is ill</p>
</div></td></tr><tr><td style="white-space:nowrap">DE639<a name="HIV.D-DE639"> </a></td><td>Client refused</td><td><div><p>Client refused vaccine</p>
</div></td></tr><tr><td style="white-space:nowrap">DE640<a name="HIV.D-DE640"> </a></td><td>Allergy to vaccine</td><td><div><p>Client has an allergy to the vaccine</p>
</div></td></tr><tr><td style="white-space:nowrap">DE641<a name="HIV.D-DE641"> </a></td><td>Other reason immunization not provided</td><td><div><p>Other reason why the immunization was not provided</p>
</div></td></tr><tr><td style="white-space:nowrap">DE642<a name="HIV.D-DE642"> </a></td><td>Other reason immunization not provided (specify)</td><td><div><p>Other reason why the immunization was not provided (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE643<a name="HIV.D-DE643"> </a></td><td>Malaria prophylaxis</td><td><div><p>Whether malaria prophylaxis was given</p>
</div></td></tr><tr><td style="white-space:nowrap">DE644<a name="HIV.D-DE644"> </a></td><td>IPTp-SP dose number provided</td><td><div><p>IPTp-SP dose number that was provided</p>
</div></td></tr><tr><td style="white-space:nowrap">DE645<a name="HIV.D-DE645"> </a></td><td>Date IPTp-SP dose provided</td><td><div><p>Date on which the IPTp-SP dose was provided</p>
</div></td></tr><tr><td style="white-space:nowrap">DE646<a name="HIV.D-DE646"> </a></td><td>Reason malaria prophylaxis not provided</td><td><div><p>Reason why the treatment was not given</p>
</div></td></tr><tr><td style="white-space:nowrap">DE647<a name="HIV.D-DE647"> </a></td><td>Client was referred</td><td><div><p>Client was referred to another provider/facility</p>
</div></td></tr><tr><td style="white-space:nowrap">DE648<a name="HIV.D-DE648"> </a></td><td>Stock out</td><td><div><p>There was a stock out of malaria prophylaxis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE649<a name="HIV.D-DE649"> </a></td><td>Expired</td><td><div><p>Malaria prophylaxis in stock was expired</p>
</div></td></tr><tr><td style="white-space:nowrap">DE650<a name="HIV.D-DE650"> </a></td><td>Other reason not provided</td><td><div><p>Other reason why the prophylaxis was not provided</p>
</div></td></tr><tr><td style="white-space:nowrap">DE651<a name="HIV.D-DE651"> </a></td><td>Other reason not provided (specify)</td><td><div><p>Other reason why the prophylaxis was not provided</p>
</div></td></tr><tr><td style="white-space:nowrap">DE652<a name="HIV.D-DE652"> </a></td><td>&gt;28 days since last missed appointment</td><td><div><p>More than 28 days have passed since client's last missed appointment</p>
</div></td></tr><tr><td style="white-space:nowrap">DE653<a name="HIV.D-DE653"> </a></td><td>AIDS-related death</td><td><div><p>Death of client was AIDS-related</p>
</div></td></tr><tr><td style="white-space:nowrap">DE654<a name="HIV.D-DE654"> </a></td><td>Date of first AIDS diagnosis</td><td><div><p>Date of client's first AIDS diagnosis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE655<a name="HIV.D-DE655"> </a></td><td>Age at final HPV vaccination dose received</td><td><div><p>Client's age at date received final HPV vaccination dose</p>
</div></td></tr><tr><td style="white-space:nowrap">DE656<a name="HIV.D-DE656"> </a></td><td>Date of cervical cancer screening test</td><td><div><p>Date of cervical cancer screening test</p>
</div></td></tr><tr><td style="white-space:nowrap">DE657<a name="HIV.D-DE657"> </a></td><td>Lifetime screening test number</td><td><div><p>Client's lifetime number of screenings for cervical cancer</p>
</div></td></tr><tr><td style="white-space:nowrap">DE658<a name="HIV.D-DE658"> </a></td><td>Cervical cancer primary screening test type</td><td><div><p>Type of cervical cancer screening test used in primary screening</p>
</div></td></tr><tr><td style="white-space:nowrap">DE659<a name="HIV.D-DE659"> </a></td><td>HPV-DNA</td><td><div><p>Screened for cervical cancer using HPV-DNA test</p>
</div></td></tr><tr><td style="white-space:nowrap">DE660<a name="HIV.D-DE660"> </a></td><td>VIA</td><td><div><p>Screened for cervical cancer using visual inspection with acetic acid (VIA)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE661<a name="HIV.D-DE661"> </a></td><td>Cervical cytology</td><td><div><p>Screened for cervical cancer using cervical cytology</p>
</div></td></tr><tr><td style="white-space:nowrap">DE662<a name="HIV.D-DE662"> </a></td><td>Other</td><td><div><p>Screened for cervical cancer using other method</p>
</div></td></tr><tr><td style="white-space:nowrap">DE663<a name="HIV.D-DE663"> </a></td><td>Other (specify)</td><td><div><p>Screened for cervical cancer using other method (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE664<a name="HIV.D-DE664"> </a></td><td>HPV-DNA cervical cancer screening test result</td><td><div><p>HPV-DNA cervical cancer screening test result</p>
</div></td></tr><tr><td style="white-space:nowrap">DE665<a name="HIV.D-DE665"> </a></td><td>Negative</td><td><div><p>HPV-DNA screening test was negative</p>
</div></td></tr><tr><td style="white-space:nowrap">DE666<a name="HIV.D-DE666"> </a></td><td>Positive</td><td><div><p>HPV-DNA screening test was positive</p>
</div></td></tr><tr><td style="white-space:nowrap">DE667<a name="HIV.D-DE667"> </a></td><td>Invalid</td><td><div><p>HPV-DNA screening test was invalid</p>
</div></td></tr><tr><td style="white-space:nowrap">DE668<a name="HIV.D-DE668"> </a></td><td>VIA cervical cancer screening test result</td><td><div><p>Screening test result for VIA</p>
</div></td></tr><tr><td style="white-space:nowrap">DE669<a name="HIV.D-DE669"> </a></td><td>Negative</td><td><div><p>Screening result is negative</p>
</div></td></tr><tr><td style="white-space:nowrap">DE670<a name="HIV.D-DE670"> </a></td><td>Positive</td><td><div><p>Screening result is positive</p>
</div></td></tr><tr><td style="white-space:nowrap">DE671<a name="HIV.D-DE671"> </a></td><td>Suspected cancer</td><td><div><p>Screening result is suspected cancer</p>
</div></td></tr><tr><td style="white-space:nowrap">DE672<a name="HIV.D-DE672"> </a></td><td>Invalid</td><td><div><p>Screening result is invalid</p>
</div></td></tr><tr><td style="white-space:nowrap">DE673<a name="HIV.D-DE673"> </a></td><td>Cervical cytology screening test result</td><td><div><p>Screening result for cervical cytology</p>
</div></td></tr><tr><td style="white-space:nowrap">DE674<a name="HIV.D-DE674"> </a></td><td>NILM</td><td><div><p>Negative for Intraepithelial Lesion Malignancy (NILM)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE675<a name="HIV.D-DE675"> </a></td><td>ASCUS</td><td><div><p>Atypical squamous cells of undetermined significance (ASCUS)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE676<a name="HIV.D-DE676"> </a></td><td>LSIL</td><td><div><p>Low grade squamous intraepithelial lesion (LSIL)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE677<a name="HIV.D-DE677"> </a></td><td>HSIL</td><td><div><p>High grade squamous intraepithelial lesion (HSIL)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE678<a name="HIV.D-DE678"> </a></td><td>Cancer</td><td><div><p>Result was positive for cancer</p>
</div></td></tr><tr><td style="white-space:nowrap">DE679<a name="HIV.D-DE679"> </a></td><td>Invalid/inadequate</td><td><div><p>Screening result was invalid or inadequate</p>
</div></td></tr><tr><td style="white-space:nowrap">DE680<a name="HIV.D-DE680"> </a></td><td>Cervical cancer triage test date</td><td><div><p>Date of triage test for cervical cancer</p>
</div></td></tr><tr><td style="white-space:nowrap">DE681<a name="HIV.D-DE681"> </a></td><td>Cervical cancer triage test type</td><td><div><p>Type of triage test for cervical cancer</p>
</div></td></tr><tr><td style="white-space:nowrap">DE682<a name="HIV.D-DE682"> </a></td><td>VIA</td><td><div><p>Triage test for cervical cancer using visual inspection with acetic acid (VIA)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE683<a name="HIV.D-DE683"> </a></td><td>Colposcopy</td><td><div><p>Triage test for cervical cancer using colposcopy</p>
</div></td></tr><tr><td style="white-space:nowrap">DE684<a name="HIV.D-DE684"> </a></td><td>Cervical cytology</td><td><div><p>Triage test for cervical cancer using cervical cytology</p>
</div></td></tr><tr><td style="white-space:nowrap">DE685<a name="HIV.D-DE685"> </a></td><td>HPV16/18</td><td><div><p>Triage test for cervical cancer using test for HPV16/18</p>
</div></td></tr><tr><td style="white-space:nowrap">DE686<a name="HIV.D-DE686"> </a></td><td>Other</td><td><div><p>Triage test for cervical cancer using another test</p>
</div></td></tr><tr><td style="white-space:nowrap">DE687<a name="HIV.D-DE687"> </a></td><td>Other (specify)</td><td><div><p>Triage test for cervical cancer using another test (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE688<a name="HIV.D-DE688"> </a></td><td>HPV16/18 test result</td><td><div><p>Test result from HPV16/18 test</p>
</div></td></tr><tr><td style="white-space:nowrap">DE689<a name="HIV.D-DE689"> </a></td><td>Positive</td><td><div><p>Test is positive for HPV16/18</p>
</div></td></tr><tr><td style="white-space:nowrap">DE690<a name="HIV.D-DE690"> </a></td><td>Negative</td><td><div><p>Test is negative for HPV16/18</p>
</div></td></tr><tr><td style="white-space:nowrap">DE691<a name="HIV.D-DE691"> </a></td><td>Cervical cancer colposcopy result</td><td><div><p>Result of cervical cancer colposcopy</p>
</div></td></tr><tr><td style="white-space:nowrap">DE692<a name="HIV.D-DE692"> </a></td><td>Normal colposcopic findings</td><td><div><p>Colposcopy has normal colposcopic findings</p>
</div></td></tr><tr><td style="white-space:nowrap">DE693<a name="HIV.D-DE693"> </a></td><td>Abnormal colposcopic findings</td><td><div><p>Colposcopy has abnormal colposcopic findings</p>
</div></td></tr><tr><td style="white-space:nowrap">DE694<a name="HIV.D-DE694"> </a></td><td>Suspicious for invasive cervical cancer</td><td><div><p>Colposcopy is suspicious for invasive cervical cancer</p>
</div></td></tr><tr><td style="white-space:nowrap">DE695<a name="HIV.D-DE695"> </a></td><td>Miscellaneous findings</td><td><div><p>Colposcopy has miscellaneous findings</p>
</div></td></tr><tr><td style="white-space:nowrap">DE696<a name="HIV.D-DE696"> </a></td><td>Inadequate</td><td><div><p>Colposcopy exam is inadequate</p>
</div></td></tr><tr><td style="white-space:nowrap">DE697<a name="HIV.D-DE697"> </a></td><td>Cervical cancer histopathology result</td><td><div><p>Result of cervical cancer histopathology</p>
</div></td></tr><tr><td style="white-space:nowrap">DE698<a name="HIV.D-DE698"> </a></td><td>Normal</td><td><div><p>Result of cervical cancer histopathology was normal</p>
</div></td></tr><tr><td style="white-space:nowrap">DE699<a name="HIV.D-DE699"> </a></td><td>LSIL (inclusive of LSIL-CIN1)</td><td><div><p>Result of cervical cancer histopathology was low-grade squamous intraepithelial lesion (LSIL)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE700<a name="HIV.D-DE700"> </a></td><td>HSIL (inclusive of HSIL-CIN2 or HSIL-CIN3)</td><td><div><p>Result of cervical cancer histopathology was high-grade squamous intraepithelial lesion (HSIL)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE701<a name="HIV.D-DE701"> </a></td><td>Invasive cervical cancer</td><td><div><p>Result of cervical cancer histopathology is invasive cervical cancer</p>
</div></td></tr><tr><td style="white-space:nowrap">DE702<a name="HIV.D-DE702"> </a></td><td>Date of additional cervical cancer triage test</td><td><div><p>Date of tertiary cervical cancer screening test</p>
</div></td></tr><tr><td style="white-space:nowrap">DE703<a name="HIV.D-DE703"> </a></td><td>Additional cervical cancer triage test type (specify)</td><td><div><p>Additional cervical cancer triage test type (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE704<a name="HIV.D-DE704"> </a></td><td>Additional cervical cancer triage test result (specify)</td><td><div><p>Additional cervical cancer triage test result (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE705<a name="HIV.D-DE705"> </a></td><td>Date of diagnosis of cervical precancer lesions or invasive cervical cancer</td><td><div><p>Date of diagnosis of cervical precancer lesions or invasive cervical cancer</p>
</div></td></tr><tr><td style="white-space:nowrap">DE706<a name="HIV.D-DE706"> </a></td><td>Cervical cancer screening outcome</td><td><div><p>Client's screening outcome for cervical cancer</p>
</div></td></tr><tr><td style="white-space:nowrap">DE707<a name="HIV.D-DE707"> </a></td><td>Positive for cervical precancer lesions</td><td><div><p>Screening outcome for cervical precancer lesions is positive</p>
</div></td></tr><tr><td style="white-space:nowrap">DE708<a name="HIV.D-DE708"> </a></td><td>Negative for cervical precancer lesions</td><td><div><p>Screening outcome for cervical precancer lesions is negative</p>
</div></td></tr><tr><td style="white-space:nowrap">DE709<a name="HIV.D-DE709"> </a></td><td>Cervical cancer diagnosis</td><td><div><p>Type of cervical cancer diagnosis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE710<a name="HIV.D-DE710"> </a></td><td>Cervical precancer lesions</td><td><div><p>Client is diagnosed with cervical precancer lesions</p>
</div></td></tr><tr><td style="white-space:nowrap">DE711<a name="HIV.D-DE711"> </a></td><td>Invasive cervical cancer</td><td><div><p>Client is diagnosed with invasive cervical cancer disease</p>
</div></td></tr><tr><td style="white-space:nowrap">DE712<a name="HIV.D-DE712"> </a></td><td>Cervical cancer stage at diagnosis</td><td><div><p>Cervical cancer stage at diagnosis of cervical cancer</p>
</div></td></tr><tr><td style="white-space:nowrap">DE713<a name="HIV.D-DE713"> </a></td><td>Stage 0</td><td><div><p>Stage 0 cervical cancer at diagnosis of cervical cancer</p>
</div></td></tr><tr><td style="white-space:nowrap">DE714<a name="HIV.D-DE714"> </a></td><td>Stage I</td><td><div><p>Stage I cervical cancer at diagnosis of cervical cancer</p>
</div></td></tr><tr><td style="white-space:nowrap">DE715<a name="HIV.D-DE715"> </a></td><td>Stage II</td><td><div><p>Stage II cervical cancer at diagnosis of cervical cancer</p>
</div></td></tr><tr><td style="white-space:nowrap">DE716<a name="HIV.D-DE716"> </a></td><td>Stage III</td><td><div><p>Stage III cervical cancer at diagnosis of cervical cancer</p>
</div></td></tr><tr><td style="white-space:nowrap">DE717<a name="HIV.D-DE717"> </a></td><td>Stage IV</td><td><div><p>Stage IV cervical cancer at diagnosis of cervical cancer</p>
</div></td></tr><tr><td style="white-space:nowrap">DE718<a name="HIV.D-DE718"> </a></td><td>Date of treatment for cervical precancer lesions</td><td><div><p>Date of treatment for cervical precancer lesions</p>
</div></td></tr><tr><td style="white-space:nowrap">DE719<a name="HIV.D-DE719"> </a></td><td>Treatment method for cervical precancer lesions</td><td><div><p>Treatment method for cervical precancer lesions</p>
</div></td></tr><tr><td style="white-space:nowrap">DE720<a name="HIV.D-DE720"> </a></td><td>Cryotherapy</td><td><div><p>Treatment for cervical precancer lesions is cryotherapy</p>
</div></td></tr><tr><td style="white-space:nowrap">DE721<a name="HIV.D-DE721"> </a></td><td>Thermal ablation</td><td><div><p>Treatment for cervical precancer lesions is Thermal ablation</p>
</div></td></tr><tr><td style="white-space:nowrap">DE722<a name="HIV.D-DE722"> </a></td><td>Laser ablation</td><td><div><p>Treatment for cervical precancer lesions is Laser ablation</p>
</div></td></tr><tr><td style="white-space:nowrap">DE723<a name="HIV.D-DE723"> </a></td><td>CKC</td><td><div><p>Treatment for cervical precancer lesions is Cold knife conization (CKC)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE724<a name="HIV.D-DE724"> </a></td><td>Laser cone biopsy</td><td><div><p>Treatment for cervical precancer lesions is Laser cone biopsy</p>
</div></td></tr><tr><td style="white-space:nowrap">DE725<a name="HIV.D-DE725"> </a></td><td>LLETZ/LEEP</td><td><div><p>Treatment for cervical precancer lesions is large loop excision of the transformation zone (LLETZ)/loop electrosurgical excision procedure (LEEP)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE726<a name="HIV.D-DE726"> </a></td><td>Other</td><td><div><p>Treatment for cervical precancer lesions is not listed</p>
</div></td></tr><tr><td style="white-space:nowrap">DE727<a name="HIV.D-DE727"> </a></td><td>Other (specify)</td><td><div><p>Treatment for cervical precancer lesions is not listed (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE728<a name="HIV.D-DE728"> </a></td><td>Date of follow-up for treatment for cervical precancer lesions</td><td><div><p>Date of follow-up for treatment for cervical precancer lesions</p>
</div></td></tr><tr><td style="white-space:nowrap">DE729<a name="HIV.D-DE729"> </a></td><td>Date of start of invasive cancer treatment</td><td><div><p>Date of start of invasive cancer treatment</p>
</div></td></tr><tr><td style="white-space:nowrap">DE730<a name="HIV.D-DE730"> </a></td><td>Invasive cervical cancer treatment episode</td><td><div><p>Client's lifetime number of treatments for invasive cervical cancer</p>
</div></td></tr><tr><td style="white-space:nowrap">DE731<a name="HIV.D-DE731"> </a></td><td>Invasive cervical cancer treatment method</td><td><div><p>Invasive cervical cancer treatment method</p>
</div></td></tr><tr><td style="white-space:nowrap">DE732<a name="HIV.D-DE732"> </a></td><td>Conization</td><td><div><p>Invasive cervical cancer treatment method is a conization</p>
</div></td></tr><tr><td style="white-space:nowrap">DE733<a name="HIV.D-DE733"> </a></td><td>Trachelectomy</td><td><div><p>Invasive cervical cancer treatment method is a trachelectomy</p>
</div></td></tr><tr><td style="white-space:nowrap">DE734<a name="HIV.D-DE734"> </a></td><td>Hysterectomy</td><td><div><p>Invasive cervical cancer treatment method is a hysterectomy</p>
</div></td></tr><tr><td style="white-space:nowrap">DE735<a name="HIV.D-DE735"> </a></td><td>Management of invasive cervical cancer</td><td><div><p>Invasive cervical cancer treatment method is management of invasive cervical cancer</p>
</div></td></tr><tr><td style="white-space:nowrap">DE736<a name="HIV.D-DE736"> </a></td><td>Radiotherapy</td><td><div><p>Invasive cervical cancer treatment method is a radiotherapy</p>
</div></td></tr><tr><td style="white-space:nowrap">DE737<a name="HIV.D-DE737"> </a></td><td>Chemotherapy</td><td><div><p>Invasive cervical cancer treatment method is a chemotherapy</p>
</div></td></tr><tr><td style="white-space:nowrap">DE738<a name="HIV.D-DE738"> </a></td><td>Chemoradiation</td><td><div><p>Invasive cervical cancer treatment method is a chemoradiation</p>
</div></td></tr><tr><td style="white-space:nowrap">DE739<a name="HIV.D-DE739"> </a></td><td>Other</td><td><div><p>Invasive cervical cancer treatment method is a not in list</p>
</div></td></tr><tr><td style="white-space:nowrap">DE740<a name="HIV.D-DE740"> </a></td><td>Other (specify)</td><td><div><p>Invasive cervical cancer treatment method is a not in list (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE741<a name="HIV.D-DE741"> </a></td><td>Treatment outcome</td><td><div><p>Treatment outcome from cervical pre-cancerous lesion treatment or invasive cancer treatment (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE742<a name="HIV.D-DE742"> </a></td><td>Secondary/other cancers diagnosed</td><td><div><p>Secondary and other cancers that client is diagnosed with (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE743<a name="HIV.D-DE743"> </a></td><td>Cancers at other sites (HPV- and non-HPV related)</td><td><div><p>Cancers at other sites that client has (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE744<a name="HIV.D-DE744"> </a></td><td>Date of death</td><td><div><p>If deceased, the date that the client died</p>
</div></td></tr><tr><td style="white-space:nowrap">DE745<a name="HIV.D-DE745"> </a></td><td>Cervical cancer screening interval amongst WLHIV</td><td><div><p>Country-specific interval between cancer screenings amongst women living with HIV (typically 3 or 5 years)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE746<a name="HIV.D-DE746"> </a></td><td>Entry point for facility-level testing</td><td><div><p>Specific point where testing is happening at a facility</p>
</div></td></tr><tr><td style="white-space:nowrap">DE747<a name="HIV.D-DE747"> </a></td><td>Provider-initiated tested in a clinic or emergency facility</td><td><div><p>The client tested though provider-initiated HIV testing &amp; counselling, which could be at an emergency facility</p>
</div></td></tr><tr><td style="white-space:nowrap">DE748<a name="HIV.D-DE748"> </a></td><td>Antenatal care clinic</td><td><div><p>The client tested at an antenatal care clinic, including labour and delivery</p>
</div></td></tr><tr><td style="white-space:nowrap">DE749<a name="HIV.D-DE749"> </a></td><td>Voluntary counselling and testing (within a health facility setting)</td><td><div><p>The client tested through voluntary counselling and testing (within a health facility setting)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE750<a name="HIV.D-DE750"> </a></td><td>Family planning clinic</td><td><div><p>The client tested at a family planning clinic</p>
</div></td></tr><tr><td style="white-space:nowrap">DE751<a name="HIV.D-DE751"> </a></td><td>Other facility-level testing</td><td><div><p>The client tested at another type of facility</p>
</div></td></tr><tr><td style="white-space:nowrap">DE752<a name="HIV.D-DE752"> </a></td><td>Tuberculosis (TB) clinic</td><td><div><p>The client tested at a TB clinic</p>
</div></td></tr><tr><td style="white-space:nowrap">DE753<a name="HIV.D-DE753"> </a></td><td>Offer other clinical services</td><td><div><p>Other clinical services offered or referrals given to the client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE754<a name="HIV.D-DE754"> </a></td><td>Assessment and provision of vaccinations</td><td><div><p>Assessment and provision of vaccinations, such as for people from Key population member type, pregnant women and infants; and, where appropriate, tetanus vaccination for adolescent boys and men receiving VMMC</p>
</div></td></tr><tr><td style="white-space:nowrap">DE755<a name="HIV.D-DE755"> </a></td><td>Hepatitis B (HBV) and hepatitis C virus (HCV) testing and treatment</td><td><div><p>Offer or refer for HBV and/or HCV testing and treatment</p>
</div></td></tr><tr><td style="white-space:nowrap">DE756<a name="HIV.D-DE756"> </a></td><td>Co-trimoxazole chemoprophylaxis to prevent pneumocystis carinii pneumonia</td><td><div><p>Offer or refer for co-trimoxazole chemoprophylaxis to prevent pneumocystis carinii pneumonia</p>
</div></td></tr><tr><td style="white-space:nowrap">DE757<a name="HIV.D-DE757"> </a></td><td>Intensified TB case finding and linkage to TB treatment</td><td><div><p>Offer or refer for intensified TB case finding and linkage to TB treatment</p>
</div></td></tr><tr><td style="white-space:nowrap">DE758<a name="HIV.D-DE758"> </a></td><td>Provision of isoniazid preventive therapy if person does not have TB</td><td><div><p>Offer or refer for provision of isoniazid preventive therapy if person does not have TB</p>
</div></td></tr><tr><td style="white-space:nowrap">DE759<a name="HIV.D-DE759"> </a></td><td>Malaria prevention (such as bed nets and prophylaxis), depending on epidemiology</td><td><div><p>Offer or refer for malaria prevention (such as bed nets and prophylaxis), depending on epidemiology</p>
</div></td></tr><tr><td style="white-space:nowrap">DE760<a name="HIV.D-DE760"> </a></td><td>Eligible for DSD ART</td><td><div><p>Client is eligible for differentiated service delivery (DSD) for ART</p>
</div></td></tr><tr><td style="white-space:nowrap">DE761<a name="HIV.D-DE761"> </a></td><td>Date DSD ART eligibility assessed</td><td><div><p>Date client was assessed for eligibility for differentiated service delivery (DSD) for ART</p>
</div></td></tr><tr><td style="white-space:nowrap">DE762<a name="HIV.D-DE762"> </a></td><td>Currently enrolled in DSD ART model</td><td><div><p>Client currently enrolled in differentiated service delivery (DSD) ART model</p>
</div></td></tr><tr><td style="white-space:nowrap">DE763<a name="HIV.D-DE763"> </a></td><td>DSD ART start date</td><td><div><p>Date client started on differentiated service delivery (DSD) for ART</p>
</div></td></tr><tr><td style="white-space:nowrap">DE764<a name="HIV.D-DE764"> </a></td><td>DSD ART model(s)</td><td><div><p>Type of DSD ART model client is enrolled in (country-specific)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE765<a name="HIV.D-DE765"> </a></td><td>Fast track ART refill</td><td><div><p>Client is enrolled in fast track ART refill (DSD ART model)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE766<a name="HIV.D-DE766"> </a></td><td>Facility adherence club</td><td><div><p>Client is enrolled in facility adherence club (DSD ART model)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE767<a name="HIV.D-DE767"> </a></td><td>Community ART distribution point</td><td><div><p>Client is enrolled in community ART distribution point (DSD ART model)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE768<a name="HIV.D-DE768"> </a></td><td>CHW/peer educator community ART group</td><td><div><p>Client is enrolled in community health worker/peer educator community ART group (DSD ART model)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE769<a name="HIV.D-DE769"> </a></td><td>Patient/client community ART group</td><td><div><p>Client is enrolled in patient/client community ART group (DSD ART model)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE770<a name="HIV.D-DE770"> </a></td><td>Other DSD ART model</td><td><div><p>Client is enrolled in another DSD ART model</p>
</div></td></tr><tr><td style="white-space:nowrap">DE771<a name="HIV.D-DE771"> </a></td><td>Other DSD ART model (specify)</td><td><div><p>Client is enrolled in another DSD ART model (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE772<a name="HIV.D-DE772"> </a></td><td>Partner testing offered</td><td><div><p>Whether client was offered partner testing</p>
</div></td></tr><tr><td style="white-space:nowrap">DE773<a name="HIV.D-DE773"> </a></td><td>Partner testing accepted</td><td><div><p>Whether partner testing was accepted</p>
</div></td></tr><tr><td style="white-space:nowrap">DE774<a name="HIV.D-DE774"> </a></td><td>Date partner contacted for index testing</td><td><div><p>Date on which client's partner was contacted for index testing</p>
</div></td></tr><tr><td style="white-space:nowrap">DE775<a name="HIV.D-DE775"> </a></td><td>Date partner tested for HIV</td><td><div><p>Date on which client's partner was tested for HIV</p>
</div></td></tr><tr><td style="white-space:nowrap">DE776<a name="HIV.D-DE776"> </a></td><td>Date of next scheduled follow-up appointment</td><td><div><p>Date of client's next scheduled follow-up appointment</p>
</div></td></tr><tr><td style="white-space:nowrap">DE777<a name="HIV.D-DE777"> </a></td><td>Type of next follow-up appointment</td><td><div><p>Type of client's next follow-up appointment (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE778<a name="HIV.D-DE778"> </a></td><td>Syndrome/STI diagnosed</td><td><div><p>Syndrome or STI for which client is diagnosed</p>
</div></td></tr><tr><td style="white-space:nowrap">DE779<a name="HIV.D-DE779"> </a></td><td>Urethral discharge syndrome</td><td><div><p>Client diagnosed with urethral discharge syndrome</p>
</div></td></tr><tr><td style="white-space:nowrap">DE780<a name="HIV.D-DE780"> </a></td><td>Vaginal discharge syndrome</td><td><div><p>Client diagnosed with vaginal discharge syndrome</p>
</div></td></tr><tr><td style="white-space:nowrap">DE781<a name="HIV.D-DE781"> </a></td><td>Lower Abdominal pain </td><td><div><p>Client diagnosed with lower abdominal pain</p>
</div></td></tr><tr><td style="white-space:nowrap">DE782<a name="HIV.D-DE782"> </a></td><td>Genital ulcer disease syndrome</td><td><div><p>Client diagnosed with genital ulcer disease syndrome</p>
</div></td></tr><tr><td style="white-space:nowrap">DE783<a name="HIV.D-DE783"> </a></td><td>Anorectal discharge</td><td><div><p>Client diagnosed with anorectal discharge</p>
</div></td></tr><tr><td style="white-space:nowrap">DE784<a name="HIV.D-DE784"> </a></td><td>Sent for testing</td><td><div><p>Specimen sent for testing</p>
</div></td></tr><tr><td style="white-space:nowrap">DE785<a name="HIV.D-DE785"> </a></td><td>Other</td><td><div><p>Other syndrome/STI diagnosed</p>
</div></td></tr><tr><td style="white-space:nowrap">DE786<a name="HIV.D-DE786"> </a></td><td>Other (specify)</td><td><div><p>Other syndrome/STI diagnosed (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE787<a name="HIV.D-DE787"> </a></td><td>Any STI syndrome diagnosed</td><td><div><p>Was the client diagnosed with any of the five STI syndromes during this visit?</p>
</div></td></tr><tr><td style="white-space:nowrap">DE788<a name="HIV.D-DE788"> </a></td><td>Date of STI test</td><td><div><p>Date on which the STI test was conducted</p>
</div></td></tr><tr><td style="white-space:nowrap">DE789<a name="HIV.D-DE789"> </a></td><td>STI tested for</td><td><div><p>STI for which the client was tested</p>
</div></td></tr><tr><td style="white-space:nowrap">DE790<a name="HIV.D-DE790"> </a></td><td>Neisseria gonorrhoeae</td><td><div><p>Client tested for Neisseria gonorrhoeae</p>
</div></td></tr><tr><td style="white-space:nowrap">DE791<a name="HIV.D-DE791"> </a></td><td>Chlamydia trachomatis</td><td><div><p>Client tested for Chlamydia trachomatis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE792<a name="HIV.D-DE792"> </a></td><td>Trichomonas vaginalis</td><td><div><p>Client tested for Trichomonas vaginalis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE793<a name="HIV.D-DE793"> </a></td><td>Syphilis (Treponema pallidum)</td><td><div><p>Client tested for Syphilis (treponema pallidum)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE794<a name="HIV.D-DE794"> </a></td><td>Herpes simplex virus (HSV1, HSV2)</td><td><div><p>Client tested for herpes simplex virus (HSV1, HSV2)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE795<a name="HIV.D-DE795"> </a></td><td>Mycoplasma genitalium</td><td><div><p>Client tested for Mycoplasma genitalium</p>
</div></td></tr><tr><td style="white-space:nowrap">DE796<a name="HIV.D-DE796"> </a></td><td>Mpox</td><td><div><p>Client tested for Mpox</p>
</div></td></tr><tr><td style="white-space:nowrap">DE797<a name="HIV.D-DE797"> </a></td><td>Hepatitis B</td><td><div><p>Client tested for Hepatitis B</p>
</div></td></tr><tr><td style="white-space:nowrap">DE798<a name="HIV.D-DE798"> </a></td><td>Hepatitis C</td><td><div><p>Client tested for Hepatitis C</p>
</div></td></tr><tr><td style="white-space:nowrap">DE799<a name="HIV.D-DE799"> </a></td><td>Other</td><td><div><p>Client tested for other STI</p>
</div></td></tr><tr><td style="white-space:nowrap">DE800<a name="HIV.D-DE800"> </a></td><td>Other (specify)</td><td><div><p>Client tested for other STI (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE801<a name="HIV.D-DE801"> </a></td><td>Syphilis test date</td><td><div><p>Date of syphilis test</p>
</div></td></tr><tr><td style="white-space:nowrap">DE802<a name="HIV.D-DE802"> </a></td><td>Syphilis test result</td><td><div><p>Result from syphilis test</p>
</div></td></tr><tr><td style="white-space:nowrap">DE803<a name="HIV.D-DE803"> </a></td><td>Positive</td><td><div><p>Test result is positive for syphilis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE804<a name="HIV.D-DE804"> </a></td><td>Negative</td><td><div><p>Test result is negative for syphilis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE805<a name="HIV.D-DE805"> </a></td><td>Inconclusive</td><td><div><p>Test result is inconclusive</p>
</div></td></tr><tr><td style="white-space:nowrap">DE806<a name="HIV.D-DE806"> </a></td><td>Syphilis treatment start date</td><td><div><p>Date of initiation of syphilis treatment</p>
</div></td></tr><tr><td style="white-space:nowrap">DE807<a name="HIV.D-DE807"> </a></td><td>Gonorrhoea test date</td><td><div><p>Date of Gonorrhoea test</p>
</div></td></tr><tr><td style="white-space:nowrap">DE808<a name="HIV.D-DE808"> </a></td><td>Gonorrhoea test result</td><td><div><p>Result from Gonorrhoea test</p>
</div></td></tr><tr><td style="white-space:nowrap">DE809<a name="HIV.D-DE809"> </a></td><td>Positive</td><td><div><p>Test result is positive for Neisseria gonorrhoeae</p>
</div></td></tr><tr><td style="white-space:nowrap">DE810<a name="HIV.D-DE810"> </a></td><td>Negative</td><td><div><p>Test result is negative for Neisseria gonorrhoeae</p>
</div></td></tr><tr><td style="white-space:nowrap">DE811<a name="HIV.D-DE811"> </a></td><td>Inconclusive</td><td><div><p>Test result is inconclusive</p>
</div></td></tr><tr><td style="white-space:nowrap">DE812<a name="HIV.D-DE812"> </a></td><td>Gonorrhoea treatment start date</td><td><div><p>Date of initiation of Gonorrhoea treatment</p>
</div></td></tr><tr><td style="white-space:nowrap">DE813<a name="HIV.D-DE813"> </a></td><td>Type of specimen</td><td><div><p>Type of specimen to be collected</p>
</div></td></tr><tr><td style="white-space:nowrap">DE814<a name="HIV.D-DE814"> </a></td><td>Blood</td><td><div><p>Blood specimen to be collected</p>
</div></td></tr><tr><td style="white-space:nowrap">DE815<a name="HIV.D-DE815"> </a></td><td>Urine</td><td><div><p>Urine specimen to be collected</p>
</div></td></tr><tr><td style="white-space:nowrap">DE816<a name="HIV.D-DE816"> </a></td><td>Cervical or vaginal swab</td><td><div><p>Cervical or vaginal swab to be collected</p>
</div></td></tr><tr><td style="white-space:nowrap">DE817<a name="HIV.D-DE817"> </a></td><td>Urethral or penile swab</td><td><div><p>Urethral or penile swab to be collected</p>
</div></td></tr><tr><td style="white-space:nowrap">DE818<a name="HIV.D-DE818"> </a></td><td>Rectal swab</td><td><div><p>Rectal swab to be collected</p>
</div></td></tr><tr><td style="white-space:nowrap">DE819<a name="HIV.D-DE819"> </a></td><td>Other</td><td><div><p>Other specimen type to be collected</p>
</div></td></tr><tr><td style="white-space:nowrap">DE820<a name="HIV.D-DE820"> </a></td><td>Other type of specimen (specify)</td><td><div><p>Other specimen type to be collected (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE821<a name="HIV.D-DE821"> </a></td><td>Syphilis test type</td><td><div><p>Type of diagnostic test used for syphilis (Treponema pallidum)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE822<a name="HIV.D-DE822"> </a></td><td>Treponemal</td><td><div><p>Treponemal test used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE823<a name="HIV.D-DE823"> </a></td><td>Non-treponemal</td><td><div><p>Non-treponemal test used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE824<a name="HIV.D-DE824"> </a></td><td>POC Test</td><td><div><p>Point-of-care (POC) test used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE825<a name="HIV.D-DE825"> </a></td><td>NAAT</td><td><div><p>Nucleic Acid Amplification Test (NAAT) used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE826<a name="HIV.D-DE826"> </a></td><td>Other</td><td><div><p>Other test used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE827<a name="HIV.D-DE827"> </a></td><td>Other syphilis test type (specify)</td><td><div><p>Other test used (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE828<a name="HIV.D-DE828"> </a></td><td>Neisseria gonorrhoeae test type</td><td><div><p>Type of diagnostic test used for Neisseria gonorrhoeae</p>
</div></td></tr><tr><td style="white-space:nowrap">DE829<a name="HIV.D-DE829"> </a></td><td>NAAT</td><td><div><p>Nucleic Acid Amplification Test (NAAT) used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE830<a name="HIV.D-DE830"> </a></td><td>POC Test</td><td><div><p>Point-of-care (POC) test used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE831<a name="HIV.D-DE831"> </a></td><td>Culture</td><td><div><p>Culture test used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE832<a name="HIV.D-DE832"> </a></td><td>Microscopy</td><td><div><p>Microscopy test used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE833<a name="HIV.D-DE833"> </a></td><td>Other</td><td><div><p>Other type of test used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE834<a name="HIV.D-DE834"> </a></td><td>Other (specify)</td><td><div><p>Other type of test used (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE835<a name="HIV.D-DE835"> </a></td><td>POC Test for Neisseria gonorrhoeae (specify)</td><td><div><p>Point-of-care (POC) test used for Neisseria gonorrhoeae (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE836<a name="HIV.D-DE836"> </a></td><td>Chlamydia trachomatis test type</td><td><div><p>Type of diagnostic test used for Chlamydia trachomatis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE837<a name="HIV.D-DE837"> </a></td><td>NAAT</td><td><div><p>Nucleic Acid Amplification Test (NAAT) used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE838<a name="HIV.D-DE838"> </a></td><td>POC Test</td><td><div><p>Point-of-care (POC) test used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE839<a name="HIV.D-DE839"> </a></td><td>Culture</td><td><div><p>Culture test used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE840<a name="HIV.D-DE840"> </a></td><td>ELISA</td><td><div><p>ELISA test used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE841<a name="HIV.D-DE841"> </a></td><td>Microscopy</td><td><div><p>Microscopy test used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE842<a name="HIV.D-DE842"> </a></td><td>Other</td><td><div><p>Other type of test used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE843<a name="HIV.D-DE843"> </a></td><td>Other test for Chlamydia (specify)</td><td><div><p>Other type of test used for Chlaymdia (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE844<a name="HIV.D-DE844"> </a></td><td>POC Test type for Chlamydia test (specify)</td><td><div><p>Point-of-care (POC) test used for Chlamydia (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE845<a name="HIV.D-DE845"> </a></td><td>Trichomonas vaginalis test type</td><td><div><p>Type of diagnostic test used for Trichomonas vaginalis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE846<a name="HIV.D-DE846"> </a></td><td>NAAT</td><td><div><p>Nucleic Acid Amplification Test (NAAT) used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE847<a name="HIV.D-DE847"> </a></td><td>POC Test</td><td><div><p>Point-of-care (POC) test used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE848<a name="HIV.D-DE848"> </a></td><td>Culture</td><td><div><p>Culture test used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE849<a name="HIV.D-DE849"> </a></td><td>Microscopy</td><td><div><p>Microscopy test used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE850<a name="HIV.D-DE850"> </a></td><td>Other</td><td><div><p>Other type of test used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE851<a name="HIV.D-DE851"> </a></td><td>Other (specify)</td><td><div><p>Other type of test used (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE852<a name="HIV.D-DE852"> </a></td><td>POC Test type for Trichomonas vaginalis test (specify)</td><td><div><p>Point-of-care (POC) test used (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE853<a name="HIV.D-DE853"> </a></td><td>Herpes simplex virus (HSV) test type</td><td><div><p>Type of diagnostic test used for Herpes simplex virus (HSV)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE854<a name="HIV.D-DE854"> </a></td><td>NAAT</td><td><div><p>Nucleic Acid Amplification Test (NAAT) used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE855<a name="HIV.D-DE855"> </a></td><td>Antibody test </td><td><div><p>Antibody test used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE856<a name="HIV.D-DE856"> </a></td><td>Other</td><td><div><p>Other type of test used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE857<a name="HIV.D-DE857"> </a></td><td>Other (specify)</td><td><div><p>Other type of test used for Herpes simplex virus (HSV) test (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE858<a name="HIV.D-DE858"> </a></td><td>Mycoplasma genitalium test type</td><td><div><p>Type of diagnostic test used for Mycoplasma genitalium</p>
</div></td></tr><tr><td style="white-space:nowrap">DE859<a name="HIV.D-DE859"> </a></td><td>NAAT</td><td><div><p>Nucleic Acid Amplification Test (NAAT) used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE860<a name="HIV.D-DE860"> </a></td><td>Microscopy </td><td><div><p>Microscopy test used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE861<a name="HIV.D-DE861"> </a></td><td>Other</td><td><div><p>Other type of test used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE862<a name="HIV.D-DE862"> </a></td><td>Other (specify)</td><td><div><p>Other type of test used for Mycoplasma genitalium test (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE863<a name="HIV.D-DE863"> </a></td><td>Test type for other STI tested for (specify)</td><td><div><p>Test type used for the other specified STI</p>
</div></td></tr><tr><td style="white-space:nowrap">DE864<a name="HIV.D-DE864"> </a></td><td>STI test result</td><td><div><p>Result from STI test</p>
</div></td></tr><tr><td style="white-space:nowrap">DE865<a name="HIV.D-DE865"> </a></td><td>Positive</td><td><div><p>Test result is positive</p>
</div></td></tr><tr><td style="white-space:nowrap">DE866<a name="HIV.D-DE866"> </a></td><td>Negative</td><td><div><p>Test result is negative</p>
</div></td></tr><tr><td style="white-space:nowrap">DE867<a name="HIV.D-DE867"> </a></td><td>Inconclusive</td><td><div><p>Test result is inconclusive</p>
</div></td></tr><tr><td style="white-space:nowrap">DE868<a name="HIV.D-DE868"> </a></td><td>Date of STI confirmatory test</td><td><div><p>Date of STI confirmatory test</p>
</div></td></tr><tr><td style="white-space:nowrap">DE869<a name="HIV.D-DE869"> </a></td><td>Confirmatory syphilis test type</td><td><div><p>Type of test ued for confirmatory syphilis test</p>
</div></td></tr><tr><td style="white-space:nowrap">DE870<a name="HIV.D-DE870"> </a></td><td>Treponemal</td><td><div><p>Treponemal test used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE871<a name="HIV.D-DE871"> </a></td><td>Non-treponemal</td><td><div><p>Non-treponemal test used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE872<a name="HIV.D-DE872"> </a></td><td>POC Test</td><td><div><p>Point-of-care (POC) test used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE873<a name="HIV.D-DE873"> </a></td><td>NAAT</td><td><div><p>Nucleic Acid Amplification Test (NAAT) used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE874<a name="HIV.D-DE874"> </a></td><td>Other</td><td><div><p>Other test used</p>
</div></td></tr><tr><td style="white-space:nowrap">DE875<a name="HIV.D-DE875"> </a></td><td>Other (specify)</td><td><div><p>Other test used for confirmatory syphilis test (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE876<a name="HIV.D-DE876"> </a></td><td>Confirmatory test type for other STI (specify)</td><td><div><p>Confirmatory test type for other STI</p>
</div></td></tr><tr><td style="white-space:nowrap">DE877<a name="HIV.D-DE877"> </a></td><td>Confirmatory STI test result</td><td><div><p>Result from confirmatory STI test</p>
</div></td></tr><tr><td style="white-space:nowrap">DE878<a name="HIV.D-DE878"> </a></td><td>Positive</td><td><div><p>Test result is positive</p>
</div></td></tr><tr><td style="white-space:nowrap">DE879<a name="HIV.D-DE879"> </a></td><td>Negative</td><td><div><p>Test result is negative</p>
</div></td></tr><tr><td style="white-space:nowrap">DE880<a name="HIV.D-DE880"> </a></td><td>Inconclusive</td><td><div><p>Test result is inconclusive</p>
</div></td></tr><tr><td style="white-space:nowrap">DE881<a name="HIV.D-DE881"> </a></td><td>Date STI treatment prescribed </td><td><div><p>Date STI treatment was prescribed to the client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE882<a name="HIV.D-DE882"> </a></td><td>Date STI treatment dispensed</td><td><div><p>Date STI treatment dispensed to the client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE883<a name="HIV.D-DE883"> </a></td><td>STI treatment dispensed (specify)</td><td><div><p>STI treatment dispensed to the client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE884<a name="HIV.D-DE884"> </a></td><td>Mid-upper arm circumference (MUAC)</td><td><div><p>Client's mid-upper arm circumference (MUAC)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE885<a name="HIV.D-DE885"> </a></td><td>Date of start of fluconazole prophylaxis</td><td><div><p>Date of client's start of fluconazole prophylaxis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE886<a name="HIV.D-DE886"> </a></td><td>Fluconazole prophylaxis</td><td><div><p>Client provided with fluconazole prophylaxis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE887<a name="HIV.D-DE887"> </a></td><td>Date started cryptococcal meningitis treatment induction regimen</td><td><div><p>Date client started cryptococcal meningitis treatment induction regimen</p>
</div></td></tr><tr><td style="white-space:nowrap">DE888<a name="HIV.D-DE888"> </a></td><td>Date completed cryptococcal meningitis treatment induction regimen</td><td><div><p>Date client completed cryptococcal meningitis treatment induction regimen</p>
</div></td></tr><tr><td style="white-space:nowrap">DE889<a name="HIV.D-DE889"> </a></td><td>Date started cryptococcal meningitis treatment maintenance regimen</td><td><div><p>Date client started cryptococcal meningitis treatment maintenance regimen</p>
</div></td></tr><tr><td style="white-space:nowrap">DE890<a name="HIV.D-DE890"> </a></td><td>Date completed cryptococcal meningitis treatment maintenance regimen</td><td><div><p>Date client completed cryptococcal meningitis treatment maintenance regimen</p>
</div></td></tr><tr><td style="white-space:nowrap">DE891<a name="HIV.D-DE891"> </a></td><td>Date started cryptococcal meningitis treatment consolidation regimen</td><td><div><p>Date client started cryptococcal meningitis treatment consolidation regimen</p>
</div></td></tr><tr><td style="white-space:nowrap">DE892<a name="HIV.D-DE892"> </a></td><td>Date completed cryptococcal meningitis treatment consolidation regimen</td><td><div><p>Date client completed cryptococcal meningitis treatment consolidation regimen</p>
</div></td></tr><tr><td style="white-space:nowrap">DE893<a name="HIV.D-DE893"> </a></td><td>Staging of liver disease</td><td><div><p>Staging of liver disease in client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE894<a name="HIV.D-DE894"> </a></td><td>F0-4, fibrosis staging</td><td><div><p>Fibrosis staging of liver disease</p>
</div></td></tr><tr><td style="white-space:nowrap">DE895<a name="HIV.D-DE895"> </a></td><td>F4 or cirrhosis, presence of cirrhosis</td><td><div><p>Presence of cirrhosis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE896<a name="HIV.D-DE896"> </a></td><td>Advanced HIV disease</td><td><div><p>Client has Advanced HIV disease (AHD)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE897<a name="HIV.D-DE897"> </a></td><td>WHO functional status</td><td><div><p>Functional status of people with advanced HIV disease</p>
</div></td></tr><tr><td style="white-space:nowrap">DE898<a name="HIV.D-DE898"> </a></td><td>Working, able to perform usual work inside and outside the home</td><td><div><p>Client is able to perform usual work inside and outside the home (working)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE899<a name="HIV.D-DE899"> </a></td><td>Ambulatory, able to perform activity of daily living (ADL), not able to work</td><td><div><p>Client is able to perform activity of daily living (ADL), not able to work (ambulatory)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE900<a name="HIV.D-DE900"> </a></td><td>Bedridden not able to perform ADL</td><td><div><p>Client is dedridden not able to perform ADL</p>
</div></td></tr><tr><td style="white-space:nowrap">DE901<a name="HIV.D-DE901"> </a></td><td>Tailored adherence counselling for advanced HIV disease</td><td><div><p>Client provided with tailored adherence counselling for advanced HIV disease</p>
</div></td></tr><tr><td style="white-space:nowrap">DE902<a name="HIV.D-DE902"> </a></td><td>Date(s) of tracing interventions</td><td><div><p>Date tracing interventions to support reengagement into HIV care conducted</p>
</div></td></tr><tr><td style="white-space:nowrap">DE903<a name="HIV.D-DE903"> </a></td><td>Medication/drug</td><td><div><p>Current or considered medication/drug, for the purpose of determining drug interactions</p>
</div></td></tr><tr><td style="white-space:nowrap">DE904<a name="HIV.D-DE904"> </a></td><td>Rifampicin</td><td><div><p>Rifampicin currently being taken by, or considered for, client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE905<a name="HIV.D-DE905"> </a></td><td>Halofantrine</td><td><div><p>Halofantrine currently being taken by, or considered for, client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE906<a name="HIV.D-DE906"> </a></td><td>Lovastatin</td><td><div><p>Lovastatin currently being taken by, or considered for, client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE907<a name="HIV.D-DE907"> </a></td><td>Simvastatin</td><td><div><p>Simvastatin currently being taken by, or considered for, client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE908<a name="HIV.D-DE908"> </a></td><td>Hormonal contraception</td><td><div><p>Hormonal contraception currently being taken by, or considered for, client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE909<a name="HIV.D-DE909"> </a></td><td>Metformin</td><td><div><p>Metformin currently being taken by, or considered for, client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE910<a name="HIV.D-DE910"> </a></td><td>Astemizole</td><td><div><p>Astemizole currently being taken by, or considered for, client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE911<a name="HIV.D-DE911"> </a></td><td>Terfenadine</td><td><div><p>Terfenadine currently being taken by, or considered for, client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE912<a name="HIV.D-DE912"> </a></td><td>TDF</td><td><div><p>TDF currently being taken by, or considered for, client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE913<a name="HIV.D-DE913"> </a></td><td>Simeprevir</td><td><div><p>Simeprevir currently being taken by, or considered for, client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE914<a name="HIV.D-DE914"> </a></td><td>Ombitasvir + paritaprevir/ritonavir + dasabuvir</td><td><div><p>Ombitasvir + paritaprevir/ritonavir + dasabuvir currently being taken by, or considered for, client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE915<a name="HIV.D-DE915"> </a></td><td>Methadone</td><td><div><p>Methadone currently being taken by, or considered for, client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE916<a name="HIV.D-DE916"> </a></td><td>Buprenorphine</td><td><div><p>Buprenorphine currently being taken by, or considered for, client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE917<a name="HIV.D-DE917"> </a></td><td>Dofetilide</td><td><div><p>Dofetilide currently being taken by, or considered for, client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE918<a name="HIV.D-DE918"> </a></td><td>Carbamazepine</td><td><div><p>Carbamazepine currently being taken by, or considered for, client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE919<a name="HIV.D-DE919"> </a></td><td>Phenobarbital</td><td><div><p>Phenobarbital currently being taken by, or considered for, client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE920<a name="HIV.D-DE920"> </a></td><td>Phenytoin</td><td><div><p>Phenytoin currently being taken by, or considered for, client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE921<a name="HIV.D-DE921"> </a></td><td>Polyvalent cation products containing Mg, Al, Fe, Ca and Zn</td><td><div><p>Polyvalent cation products containing Mg, Al, Fe, Ca and Zn currently being taken by, or considered for, client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE922<a name="HIV.D-DE922"> </a></td><td>Amodiaquine</td><td><div><p>Amodiaquine currently being taken by, or considered for, client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE923<a name="HIV.D-DE923"> </a></td><td>Cisapride</td><td><div><p>Cisapride currently being taken by, or considered for, client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE924<a name="HIV.D-DE924"> </a></td><td>Ergotamine</td><td><div><p>Ergotamine currently being taken by, or considered for, client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE925<a name="HIV.D-DE925"> </a></td><td>Dihydroergotamine</td><td><div><p>Dihydroergotamine currently being taken by, or considered for, client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE926<a name="HIV.D-DE926"> </a></td><td>Midazolam</td><td><div><p>Midazolam currently being taken by, or considered for, client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE927<a name="HIV.D-DE927"> </a></td><td>Triazolam</td><td><div><p>Triazolam currently being taken by, or considered for, client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE928<a name="HIV.D-DE928"> </a></td><td>Estrogen-based hormonal contraception</td><td><div><p>Estrogen-based hormonal contraception currently being taken by, or considered for, client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE929<a name="HIV.D-DE929"> </a></td><td>Ribavirin</td><td><div><p>Ribavirin currently being taken by, or considered for, client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE930<a name="HIV.D-DE930"> </a></td><td>Peginterferon alfa-2a</td><td><div><p>Peginterferon alfa-2a currently being taken by, or considered for, client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE931<a name="HIV.D-DE931"> </a></td><td>Other</td><td><div><p>Other medication currently being taken by, or considered for, client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE932<a name="HIV.D-DE932"> </a></td><td>Other (specify)</td><td><div><p>Other medication currently being taken by, or considered for, client (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE933<a name="HIV.D-DE933"> </a></td><td>Medication change recommended</td><td><div><p>A medication change is recommended for the client based upon current or considered medications</p>
</div></td></tr><tr><td style="white-space:nowrap">DE934<a name="HIV.D-DE934"> </a></td><td>WHO HIV clinical stage condition or symptom</td><td><div><p>New or recurrent clinical events used to categorize HIV disease severity based at baseline and follow up</p>
</div></td></tr><tr><td style="white-space:nowrap">DE935<a name="HIV.D-DE935"> </a></td><td>Pulmonary TB</td><td><div><p>Client's symptoms include pulmonary TB</p>
</div></td></tr><tr><td style="white-space:nowrap">DE936<a name="HIV.D-DE936"> </a></td><td>Lymph node TB</td><td><div><p>Client's symptoms include lymph node TB</p>
</div></td></tr><tr><td style="white-space:nowrap">DE937<a name="HIV.D-DE937"> </a></td><td>Extrapulmonary TB</td><td><div><p>Client's symptoms include extrapulmonary tuberculosis (TB)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE938<a name="HIV.D-DE938"> </a></td><td>TB disease</td><td><div><p>Whether the client has tuberculosis (TB) disease. Sometimes known as active TB</p>
</div></td></tr><tr><td style="white-space:nowrap">DE939<a name="HIV.D-DE939"> </a></td><td>TB diagnosis result</td><td><div><p>Final result of the TB investigation (bacteriological and/or clinical)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE940<a name="HIV.D-DE940"> </a></td><td>Diagnosed TB</td><td><div><p>Client is diagnosed with TB disease</p>
</div></td></tr><tr><td style="white-space:nowrap">DE941<a name="HIV.D-DE941"> </a></td><td>TB excluded</td><td><div><p>Client is not diagnosed with TB</p>
</div></td></tr><tr><td style="white-space:nowrap">DE942<a name="HIV.D-DE942"> </a></td><td>Method of TB diagnosis</td><td><div><p>Method used to set the TB diagnosis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE943<a name="HIV.D-DE943"> </a></td><td>Bacteriologically confirmed</td><td><div><p>A person from whom a biological specimen is positive by smear microscopy, culture or a WHO-recommended rapid diagnostic</p>
</div></td></tr><tr><td style="white-space:nowrap">DE944<a name="HIV.D-DE944"> </a></td><td>Clinically diagnosed</td><td><div><p>A person who does not fulfil the criteria for bacteriological confirmation but has been diagnosed with TB disease by a medical practitioner who has decided to give the person a full course of TB treatment</p>
</div></td></tr><tr><td style="white-space:nowrap">DE945<a name="HIV.D-DE945"> </a></td><td>Presumptive TB</td><td><div><p>Client has signs or symptoms of tuberculosis (TB) without laboratory confirmation</p>
</div></td></tr><tr><td style="white-space:nowrap">DE946<a name="HIV.D-DE946"> </a></td><td>Presumptive TB registration date</td><td><div><p>Date client is registered as having signs or symptoms of tuberculosis (TB) without laboratory confirmation</p>
</div></td></tr><tr><td style="white-space:nowrap">DE947<a name="HIV.D-DE947"> </a></td><td>TB treatment history</td><td><div><p>History of previous TB treatment</p>
</div></td></tr><tr><td style="white-space:nowrap">DE948<a name="HIV.D-DE948"> </a></td><td>New</td><td><div><p>A person with TB disease who has never been treated for TB before or has only previously ever taken TB drugs for less than 1 month</p>
</div></td></tr><tr><td style="white-space:nowrap">DE949<a name="HIV.D-DE949"> </a></td><td>Recurrent</td><td><div><p>A person with TB disease who was previously treated for TB, was declared cured or treatment completed at the end of their most recent course of TB treatment and is now diagnosed with a new episode of TB.</p>
</div></td></tr><tr><td style="white-space:nowrap">DE950<a name="HIV.D-DE950"> </a></td><td>Re-registered</td><td><div><p>A person with TB disease who had been notified previously as a TB case, but was not declared cured or treatment completed, and is now being registered for a new course of TB treatment.</p>
</div></td></tr><tr><td style="white-space:nowrap">DE951<a name="HIV.D-DE951"> </a></td><td>Unknown</td><td><div><p>A person with TB disease who has undocumented history of TB treatment</p>
</div></td></tr><tr><td style="white-space:nowrap">DE952<a name="HIV.D-DE952"> </a></td><td>Date of TB diagnosis</td><td><div><p>The date when the diagnosis was established</p>
</div></td></tr><tr><td style="white-space:nowrap">DE953<a name="HIV.D-DE953"> </a></td><td>Currently on TB preventive treatment (TPT)</td><td><div><p>Client is currently taking TPT</p>
</div></td></tr><tr><td style="white-space:nowrap">DE954<a name="HIV.D-DE954"> </a></td><td>TB preventive treatment (TPT) start date</td><td><div><p>The date on which the client began taking TPT</p>
</div></td></tr><tr><td style="white-space:nowrap">DE955<a name="HIV.D-DE955"> </a></td><td>TB preventive treatment (TPT) completion date</td><td><div><p>The date on which the client completed TPT</p>
</div></td></tr><tr><td style="white-space:nowrap">DE956<a name="HIV.D-DE956"> </a></td><td>TB screening algorithm</td><td><div><p>Screening algorithm selected for screening activities</p>
</div></td></tr><tr><td style="white-space:nowrap">DE957<a name="HIV.D-DE957"> </a></td><td>Screening with cough</td><td><div><p>Client screened for TB based on cough symptom</p>
</div></td></tr><tr><td style="white-space:nowrap">DE958<a name="HIV.D-DE958"> </a></td><td>Screening with any TB symptom</td><td><div><p>Client screened for TB based on any TB symptom</p>
</div></td></tr><tr><td style="white-space:nowrap">DE959<a name="HIV.D-DE959"> </a></td><td>W4SS single screening algorithm</td><td><div><p>Client screened for TB based on the WHO-recommended four-symptom screen</p>
</div></td></tr><tr><td style="white-space:nowrap">DE960<a name="HIV.D-DE960"> </a></td><td>CRP single screening algorithm</td><td><div><p>Client screened for TB based on C-reactive protein (CRP) testing</p>
</div></td></tr><tr><td style="white-space:nowrap">DE961<a name="HIV.D-DE961"> </a></td><td>CXR single screening algorithm</td><td><div><p>Client screened for TB with a chest radiography (CXR)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE962<a name="HIV.D-DE962"> </a></td><td>Parallel screening algorithm with W4SS and CRP</td><td><div><p>Client screened for TB using parallel screening with WHO-recommended four-symptom screen and C-reactive protein (CRP) testing</p>
</div></td></tr><tr><td style="white-space:nowrap">DE963<a name="HIV.D-DE963"> </a></td><td>Sequential positive screening algorithm with W4SS and CRP</td><td><div><p>Client screened for TB using sequential positive screening with WHO-recommended four-symptom screen and C-reactive protein (CRP) testing.</p>
</div></td></tr><tr><td style="white-space:nowrap">DE964<a name="HIV.D-DE964"> </a></td><td>Sequential negative screening algorithm with W4SS and CRP</td><td><div><p>Client screened for TB using sequential negative screening with WHO-recommended four-symptom screen and C-reactive protein (CRP) testing</p>
</div></td></tr><tr><td style="white-space:nowrap">DE965<a name="HIV.D-DE965"> </a></td><td>Parallel screening algorithm with W4SS and CXR</td><td><div><p>Client screened for TB using the parallel screening algorithm with W4SS and CXR</p>
</div></td></tr><tr><td style="white-space:nowrap">DE966<a name="HIV.D-DE966"> </a></td><td>Sequential positive screening algorithm with W4SS and CXR</td><td><div><p>Client screened for TB using sequential positive screening with WHO-recommended four-symptom screen and chest radiography</p>
</div></td></tr><tr><td style="white-space:nowrap">DE967<a name="HIV.D-DE967"> </a></td><td>Sequential negative screening algorithm with W4SS and CXR</td><td><div><p>Client screened for TB using sequential negative screening with WHO-recommended four-symptom screen and chest radiography</p>
</div></td></tr><tr><td style="white-space:nowrap">DE968<a name="HIV.D-DE968"> </a></td><td>Screening with mWRD</td><td><div><p>Client screened for TB with a molecular WHO-recommended rapid diagnostic test (mWRD), such as an Xpert MTB/RIF test to detect Mycobacterium tuberculosis (MTB)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE969<a name="HIV.D-DE969"> </a></td><td>Clinical assessment</td><td><div><p>Client screened for with a clinical evaluation for tuberculosis (TB) based on national guidelines. Clinical assessment may be used as an eligibility evaluation for testing with LF-LAM or for empiric TB treatment.</p>
</div></td></tr><tr><td style="white-space:nowrap">DE970<a name="HIV.D-DE970"> </a></td><td>Other TB screening algorithm</td><td><div><p>Client screened for tuberculosis (TB) with a different screening method not listed</p>
</div></td></tr><tr><td style="white-space:nowrap">DE971<a name="HIV.D-DE971"> </a></td><td>Other TB screening algorithm (specify)</td><td><div><p>Client screened for tuberculosis (TB) with a different screening method not listed (specify)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE972<a name="HIV.D-DE972"> </a></td><td>TB screening conducted</td><td><div><p>A screening for tuberculosis (TB) was performed</p>
</div></td></tr><tr><td style="white-space:nowrap">DE973<a name="HIV.D-DE973"> </a></td><td>Symptoms of TB</td><td><div><p>Symptoms that may indicate TB disease in clients living with HIV, based on a clinical algorithm</p>
</div></td></tr><tr><td style="white-space:nowrap">DE974<a name="HIV.D-DE974"> </a></td><td>Current cough</td><td><div><p>Client has a cough regardless of duration</p>
</div></td></tr><tr><td style="white-space:nowrap">DE975<a name="HIV.D-DE975"> </a></td><td>Prolonged cough (&gt;=2w)</td><td><div><p>Client has a prolonged cough of 2 weeks or more</p>
</div></td></tr><tr><td style="white-space:nowrap">DE976<a name="HIV.D-DE976"> </a></td><td>Fever of 39 °C or greater</td><td><div><p>Client has a fever with a measured temperature of 102.2 °F/39 °C or greater</p>
</div></td></tr><tr><td style="white-space:nowrap">DE977<a name="HIV.D-DE977"> </a></td><td>Weight loss (reported)</td><td><div><p>Unexplained weight loss</p>
</div></td></tr><tr><td style="white-space:nowrap">DE978<a name="HIV.D-DE978"> </a></td><td>Night sweats</td><td><div><p>Client reports experiencing night sweats</p>
</div></td></tr><tr><td style="white-space:nowrap">DE979<a name="HIV.D-DE979"> </a></td><td>Poor weight gain</td><td><div><p>Client reports poor weight gain of child or infant or growth curve flattening or weight for age &lt;-2 Z-scores.</p>
</div></td></tr><tr><td style="white-space:nowrap">DE980<a name="HIV.D-DE980"> </a></td><td>Reduced playfulness</td><td><div><p>Client reports reduced playfulness of child</p>
</div></td></tr><tr><td style="white-space:nowrap">DE981<a name="HIV.D-DE981"> </a></td><td>Chest pain</td><td><div><p>Client reports chest pain</p>
</div></td></tr><tr><td style="white-space:nowrap">DE982<a name="HIV.D-DE982"> </a></td><td>Haemoptysis</td><td><div><p>Client reports experiencing haemoptysis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE983<a name="HIV.D-DE983"> </a></td><td>Lethargy</td><td><div><p>Client reports lethargy</p>
</div></td></tr><tr><td style="white-space:nowrap">DE984<a name="HIV.D-DE984"> </a></td><td>None</td><td><div><p>No symptoms of TB identified</p>
</div></td></tr><tr><td style="white-space:nowrap">DE985<a name="HIV.D-DE985"> </a></td><td>History of contact with a person with TB</td><td><div><p>Client had a history of a contact with a person with TB</p>
</div></td></tr><tr><td style="white-space:nowrap">DE986<a name="HIV.D-DE986"> </a></td><td>TB screening result</td><td><div><p>Record the result of the tuberculosis (TB) screening</p>
</div></td></tr><tr><td style="white-space:nowrap">DE987<a name="HIV.D-DE987"> </a></td><td>Screen positive for TB</td><td><div><p>Screening result was positive for tuberculosis (TB)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE988<a name="HIV.D-DE988"> </a></td><td>Screen negative for TB</td><td><div><p>Screening result was negative for tuberculosis (TB)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE989<a name="HIV.D-DE989"> </a></td><td>Inconclusive</td><td><div><p>Screening result was inconclusive for tuberculosis (TB)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE990<a name="HIV.D-DE990"> </a></td><td>TB screening date</td><td><div><p>Date the TB screening was conducted</p>
</div></td></tr><tr><td style="white-space:nowrap">DE991<a name="HIV.D-DE991"> </a></td><td>TB screening result date</td><td><div><p>The date when the result of TB screening is available</p>
</div></td></tr><tr><td style="white-space:nowrap">DE992<a name="HIV.D-DE992"> </a></td><td>TB diagnostic test category</td><td><div><p>The type of diagnostic test performed to detect tuberculosis (TB) disease</p>
</div></td></tr><tr><td style="white-space:nowrap">DE993<a name="HIV.D-DE993"> </a></td><td>LF-LAM</td><td><div><p>Client tested for tuberculosis with a lateral flow urine lipoarabinomannan assay</p>
</div></td></tr><tr><td style="white-space:nowrap">DE994<a name="HIV.D-DE994"> </a></td><td>mWRD test for TB</td><td><div><p>Client tested with a WHO-recommended molecular diagnostic test to detect Mycobacterium tuberculosis (MTB)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE995<a name="HIV.D-DE995"> </a></td><td>Microscopy - Sputum acid-fast bacilli (AFB)</td><td><div><p>Client tested for tuberculosis with a sputum acid-fast bacilli (AFB)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE996<a name="HIV.D-DE996"> </a></td><td>TB Culture</td><td><div><p>Client tested for tuberculosis (TB) with a culture</p>
</div></td></tr><tr><td style="white-space:nowrap">DE997<a name="HIV.D-DE997"> </a></td><td>TB diagnostic test date</td><td><div><p>The date when TB diagnostic test was performed</p>
</div></td></tr><tr><td style="white-space:nowrap">DE998<a name="HIV.D-DE998"> </a></td><td>Test sample collection date</td><td><div><p>The date when the test sample was collected from the client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE999<a name="HIV.D-DE999"> </a></td><td>TB diagnostic test result date</td><td><div><p>The date when the result of the TB diagnostic test is available</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1000<a name="HIV.D-DE1000"> </a></td><td>TB treatment started</td><td><div><p>Indicates if TB treatment was started</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1001<a name="HIV.D-DE1001"> </a></td><td>TB treatment start date</td><td><div><p>The date on which the client start or restarted tuberculosis (TB) treatment</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1002<a name="HIV.D-DE1002"> </a></td><td>TB treatment outcome</td><td><div><p>Indicates patient's TB treatment outcome</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1003<a name="HIV.D-DE1003"> </a></td><td>Treatment failed</td><td><div><p>The treatment regimen terminated or permanently changed to a new regimen or treatment strategy. Reasons for the change include:</p>
<ul>
<li>no clinical response or no bacteriological response, or both (see note;</li>
<li>adverse drug reaction; or</li>
<li>evidence of additional drug-resistance to medicines in the regimen.</li>
</ul>
</div></td></tr><tr><td style="white-space:nowrap">DE1004<a name="HIV.D-DE1004"> </a></td><td>Cured</td><td><div><p>Client with pulmonary TB with bacteriologically confirmed TB at the beginning of treatment who completed treatment as recommended by the national policy, with evidence of bacteriological response and no evidence of failure.</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1005<a name="HIV.D-DE1005"> </a></td><td>Treatment completed</td><td><div><p>Patient completed treatment as recommended by the national policy but the outcome does not meet the definition for cure or treatment failure</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1006<a name="HIV.D-DE1006"> </a></td><td>Died</td><td><div><p>Client died before starting treatment or during the course of treatment</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1007<a name="HIV.D-DE1007"> </a></td><td>Lost to follow-up</td><td><div><p>Client was lost to follow-up</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1008<a name="HIV.D-DE1008"> </a></td><td>Not evaluated</td><td><div><p>No treatment outcome was assigned. This includes cases 'transferred out' to another treatment unit and whose treatment outcome is unknown; however, it excludes those lost to follow-up.</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1009<a name="HIV.D-DE1009"> </a></td><td>TB treatment completion date</td><td><div><p>Date client completes TB treatment</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1010<a name="HIV.D-DE1010"> </a></td><td>TB treatment regimen composition</td><td><div><p>TB drugs currently being taken by the client</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1011<a name="HIV.D-DE1011"> </a></td><td>Isoniazid</td><td><div><p>Client is currently taking isoniazid</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1012<a name="HIV.D-DE1012"> </a></td><td>Rifampicin</td><td><div><p>Client is currently taking rifampicin</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1013<a name="HIV.D-DE1013"> </a></td><td>Rifabutin</td><td><div><p>Client is currently taking rifabutin</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1014<a name="HIV.D-DE1014"> </a></td><td>Ethambutol</td><td><div><p>Client is currently taking ethambutol</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1015<a name="HIV.D-DE1015"> </a></td><td>Levofloxacin</td><td><div><p>Client is currently taking levofloxacin</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1016<a name="HIV.D-DE1016"> </a></td><td>Pyrazinamide</td><td><div><p>Client is currently taking pyrazinamide, a first-line anti-tuberculosis drug</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1017<a name="HIV.D-DE1017"> </a></td><td>Eligible for TB preventive treatment</td><td><div><p>Client is eligible for tuberculosis preventive treatment (TPT)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1018<a name="HIV.D-DE1018"> </a></td><td>Date when eligibility for TB preventive treatment (TPT) was determined</td><td><div><p>Date when a determination of the client's eligibility for TPT was made</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1019<a name="HIV.D-DE1019"> </a></td><td>TB status at ART start</td><td><div><p>Client's tuberculosis (TB) status when antiretroviral therapy (ART) is started</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1020<a name="HIV.D-DE1020"> </a></td><td>Symptomatic for TB</td><td><div><p>Signs or symptoms of tuberculosis (TB) without laboratory confirmation</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1021<a name="HIV.D-DE1021"> </a></td><td>Diagnosed TB</td><td><div><p>Laboratory confirmed tuberculosis (TB) diagnosis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1022<a name="HIV.D-DE1022"> </a></td><td>None</td><td><div><p>Client has no signs or symptoms of tuberculosis (TB) and is not diagnosed with tuberculosis (TB)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1023<a name="HIV.D-DE1023"> </a></td><td>TB prevention services accepted</td><td><div><p>Indicates if the client accepts to be evaluated for TB infection and to take the treatment in case he/she is eligible</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1024<a name="HIV.D-DE1024"> </a></td><td>TB meningitis</td><td><div><p>Type of extrapulmonary TB identified for the client is TB meningitis</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1025<a name="HIV.D-DE1025"> </a></td><td>C reactive protein test date</td><td><div><p>The date on which the client has a test for C reactive protein</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1026<a name="HIV.D-DE1026"> </a></td><td>C reactive protein test result</td><td><div><p>Test result of the client's C reactive protein test result in mg/L</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1027<a name="HIV.D-DE1027"> </a></td><td>C reactive protein test result date</td><td><div><p>The date when the client's test result for C reactive protein is available</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1028<a name="HIV.D-DE1028"> </a></td><td>TPT regimen type</td><td><div><p>Type of TPT regimen the client is currently on</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1029<a name="HIV.D-DE1029"> </a></td><td>3HP</td><td><div><p>The client's current TPT regimen is 3HP</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1030<a name="HIV.D-DE1030"> </a></td><td>1HP</td><td><div><p>The client's current TPT regimen is 1HP</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1031<a name="HIV.D-DE1031"> </a></td><td>6H</td><td><div><p>The client's current TPT regimen is 6H</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1032<a name="HIV.D-DE1032"> </a></td><td>Six months of levofloxacin daily</td><td><div><p>The client's current TPT regimen is six months of levofloxacin daily</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1033<a name="HIV.D-DE1033"> </a></td><td>Other TB preventive treatment (TPT) regimen</td><td><div><p>The client's current TPT regimen is another regimen than those listed above</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1034<a name="HIV.D-DE1034"> </a></td><td>TB preventive treatment (TPT) status</td><td><div><p>Indicates the current status of TB preventive treatment (TPT)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1035<a name="HIV.D-DE1035"> </a></td><td>Not started</td><td><div><p>The client did not start the TB preventive treatment (TPT)</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1036<a name="HIV.D-DE1036"> </a></td><td>On TPT</td><td><div><p>The client started the TB preventive treatment (TPT) and is currently taking the medication, without treatment interruptions</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1037<a name="HIV.D-DE1037"> </a></td><td>On TPT with interruptions</td><td><div><p>The client started the TB preventive treatment (TPT) and is currently taking the medication, with treatment interruptions</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1038<a name="HIV.D-DE1038"> </a></td><td>On hold</td><td><div><p>The health care worker has temporarily stopped the TB preventive treatment (TPT), but TPT is expected to continue again later. May also be called &quot;suspended&quot;.</p>
</div></td></tr><tr><td style="white-space:nowrap">DE1039<a name="HIV.D-DE1039"> </a></td><td>Completed</td><td><div><p>TB preventive treatment (TPT) was completed</p>
</div></td></tr></table></div>
  </text>
  <url value="http://worldhealthorganization.github.io/smart-hiv/CodeSystem/HIV.D"/>
  <version value="0.1.0"/>
  <name value="HIV_D"/>
  <title value="HIV.D  CodeSystem"/>
  <status value="draft"/>
  <experimental value="false"/>
  <date value="2024-05-28T18:53:31+00:00"/>
  <publisher value="WHO"/>
  <contact>
    <name value="WHO"/>
    <telecom>
      <system value="url"/>
      <value value="http://who.int"/>
    </telecom>
  </contact>
  <description value="CodeSystem for HIV.D Data Elements"/>
  <caseSensitive value="false"/>
  <content value="complete"/>
  <count value="1039"/>
  <concept>
    <code value="DE1"/>
    <display value="Reason for visit"/>
    <definition value="Whether visit was scheduled or unscheduled, clinical only, or for ARV drug pick-up"/>
  </concept>
  <concept>
    <code value="DE2"/>
    <display value="First clinical visit"/>
    <definition value="The client's first appointment for clinical care by a provider at the facility"/>
  </concept>
  <concept>
    <code value="DE3"/>
    <display value="Clinical visit"/>
    <definition value="Appointment for clinical care by a provider"/>
  </concept>
  <concept>
    <code value="DE4"/>
    <display value="ART initiation"/>
    <definition value="Appointment for initiation of ART"/>
  </concept>
  <concept>
    <code value="DE5"/>
    <display value="ART drug pick up"/>
    <definition value="Appointment for an antiretroviral drug pick up"/>
  </concept>
  <concept>
    <code value="DE6"/>
    <display value="Issues and concerns"/>
    <definition value="Visit to address issues and concerns"/>
  </concept>
  <concept>
    <code value="DE7"/>
    <display value="Post-treatment follow-up visit for cervical precancer lesions or invasive cervical cancer"/>
    <definition value="Appointment for a post-treatment follow-up visit for cervical precancer lesions or invasive cervical cancer"/>
  </concept>
  <concept>
    <code value="DE8"/>
    <display value="Scheduled visit"/>
    <definition value="Is this is a scheduled visit?"/>
  </concept>
  <concept>
    <code value="DE9"/>
    <display value="Body temperature"/>
    <definition value="Temperature of the client in Celsius"/>
  </concept>
  <concept>
    <code value="DE10"/>
    <display value="Respiratory rate"/>
    <definition value="The number of breaths per minute"/>
  </concept>
  <concept>
    <code value="DE11"/>
    <display value="Heart rate"/>
    <definition value="The number of heartbeats per minute"/>
  </concept>
  <concept>
    <code value="DE12"/>
    <display value="Body height"/>
    <definition value="The client's height in centimetres"/>
  </concept>
  <concept>
    <code value="DE13"/>
    <display value="Body weight"/>
    <definition value="The client's current weight in kilograms"/>
  </concept>
  <concept>
    <code value="DE14"/>
    <display value="Systolic blood pressure"/>
    <definition value="Systolic blood pressure (SBP) in mmHg"/>
  </concept>
  <concept>
    <code value="DE15"/>
    <display value="Diastolic blood pressure"/>
    <definition value="Diastolic blood pressure (DBP) in mmHg"/>
  </concept>
  <concept>
    <code value="DE16"/>
    <display value="Blood pressure cannot be taken"/>
    <definition value="If the client's blood pressure cannot be taken, this should be indicated here. Otherwise, blood pressure should be measured."/>
  </concept>
  <concept>
    <code value="DE17"/>
    <display value="Signs of serious illness"/>
    <definition value="Signs that may indicate the client has a serious illness and needs triage or an emergency referral"/>
  </concept>
  <concept>
    <code value="DE18"/>
    <display value="Fever of 39 C or greater"/>
    <definition value="Client has a fever with a measured temperature of 102.2 F/39 C or greater"/>
  </concept>
  <concept>
    <code value="DE19"/>
    <display value="Tachycardia"/>
    <definition value="Heart rate above a rate per minute based on age"/>
  </concept>
  <concept>
    <code value="DE20"/>
    <display value="Tachypnea"/>
    <definition value="Respiratory rate above a number of breaths per minute based on age"/>
  </concept>
  <concept>
    <code value="DE21"/>
    <display value="Unable to walk unaided"/>
    <definition value="Client is not able to walk without help"/>
  </concept>
  <concept>
    <code value="DE22"/>
    <display value="Lethargy"/>
    <definition value="Client is exhibiting lethargy as a sign of serious illness"/>
  </concept>
  <concept>
    <code value="DE23"/>
    <display value="Unconsciousness"/>
    <definition value="Client is currently unconscious"/>
  </concept>
  <concept>
    <code value="DE24"/>
    <display value="Convulsions"/>
    <definition value="Client is convulsing"/>
  </concept>
  <concept>
    <code value="DE25"/>
    <display value="Unable to drink"/>
    <definition value="Child is not able to drink"/>
  </concept>
  <concept>
    <code value="DE26"/>
    <display value="Unable to breastfeed"/>
    <definition value="Infant or child is not able to breastfeed"/>
  </concept>
  <concept>
    <code value="DE27"/>
    <display value="Repeated vomiting"/>
    <definition value="Client is repeatedly vomiting"/>
  </concept>
  <concept>
    <code value="DE28"/>
    <display value="Headache"/>
    <definition value="Client is exhibiting a headache"/>
  </concept>
  <concept>
    <code value="DE29"/>
    <display value="Other sign of serious illness"/>
    <definition value="Client is exhibiting another sign of a serious illness"/>
  </concept>
  <concept>
    <code value="DE30"/>
    <display value="Other sign of serious illness (specify)"/>
    <definition value="Client is exhibiting another sign of a serious illness (specify)"/>
  </concept>
  <concept>
    <code value="DE31"/>
    <display value="Currently pregnant"/>
    <definition value="Client is currently pregnant"/>
  </concept>
  <concept>
    <code value="DE32"/>
    <display value="Breastfeeding"/>
    <definition value="Client is giving infant breast milk"/>
  </concept>
  <concept>
    <code value="DE33"/>
    <display value="Number of pregnancies (gravida)"/>
    <definition value="Total number of times the woman has been pregnant (gravida)"/>
  </concept>
  <concept>
    <code value="DE34"/>
    <display value="Number of miscarriages and/or abortions"/>
    <definition value="Total number of pregnancies lost/ended due to miscarriages and/or abortions before 22 weeks/5 months"/>
  </concept>
  <concept>
    <code value="DE35"/>
    <display value="Number of live births"/>
    <definition value="Total number of live births after 22 weeks"/>
  </concept>
  <concept>
    <code value="DE36"/>
    <display value="Parity"/>
    <definition value="Calculated parity is the total number of live and stillbirths"/>
  </concept>
  <concept>
    <code value="DE37"/>
    <display value="Serodiscordant partner"/>
    <definition value="Client's HIV status is different from a current partner's HIV status"/>
  </concept>
  <concept>
    <code value="DE38"/>
    <display value="On ART"/>
    <definition value="Client is currently taking ART"/>
  </concept>
  <concept>
    <code value="DE39"/>
    <display value="ART start date"/>
    <definition value="The date on which the client started or restarted ART"/>
  </concept>
  <concept>
    <code value="DE40"/>
    <display value="Stopped ART"/>
    <definition value="Client stopped taking ART"/>
  </concept>
  <concept>
    <code value="DE41"/>
    <display value="Date ART stopped"/>
    <definition value="Date on which client stopped ART"/>
  </concept>
  <concept>
    <code value="DE42"/>
    <display value="Established on ART"/>
    <definition value="Is the client successfully established on ART?"/>
  </concept>
  <concept>
    <code value="DE43"/>
    <display value="ART start type"/>
    <definition value="Whether the client is ART naive or is restarting ART"/>
  </concept>
  <concept>
    <code value="DE44"/>
    <display value="First-time user of ART"/>
    <definition value="Client is ART naive, having never taken ART to treat HIV before"/>
  </concept>
  <concept>
    <code value="DE45"/>
    <display value="Restarting ART"/>
    <definition value="Client is restarting ART after stopping treatment for any reason"/>
  </concept>
  <concept>
    <code value="DE46"/>
    <display value="Date of initiation on ART"/>
    <definition value="The date on which the client was first initiated on ART"/>
  </concept>
  <concept>
    <code value="DE47"/>
    <display value="Time on ART"/>
    <definition value="Time the client has been on ART since starting or restarting it in years and months"/>
  </concept>
  <concept>
    <code value="DE48"/>
    <display value="Date(s) ART restarted"/>
    <definition value="Date(s) client restarted ART after stopping (intentionally interrupting) for any number of reasons (see &quot;Reason ART stopped&quot;)"/>
  </concept>
  <concept>
    <code value="DE49"/>
    <display value="ART cohort"/>
    <definition value="Month and year client originally started ART (documented) at a health facility in the system. The cohort is a group of patients who started ART in the same month (or quarter) and year, whose status is followed over time, using the ART register."/>
  </concept>
  <concept>
    <code value="DE50"/>
    <display value="Transfer in for HIV care"/>
    <definition value="Client is transferring in with records or known ART drugs and ART start date"/>
  </concept>
  <concept>
    <code value="DE51"/>
    <display value="Date of transfer in"/>
    <definition value="Date client presented at facility (with transfer/referral slip) from another facility (and on ART) within the system"/>
  </concept>
  <concept>
    <code value="DE52"/>
    <display value="Facility transferred from"/>
    <definition value="Name of health facility client was transferred from"/>
  </concept>
  <concept>
    <code value="DE53"/>
    <display value="Date enrolled in HIV care"/>
    <definition value="Date client first enrols in HIV care at the facility. Begins when a person with a confirmed HIV diagnosis presents to a facility where HIV care is provided and a medical record, patient card, file or chart is opened for the first time. This could be at an HIV care/ART, MNCH or TB clinic."/>
  </concept>
  <concept>
    <code value="DE54"/>
    <display value="Age at enrolment"/>
    <definition value="Client's age when the client was enrolled in ART care"/>
  </concept>
  <concept>
    <code value="DE55"/>
    <display value="Facility where client first enrolled in HIV care"/>
    <definition value="Facility where the client first enrolled in HIV care"/>
  </concept>
  <concept>
    <code value="DE56"/>
    <display value="Antiretroviral (ARV) drugs received prior to enrolment"/>
    <definition value="Whether or not the client received ARV drugs prior to enrolling into HIV care"/>
  </concept>
  <concept>
    <code value="DE57"/>
    <display value="No prior ARVs"/>
    <definition value="Client received no prior ARVs"/>
  </concept>
  <concept>
    <code value="DE58"/>
    <display value="Received ARVs prior without records/documentation"/>
    <definition value="Client received ARVs prior without records/documentation"/>
  </concept>
  <concept>
    <code value="DE59"/>
    <display value="Received ARVs during pregnancy or breastfeeding"/>
    <definition value="Client received ARVs during pregnancy or breastfeeding"/>
  </concept>
  <concept>
    <code value="DE60"/>
    <display value="Received ARVs for PEP or PrEP"/>
    <definition value="Client received ARVs for post-exposure prophylaxis (PEP) or PrEP"/>
  </concept>
  <concept>
    <code value="DE61"/>
    <display value="ARV prophylaxis for an HIV-exposed infant"/>
    <definition value="Client received ARV prophylaxis for an HIV-exposed infant"/>
  </concept>
  <concept>
    <code value="DE62"/>
    <display value="Date ARV drugs received prior to enrolment"/>
    <definition value="Date ARV drugs were started prior to enrolment into HIV care/ART"/>
  </concept>
  <concept>
    <code value="DE63"/>
    <display value="Location ARV drugs received prior to enrolment"/>
    <definition value="Health facility (or other location) where ARV drugs were received prior to enrolment into HIV care/ART"/>
  </concept>
  <concept>
    <code value="DE64"/>
    <display value="ARV drug regimen received prior to enrolment"/>
    <definition value="ARV drug regimen received prior to enrolment into HIV care/ART"/>
  </concept>
  <concept>
    <code value="DE65"/>
    <display value="Existing chronic health conditions"/>
    <definition value="Does the client have any current chronic health conditions or problems?"/>
  </concept>
  <concept>
    <code value="DE66"/>
    <display value="No chronic or past health conditions"/>
    <definition value="Client does not have chronic diseases or any past health conditions"/>
  </concept>
  <concept>
    <code value="DE67"/>
    <display value="Don't know"/>
    <definition value="Client does not know whether she has any chronic diseases or past health conditions"/>
  </concept>
  <concept>
    <code value="DE68"/>
    <display value="Diabetes other or unspecified"/>
    <definition value="Client has diabetes of other or unspecified type"/>
  </concept>
  <concept>
    <code value="DE69"/>
    <display value="Diabetes pre-existing type 1"/>
    <definition value="Client has pre-existing type 1 diabetes mellitus"/>
  </concept>
  <concept>
    <code value="DE70"/>
    <display value="Diabetes pre-existing type 2"/>
    <definition value="Client has pre-existing type 2 diabetes mellitus"/>
  </concept>
  <concept>
    <code value="DE71"/>
    <display value="Hypertension"/>
    <definition value="High blood pressure"/>
  </concept>
  <concept>
    <code value="DE72"/>
    <display value="Other"/>
    <definition value="Other health conditions not included in the list"/>
  </concept>
  <concept>
    <code value="DE73"/>
    <display value="Other (specify)"/>
    <definition value="Other health conditions not included in the list (specify)"/>
  </concept>
  <concept>
    <code value="DE74"/>
    <display value="Original first-line ART regimen"/>
    <definition value="Original full, first-line ARV drug regimen patient started on at this facility"/>
  </concept>
  <concept>
    <code value="DE75"/>
    <display value="Current ART regimen"/>
    <definition value="The current ART regimen the client is taking"/>
  </concept>
  <concept>
    <code value="DE76"/>
    <display value="Current ART regimen start date"/>
    <definition value="The date on which the client started taking the current ART regimen"/>
  </concept>
  <concept>
    <code value="DE77"/>
    <display value="Preferred first-line ART regimen"/>
    <definition value="The preferred first-line ART regimen for the client according to WHO (or national) guidelines"/>
  </concept>
  <concept>
    <code value="DE78"/>
    <display value="Alternative first-line ART regimen"/>
    <definition value="The alternative first-line ART regimen for the client according to WHO (or national) guidelines"/>
  </concept>
  <concept>
    <code value="DE79"/>
    <display value="First-line ART regimen under special circumstances"/>
    <definition value="The first-line ART regimen for the client under special circumstances according to WHO (or national) guidelines"/>
  </concept>
  <concept>
    <code value="DE80"/>
    <display value="Preferred second-line ART regimen"/>
    <definition value="The preferred second-line ART regimen for the client according to WHO (or national) guidelines"/>
  </concept>
  <concept>
    <code value="DE81"/>
    <display value="Alternative second-line ART regimen"/>
    <definition value="The alternative second-line ART regimen for the client according to WHO (or national) guidelines"/>
  </concept>
  <concept>
    <code value="DE82"/>
    <display value="Optimal regimen for transition"/>
    <definition value="The optimal regimen for transition to DTG-based regimens for children established on ART"/>
  </concept>
  <concept>
    <code value="DE83"/>
    <display value="Current ART regimen (first-, second-, or third-line)"/>
    <definition value="ART regimen for treating clients living with HIV, based on national guidance"/>
  </concept>
  <concept>
    <code value="DE84"/>
    <display value="First-line ART regimen for adults and adolescents"/>
    <definition value="First-line ART regimen for adults and adolescents living with HIV"/>
  </concept>
  <concept>
    <code value="DE85"/>
    <display value="First-line ART regimen for children"/>
    <definition value="First-line ART regimen for children living with HIV"/>
  </concept>
  <concept>
    <code value="DE86"/>
    <display value="First-line ART regimen for neonates"/>
    <definition value="First-line ART regimen for neonates living with HIV"/>
  </concept>
  <concept>
    <code value="DE87"/>
    <display value="Second-line ART regimen for adults and adolescents"/>
    <definition value="Second-line ART regimen for adults and adolescents living with HIV"/>
  </concept>
  <concept>
    <code value="DE88"/>
    <display value="Second-line ART regimen for children"/>
    <definition value="Second-line ART regimen for children living with HIV"/>
  </concept>
  <concept>
    <code value="DE89"/>
    <display value="Third-line ART regimen"/>
    <definition value="Third-line ART regimen for people living with HIV (Not defined by WHO. National programmes should develop policies for third-line ART)"/>
  </concept>
  <concept>
    <code value="DE90"/>
    <display value="ART regimen"/>
    <definition value="List of ART regimens"/>
  </concept>
  <concept>
    <code value="DE91"/>
    <display value="ABC + 3TC + ATV/r"/>
    <definition value="Regimen containing abacavir, lamivudine, and atazanavir/ritonavir"/>
  </concept>
  <concept>
    <code value="DE92"/>
    <display value="ABC + 3TC + DTG"/>
    <definition value="Regimen containing abacavir, lamivudine, and dolutegravir"/>
  </concept>
  <concept>
    <code value="DE93"/>
    <display value="ABC + 3TC + EFV"/>
    <definition value="Regimen containing abacavir, lamivudine, and efavarinez"/>
  </concept>
  <concept>
    <code value="DE94"/>
    <display value="ABC + 3TC + LPV/r"/>
    <definition value="Regimen containing abacavir, lamivudine, and lopinavir/ritonavir"/>
  </concept>
  <concept>
    <code value="DE95"/>
    <display value="ABC + 3TC + NVP"/>
    <definition value="Regimen containing abacavir, lamivudine, and nevirapine"/>
  </concept>
  <concept>
    <code value="DE96"/>
    <display value="ABC + 3TC + RAL"/>
    <definition value="Regimen containing abacavir, lamivudine, and raltegravir"/>
  </concept>
  <concept>
    <code value="DE97"/>
    <display value="AZT + 3TC + ATV/r"/>
    <definition value="Regimen containing zidovudine, lamivudine, and atazanavir/ritonavir"/>
  </concept>
  <concept>
    <code value="DE98"/>
    <display value="AZT + 3TC + DRV/r"/>
    <definition value="Regimen containing zidovudine, lamivudine, and darunavir/ritonavir"/>
  </concept>
  <concept>
    <code value="DE99"/>
    <display value="AZT + 3TC + DTG"/>
    <definition value="Regimen containing zidovudine, lamivudine, and dolutegravir"/>
  </concept>
  <concept>
    <code value="DE100"/>
    <display value="AZT + 3TC + EFV"/>
    <definition value="Regimen containing zidovudine, lamivudine, and efavirenz"/>
  </concept>
  <concept>
    <code value="DE101"/>
    <display value="AZT + 3TC + EFV 600 mg"/>
    <definition value="Regimen containing zidovudine, lamivudine, and efavirenz 600 mg"/>
  </concept>
  <concept>
    <code value="DE102"/>
    <display value="AZT + 3TC + LPV/r"/>
    <definition value="Regimen containing zidovudine, lamivudine, and lopinavir/ritonavir"/>
  </concept>
  <concept>
    <code value="DE103"/>
    <display value="AZT + 3TC + NVP"/>
    <definition value="Regimen containing zidovudine, lamivudine, and nevirapine"/>
  </concept>
  <concept>
    <code value="DE104"/>
    <display value="AZT + 3TC + RAL"/>
    <definition value="Regimen containing zidovudine, lamivudine, and raltegravir"/>
  </concept>
  <concept>
    <code value="DE105"/>
    <display value="TAF + 3TC + DTG"/>
    <definition value="Regimen containing tenofovir alafenamide, lamivudine, and dolutegravir"/>
  </concept>
  <concept>
    <code value="DE106"/>
    <display value="TAF + FTC + DTG"/>
    <definition value="Regimen containing tenofovir alafenamide, emtricitabine, and dolutegravir"/>
  </concept>
  <concept>
    <code value="DE107"/>
    <display value="TDF + 3TC + ATV/r"/>
    <definition value="Regimen containing tenofovir disoproxil fumarate, lamivudine, and atazanavir/ritonavir"/>
  </concept>
  <concept>
    <code value="DE108"/>
    <display value="TDF + 3TC + DRV/r"/>
    <definition value="Regimen containing tenofovir disoproxil fumarate, lamivudine, and darunavir/ritonavir"/>
  </concept>
  <concept>
    <code value="DE109"/>
    <display value="TDF + 3TC + DTG"/>
    <definition value="Regimen containing tenofovir disoproxil fumarate, lamivudine, and dolutegravir"/>
  </concept>
  <concept>
    <code value="DE110"/>
    <display value="TDF + 3TC + EFV"/>
    <definition value="Regimen containing tenofovir disoproxil fumarate, lamivudine, and efavirenz"/>
  </concept>
  <concept>
    <code value="DE111"/>
    <display value="TDF + 3TC + EFV 400 mg"/>
    <definition value="Regimen containing tenofovir disoproxil fumarate, lamivudine, and efavirenz (400 mg)"/>
  </concept>
  <concept>
    <code value="DE112"/>
    <display value="TDF + 3TC + EFV 600 mg"/>
    <definition value="Regimen containing tenofovir disoproxil fumarate, lamivudine, and efavirenz (600 mg)"/>
  </concept>
  <concept>
    <code value="DE113"/>
    <display value="TDF + 3TC + LPV/r"/>
    <definition value="Regimen containing tenofovir disoproxil fumarate, lamivudine, and lopinavir/ritonavir"/>
  </concept>
  <concept>
    <code value="DE114"/>
    <display value="TDF + 3TC + NVP"/>
    <definition value="Regimen containing tenofovir disoproxil fumarate, lamivudine, and nevirapine"/>
  </concept>
  <concept>
    <code value="DE115"/>
    <display value="TDF + 3TC + PI/r"/>
    <definition value="Regimen containing tenofovir disoproxil fumarate, lamivudine, and a boosted protease inhibitor"/>
  </concept>
  <concept>
    <code value="DE116"/>
    <display value="TDF + 3TC + RAL"/>
    <definition value="Regimen containing tenofovir disoproxil fumarate, lamivudine, and raltegravir"/>
  </concept>
  <concept>
    <code value="DE117"/>
    <display value="TDF + FTC + ATV/r"/>
    <definition value="Regimen containing tenofovir disoproxil fumarate, emtricitabine, and atazanavir/ritonavir"/>
  </concept>
  <concept>
    <code value="DE118"/>
    <display value="TDF + FTC + DRV/r"/>
    <definition value="Regimen containing tenofovir disoproxil fumarate, emtricitabine, and darunavir/ritonavir"/>
  </concept>
  <concept>
    <code value="DE119"/>
    <display value="TDF + FTC + DTG"/>
    <definition value="Regimen containing tenofovir disoproxil fumarate, emtricitabine, and dolutegravir"/>
  </concept>
  <concept>
    <code value="DE120"/>
    <display value="TDF + FTC + EFV"/>
    <definition value="Regimen containing tenofovir disoproxil fumarate, emtricitabine, and efavirenz"/>
  </concept>
  <concept>
    <code value="DE121"/>
    <display value="TDF + FTC + EFV 600 mg"/>
    <definition value="Regimen containing tenofovir disoproxil fumarate, emtricitabine, and efavirenz (600 mg)"/>
  </concept>
  <concept>
    <code value="DE122"/>
    <display value="TDF + FTC + LPV/r"/>
    <definition value="Regimen containing tenofovir disoproxil fumarate, emtricitabine, and lopinavir/ritonavir"/>
  </concept>
  <concept>
    <code value="DE123"/>
    <display value="TDF + FTC + NVP"/>
    <definition value="Regimen containing tenofovir disoproxil fumarate, emtricitabine, and nevirapine"/>
  </concept>
  <concept>
    <code value="DE124"/>
    <display value="TDF + FTC + PI/r"/>
    <definition value="Regimen containing tenofovir disoproxil fumarate, emtricitabine, and a boosted protease inhibitor"/>
  </concept>
  <concept>
    <code value="DE125"/>
    <display value="TDF + FTC + RAL"/>
    <definition value="Regimen containing tenofovir disoproxil fumarate, emtricitabine, and raltegravir"/>
  </concept>
  <concept>
    <code value="DE126"/>
    <display value="Other"/>
    <definition value="Other regimen based upon WHO recommendations"/>
  </concept>
  <concept>
    <code value="DE127"/>
    <display value="Other (specify)"/>
    <definition value="Other regimen based upon WHO recommendations (specify)"/>
  </concept>
  <concept>
    <code value="DE128"/>
    <display value="ART regimen composition"/>
    <definition value="Drug composition of client's current ART regimen"/>
  </concept>
  <concept>
    <code value="DE129"/>
    <display value="ABC"/>
    <definition value="Treated with abacavir (ABC)"/>
  </concept>
  <concept>
    <code value="DE130"/>
    <display value="FTC"/>
    <definition value="Treated with emtricitabine (FTC)"/>
  </concept>
  <concept>
    <code value="DE131"/>
    <display value="3TC"/>
    <definition value="Treated with lamivudine (3TC)"/>
  </concept>
  <concept>
    <code value="DE132"/>
    <display value="AZT"/>
    <definition value="Treated with zidovudine (AZT)"/>
  </concept>
  <concept>
    <code value="DE133"/>
    <display value="DDI"/>
    <definition value="Treated with didanosine (DDI)"/>
  </concept>
  <concept>
    <code value="DE134"/>
    <display value="D4T"/>
    <definition value="Treated with stavudine (D4T)"/>
  </concept>
  <concept>
    <code value="DE135"/>
    <display value="TDF"/>
    <definition value="Treated with tenofovir (TDF)"/>
  </concept>
  <concept>
    <code value="DE136"/>
    <display value="EFV"/>
    <definition value="Treated with efavirenz (EFV)"/>
  </concept>
  <concept>
    <code value="DE137"/>
    <display value="ETV"/>
    <definition value="Treated with etravirine (ETV)"/>
  </concept>
  <concept>
    <code value="DE138"/>
    <display value="NVP"/>
    <definition value="Treated with nevirapine (NVP)"/>
  </concept>
  <concept>
    <code value="DE139"/>
    <display value="RIL"/>
    <definition value="Treated with rilpivirine (RIL)"/>
  </concept>
  <concept>
    <code value="DE140"/>
    <display value="ATV/r"/>
    <definition value="Treated with atazanavir/ritonavir (ATV/r)"/>
  </concept>
  <concept>
    <code value="DE141"/>
    <display value="LPV/r"/>
    <definition value="Treated with lopinavir/ritonavir (LPV/r)"/>
  </concept>
  <concept>
    <code value="DE142"/>
    <display value="DRV/r"/>
    <definition value="Treated with darunavir/ritonavir (DRV/r)"/>
  </concept>
  <concept>
    <code value="DE143"/>
    <display value="RTV"/>
    <definition value="Treated with ritonavir (RTV)"/>
  </concept>
  <concept>
    <code value="DE144"/>
    <display value="DTG"/>
    <definition value="Treated with dolutegravir (DTG)"/>
  </concept>
  <concept>
    <code value="DE145"/>
    <display value="RAL"/>
    <definition value="Treated with raltegravir (RAL)"/>
  </concept>
  <concept>
    <code value="DE146"/>
    <display value="ART regimen drug class"/>
    <definition value="Drug class of current ART regimen"/>
  </concept>
  <concept>
    <code value="DE147"/>
    <display value="NRTI"/>
    <definition value="Treated with nucleoside reverse transcriptase inhibitors (NRTIs)"/>
  </concept>
  <concept>
    <code value="DE148"/>
    <display value="NtRTI"/>
    <definition value="Treated with nucleotide reverse-transcriptase inhibitors (NtRTIs)"/>
  </concept>
  <concept>
    <code value="DE149"/>
    <display value="NNRTI"/>
    <definition value="Treated with non-nucleoside reverse transcriptase inhibitors (NNRTIs)"/>
  </concept>
  <concept>
    <code value="DE150"/>
    <display value="PI"/>
    <definition value="Treated with protease inhibitors (PIs)"/>
  </concept>
  <concept>
    <code value="DE151"/>
    <display value="INSTI"/>
    <definition value="Treated with integrase strand transfer inhibitors (INSTIs)"/>
  </concept>
  <concept>
    <code value="DE152"/>
    <display value="Prevention services offered and referrals"/>
    <definition value="Offer or refer for prevention services"/>
  </concept>
  <concept>
    <code value="DE153"/>
    <display value="Offer male and female condoms and condom-compatible lubricants"/>
    <definition value="Offer male and female condoms and condom-compatible lubricants"/>
  </concept>
  <concept>
    <code value="DE154"/>
    <display value="Harm reduction for people who inject drugs"/>
    <definition value="Offer or refer people who inject drugs to harm reduction services (needle and syringe programmes, opioid substitution therapy, other drug-dependence treatment and opioid overdose prevention and management)"/>
  </concept>
  <concept>
    <code value="DE155"/>
    <display value="Behavioural interventions to support risk reduction"/>
    <definition value="Offer or refer to services for behavioural interventions to support risk reduction, particularly for people with HIV and members of key populations"/>
  </concept>
  <concept>
    <code value="DE156"/>
    <display value="Sexual and reproductive health integrated services"/>
    <definition value="Offer or refer to sexual and reproductive health services"/>
  </concept>
  <concept>
    <code value="DE157"/>
    <display value="Contraception and family planning"/>
    <definition value="Offer contraception and family planning services"/>
  </concept>
  <concept>
    <code value="DE158"/>
    <display value="Check pregnancy status"/>
    <definition value="Check woman's pregnancy status"/>
  </concept>
  <concept>
    <code value="DE159"/>
    <display value="Prevention of mother-to-child transmission"/>
    <definition value="Offer prevention of mother-to-child transmission services (counselling)"/>
  </concept>
  <concept>
    <code value="DE160"/>
    <display value="STI testing and treatment"/>
    <definition value="Offer STI testing and treatment services"/>
  </concept>
  <concept>
    <code value="DE161"/>
    <display value="HBsAg test date"/>
    <definition value="Date client was tested for hepatitis B virus (HBV)"/>
  </concept>
  <concept>
    <code value="DE162"/>
    <display value="HBsAg test result"/>
    <definition value="Hepatitis B virus test result (HBsAg)"/>
  </concept>
  <concept>
    <code value="DE163"/>
    <display value="Positive"/>
    <definition value="HBsAg test result was positive"/>
  </concept>
  <concept>
    <code value="DE164"/>
    <display value="Negative"/>
    <definition value="HBsAg test result was negative"/>
  </concept>
  <concept>
    <code value="DE165"/>
    <display value="Indeterminate"/>
    <definition value="HBsAg test result was indeterminate"/>
  </concept>
  <concept>
    <code value="DE166"/>
    <display value="Date HBV test result returned to client"/>
    <definition value="Date HBV test result (HBsAG) was returned to client"/>
  </concept>
  <concept>
    <code value="DE167"/>
    <display value="HBV treatment (TDF) start date"/>
    <definition value="Date when client started treatment (TDF) for hepatitis B virus (HBV)"/>
  </concept>
  <concept>
    <code value="DE168"/>
    <display value="HBV treatment regimen prescribed"/>
    <definition value="Hepatitis B virus treatment regimen prescribed"/>
  </concept>
  <concept>
    <code value="DE169"/>
    <display value="HCV test date"/>
    <definition value="Date client was tested for hepatitis C virus (HCV antibody, HCV RNA or HCV core antigen)"/>
  </concept>
  <concept>
    <code value="DE170"/>
    <display value="HCV test result"/>
    <definition value="Hepatitis C virus test result (HCV antibody, HCV RNA or HCV core antigen)"/>
  </concept>
  <concept>
    <code value="DE171"/>
    <display value="Positive"/>
    <definition value="HCV test result was positive"/>
  </concept>
  <concept>
    <code value="DE172"/>
    <display value="Negative"/>
    <definition value="HCV test result was negative"/>
  </concept>
  <concept>
    <code value="DE173"/>
    <display value="Indeterminate"/>
    <definition value="HCV test result was indeterminate"/>
  </concept>
  <concept>
    <code value="DE174"/>
    <display value="Date HCV test result returned to client"/>
    <definition value="Date HCV test result was returned to client"/>
  </concept>
  <concept>
    <code value="DE175"/>
    <display value="HCV treatment start date"/>
    <definition value="Date when client started treatment for hepatitis C virus (HCV)"/>
  </concept>
  <concept>
    <code value="DE176"/>
    <display value="HCV treatment completion date"/>
    <definition value="Date when client completed treatment for hepatitis C virus (HCV)"/>
  </concept>
  <concept>
    <code value="DE177"/>
    <display value="HCV treatment regimen prescribed"/>
    <definition value="Hepatitis C virus treatment regimen prescribed"/>
  </concept>
  <concept>
    <code value="DE178"/>
    <display value="HCV viral load test date"/>
    <definition value="Hepatitis C viral load test date"/>
  </concept>
  <concept>
    <code value="DE179"/>
    <display value="HCV viral load test result"/>
    <definition value="Hepatitis C viral load test result (qualitative)"/>
  </concept>
  <concept>
    <code value="DE180"/>
    <display value="Detected"/>
    <definition value="HCV was detected"/>
  </concept>
  <concept>
    <code value="DE181"/>
    <display value="Not detected"/>
    <definition value="HCV was not detected"/>
  </concept>
  <concept>
    <code value="DE182"/>
    <display value="HCV medicine type"/>
    <definition value="Type of medicine client is prescribed"/>
  </concept>
  <concept>
    <code value="DE183"/>
    <display value="Interferon"/>
    <definition value="Client is prescribed interferon"/>
  </concept>
  <concept>
    <code value="DE184"/>
    <display value="Direct acting antivirals"/>
    <definition value="Client is prescribed direct acting antivirals"/>
  </concept>
  <concept>
    <code value="DE185"/>
    <display value="Currently on TDF-based ART"/>
    <definition value="Client is currently on TDF-based ART regimen"/>
  </concept>
  <concept>
    <code value="DE186"/>
    <display value="HIV clinical stage"/>
    <definition value="WHO clinical stage of client based on signs and symptoms. WHO clinical staging is a way to categorize HIV disease severity based on new or recurrent clinical events. There are 4 WHO clinical stages that range from mild symptoms (WHO clinical stage 1) to severe symptoms (WHO clinical stage 4)."/>
  </concept>
  <concept>
    <code value="DE187"/>
    <display value="WHO HIV clinical stage 1"/>
    <definition value="Client is currently assessed to be at a clinical stage 1, based on clinical assessment and diagnostics"/>
  </concept>
  <concept>
    <code value="DE188"/>
    <display value="WHO HIV clinical stage 2"/>
    <definition value="Client is currently assessed to be at a clinical stage 2, based on clinical assessment and diagnostics"/>
  </concept>
  <concept>
    <code value="DE189"/>
    <display value="WHO HIV clinical stage 3"/>
    <definition value="Client is currently assessed to be at a clinical stage 3, based on clinical assessment and diagnostics"/>
  </concept>
  <concept>
    <code value="DE190"/>
    <display value="WHO HIV clinical stage 4"/>
    <definition value="Client is currently assessed to be at a clinical stage 4, based on clinical assessment and diagnostics"/>
  </concept>
  <concept>
    <code value="DE191"/>
    <display value="Number of missed doses"/>
    <definition value="Number of doses of antiretroviral therapy (ART) the client missed since the last visit, used for monitoring adherence"/>
  </concept>
  <concept>
    <code value="DE192"/>
    <display value="Received viral load test result"/>
    <definition value="Client received results from viral load test"/>
  </concept>
  <concept>
    <code value="DE193"/>
    <display value="Date viral load test results received by client"/>
    <definition value="The date on which the client received results from viral load test"/>
  </concept>
  <concept>
    <code value="DE194"/>
    <display value="Date of viral load sample collection"/>
    <definition value="Date and time when the sample was collected to test the client's HIV viral load"/>
  </concept>
  <concept>
    <code value="DE195"/>
    <display value="Date of scheduled review of viral load test results"/>
    <definition value="Expected date when client's viral load test results will be returned and reviewed"/>
  </concept>
  <concept>
    <code value="DE196"/>
    <display value="Date of ART interruption"/>
    <definition value="Date of client's ART interruption (ART stop or missed drug pick-up)"/>
  </concept>
  <concept>
    <code value="DE197"/>
    <display value="Reason(s) for adherence problem"/>
    <definition value="Reason why client was not adherent"/>
  </concept>
  <concept>
    <code value="DE198"/>
    <display value="Forgot"/>
    <definition value="Client reported not being adherent because they forgot"/>
  </concept>
  <concept>
    <code value="DE199"/>
    <display value="Toxicity/side effects"/>
    <definition value="Client reported not being adherent because of toxicity/side effects"/>
  </concept>
  <concept>
    <code value="DE200"/>
    <display value="Busy"/>
    <definition value="Client reported not being adherent because they were busy"/>
  </concept>
  <concept>
    <code value="DE201"/>
    <display value="Change of routine"/>
    <definition value="Client reported not being adherent because of a change of routine"/>
  </concept>
  <concept>
    <code value="DE202"/>
    <display value="Travel cost"/>
    <definition value="Client reported not being adherent because of travel cost"/>
  </concept>
  <concept>
    <code value="DE203"/>
    <display value="Distance to clinic"/>
    <definition value="Client reported not being adherent because of distance to clinic"/>
  </concept>
  <concept>
    <code value="DE204"/>
    <display value="Client lost/ran out of pills"/>
    <definition value="Client reported not being adherent because client lost/ran out of pills"/>
  </concept>
  <concept>
    <code value="DE205"/>
    <display value="Stock-out"/>
    <definition value="Client reported not being adherent because of a stock-out"/>
  </concept>
  <concept>
    <code value="DE206"/>
    <display value="Too ill"/>
    <definition value="Client reported not being adherent because of being too ill"/>
  </concept>
  <concept>
    <code value="DE207"/>
    <display value="Pill burden"/>
    <definition value="Client reported not being adherent because of the pill burden"/>
  </concept>
  <concept>
    <code value="DE208"/>
    <display value="Felt well"/>
    <definition value="Client reported not being adherent because they felt well"/>
  </concept>
  <concept>
    <code value="DE209"/>
    <display value="Depression"/>
    <definition value="Client reported not being adherent because of depression"/>
  </concept>
  <concept>
    <code value="DE210"/>
    <display value="Alcohol use"/>
    <definition value="Client reported not being adherent because of alcohol use"/>
  </concept>
  <concept>
    <code value="DE211"/>
    <display value="Substance use"/>
    <definition value="Client reported not being adherent because of substance use (i.e. drugs)"/>
  </concept>
  <concept>
    <code value="DE212"/>
    <display value="Stigma/disclosure concerns"/>
    <definition value="Client reported not being adherent because of stigma/disclosure concerns"/>
  </concept>
  <concept>
    <code value="DE213"/>
    <display value="Lack of food"/>
    <definition value="Client reported not being adherent because of a lack of food"/>
  </concept>
  <concept>
    <code value="DE214"/>
    <display value="Poor palatability"/>
    <definition value="Client reported not being adherent because of poor palatability"/>
  </concept>
  <concept>
    <code value="DE215"/>
    <display value="Other reason for nonadherence"/>
    <definition value="Client reported not being adherent because of other reason for nonadherence"/>
  </concept>
  <concept>
    <code value="DE216"/>
    <display value="Other reason for nonadherence (specify)"/>
    <definition value="Client reported not being adherent because of other reason for nonadherence (specify)"/>
  </concept>
  <concept>
    <code value="DE217"/>
    <display value="Reason ART stopped"/>
    <definition value="Reason client intentionally stopped ART"/>
  </concept>
  <concept>
    <code value="DE218"/>
    <display value="Toxicity/side effects"/>
    <definition value="Client stopped ART because of toxicity/side effects"/>
  </concept>
  <concept>
    <code value="DE219"/>
    <display value="Severe illness, hospitalization"/>
    <definition value="Client stopped ART because of severe illness, hospitalization"/>
  </concept>
  <concept>
    <code value="DE220"/>
    <display value="Drugs out of stock"/>
    <definition value="Client stopped ART because drugs were out of stock"/>
  </concept>
  <concept>
    <code value="DE221"/>
    <display value="Client lacks finances"/>
    <definition value="Client stopped ART because of lack of finances"/>
  </concept>
  <concept>
    <code value="DE222"/>
    <display value="Excluded HIV infection in infant"/>
    <definition value="Client stopped ART because HIV infection in infant was excluded"/>
  </concept>
  <concept>
    <code value="DE223"/>
    <display value="Other reason for stopping ART"/>
    <definition value="Client stopped ART because of other reason"/>
  </concept>
  <concept>
    <code value="DE224"/>
    <display value="Other reason for stopping ART (specify)"/>
    <definition value="Client stopped ART because of other reason (specify)"/>
  </concept>
  <concept>
    <code value="DE225"/>
    <display value="Treatment failure"/>
    <definition value="ART treatment failure"/>
  </concept>
  <concept>
    <code value="DE226"/>
    <display value="Clinical failure"/>
    <definition value="New or recurrent clinical event indicating severe immunodeficiency in adults or advanced or severe immunodeficiency in children"/>
  </concept>
  <concept>
    <code value="DE227"/>
    <display value="Immunological failure"/>
    <definition value="CD4 count at or below 250 cells/mm3 following clinical failure"/>
  </concept>
  <concept>
    <code value="DE228"/>
    <display value="Virological failure"/>
    <definition value="The inability to achieve or maintain viral suppression below a certain threshold indicated by viral load above 1000 copies/mL based on two consecutive viral load measurements in 3 months, with adherence support following the first viral load test"/>
  </concept>
  <concept>
    <code value="DE229"/>
    <display value="General care activities recommended"/>
    <definition value="General care activities to be performed during the care visit"/>
  </concept>
  <concept>
    <code value="DE230"/>
    <display value="Determine WHO clinical stage"/>
    <definition value="Determine WHO clinical stage based on past and current HIV-related conditions"/>
  </concept>
  <concept>
    <code value="DE231"/>
    <display value="Determine if advanced disease"/>
    <definition value="Determine if client is in an advanced stage of HIV, as a special package of services may be provided"/>
  </concept>
  <concept>
    <code value="DE232"/>
    <display value="Prepare for ART"/>
    <definition value="Prepare client new to ART"/>
  </concept>
  <concept>
    <code value="DE233"/>
    <display value="Prepare, assess and support adherence"/>
    <definition value="Prepare, assess and support adherence"/>
  </concept>
  <concept>
    <code value="DE234"/>
    <display value="Manage current medications"/>
    <definition value="Manage current medications being taken by the client"/>
  </concept>
  <concept>
    <code value="DE235"/>
    <display value="Check pregnancy status"/>
    <definition value="Check woman's pregnancy status"/>
  </concept>
  <concept>
    <code value="DE236"/>
    <display value="Provide family planning and contraception"/>
    <definition value="Provide family planning and contraception counselling"/>
  </concept>
  <concept>
    <code value="DE237"/>
    <display value="Support disclosure and partner notification"/>
    <definition value="Support disclosure and partner notification"/>
  </concept>
  <concept>
    <code value="DE238"/>
    <display value="Counsel on risk reduction and prevention"/>
    <definition value="Counsel on risk reduction and combination HIV prevention approaches"/>
  </concept>
  <concept>
    <code value="DE239"/>
    <display value="Assess, prevent and manage noncommunicable diseases"/>
    <definition value="Assess, prevent and manage noncommunicable diseases"/>
  </concept>
  <concept>
    <code value="DE240"/>
    <display value="Screen for and manage mental health problems"/>
    <definition value="Screen for and manage mental health problems"/>
  </concept>
  <concept>
    <code value="DE241"/>
    <display value="Screen for and manage and substance use issues"/>
    <definition value="Screen for and manage and substance use issues"/>
  </concept>
  <concept>
    <code value="DE242"/>
    <display value="Provide psychosocial counselling and support"/>
    <definition value="Provide psychosocial counselling and support"/>
  </concept>
  <concept>
    <code value="DE243"/>
    <display value="Manage pain and symptoms"/>
    <definition value="Manage pain and symptoms client is experiencing"/>
  </concept>
  <concept>
    <code value="DE244"/>
    <display value="Conduct a nutritional assessment and counsel on nutrition"/>
    <definition value="Conduct a nutritional assessment and counsel on nutrition"/>
  </concept>
  <concept>
    <code value="DE245"/>
    <display value="Conduct a growth and development assessment"/>
    <definition value="Conduct a growth and development assessment"/>
  </concept>
  <concept>
    <code value="DE246"/>
    <display value="Provide support on infant and child feeding"/>
    <definition value="Provide support on infant and child feeding to mother or care giver"/>
  </concept>
  <concept>
    <code value="DE247"/>
    <display value="Preventing and treating coinfections"/>
    <definition value="Coinfection prevention and treatment activities performed during the care visit"/>
  </concept>
  <concept>
    <code value="DE248"/>
    <display value="Provide co-trimoxazole preventive therapy (CPT)"/>
    <definition value="Provide co-trimoxazole prophylaxis for clients new to ART or identified as taking it"/>
  </concept>
  <concept>
    <code value="DE249"/>
    <display value="Intensified TB case finding and linkage to TB treatment"/>
    <definition value="Offer or refer for intensified TB case finding and linkage to TB treatment"/>
  </concept>
  <concept>
    <code value="DE250"/>
    <display value="Provide isoniazid preventive therapy"/>
    <definition value="Provide isoniazid preventive therapy"/>
  </concept>
  <concept>
    <code value="DE251"/>
    <display value="Screen for cryptococcal infection and fungal prophylaxis"/>
    <definition value="Screen for cryptococcal infection and fungal prophylaxis"/>
  </concept>
  <concept>
    <code value="DE252"/>
    <display value="Screen for hepatitis B"/>
    <definition value="Screen for hepatitis B virus"/>
  </concept>
  <concept>
    <code value="DE253"/>
    <display value="Screen for hepatitis C"/>
    <definition value="Screen for hepatitis C virus"/>
  </concept>
  <concept>
    <code value="DE254"/>
    <display value="Prevent malaria"/>
    <definition value="Prevent malaria including with insecticide-treated bed-nets and prophylaxis"/>
  </concept>
  <concept>
    <code value="DE255"/>
    <display value="Screen for STIs"/>
    <definition value="Screen for STIs"/>
  </concept>
  <concept>
    <code value="DE256"/>
    <display value="Prevent and screen for cervical cancer"/>
    <definition value="Prevent and screen for cervical cancer"/>
  </concept>
  <concept>
    <code value="DE257"/>
    <display value="Anal cancer screening (for men who have sex with men)"/>
    <definition value="Offer anal cancer screening (for men who have sex with men)"/>
  </concept>
  <concept>
    <code value="DE258"/>
    <display value="Assessment and provision of vaccinations"/>
    <definition value="Assessment and provision of vaccinations, such as for people from key populations, pregnant women and infants; and, where appropriate, tetanus vaccination for adolescent boys and men receiving VMMC"/>
  </concept>
  <concept>
    <code value="DE259"/>
    <display value="Risk factors, comorbidities and coinfections signs and symptoms"/>
    <definition value="Signs and symptoms of opportunistic infections or other comorbidities experienced by client"/>
  </concept>
  <concept>
    <code value="DE260"/>
    <display value="Oral candidiasis"/>
    <definition value="Client's comorbidities or coinfections or symptoms of these include oral candidiasis (after the first 6-8 weeks of life)"/>
  </concept>
  <concept>
    <code value="DE261"/>
    <display value="Vaginal candidiasis"/>
    <definition value="Client's comorbidities or coinfections or symptoms of these include vaginal candidiasis"/>
  </concept>
  <concept>
    <code value="DE262"/>
    <display value="Cough"/>
    <definition value="Client's comorbidities or coinfections or symptoms of these include cough"/>
  </concept>
  <concept>
    <code value="DE263"/>
    <display value="Prolonged fever"/>
    <definition value="Client's comorbidities or coinfections or symptoms of these include prolonged fever"/>
  </concept>
  <concept>
    <code value="DE264"/>
    <display value="Night sweats"/>
    <definition value="Client's comorbidities or coinfections or symptoms of these include night sweats"/>
  </concept>
  <concept>
    <code value="DE265"/>
    <display value="Weight loss"/>
    <definition value="Client's comorbidities or coinfections or symptoms of these include weight loss"/>
  </concept>
  <concept>
    <code value="DE266"/>
    <display value="Difficulty breathing"/>
    <definition value="Client's comorbidities or coinfections or symptoms of these include difficulty breathing"/>
  </concept>
  <concept>
    <code value="DE267"/>
    <display value="Pneumonia"/>
    <definition value="Client's comorbidities or coinfections or symptoms of these include pneumonia"/>
  </concept>
  <concept>
    <code value="DE268"/>
    <display value="Urethral discharge"/>
    <definition value="Client's comorbidities or coinfections or symptoms of these include urethral discharge"/>
  </concept>
  <concept>
    <code value="DE269"/>
    <display value="Syphilis"/>
    <definition value="Client's comorbidities or coinfections or symptoms of these include syphilis"/>
  </concept>
  <concept>
    <code value="DE270"/>
    <display value="Pelvic inflammatory disease"/>
    <definition value="Client's comorbidities or coinfections or symptoms of these include pelvic inflammatory disease"/>
  </concept>
  <concept>
    <code value="DE271"/>
    <display value="Ulcers - skin"/>
    <definition value="Client's comorbidities or coinfections or symptoms of these include ulcers - skin"/>
  </concept>
  <concept>
    <code value="DE272"/>
    <display value="Ulcers - mouth or other"/>
    <definition value="Client's comorbidities or coinfections or symptoms of these include ulcers - mouth or other"/>
  </concept>
  <concept>
    <code value="DE273"/>
    <display value="Ulcers - male genital"/>
    <definition value="Client's comorbidities or coinfections or symptoms of these include ulcers - male genital"/>
  </concept>
  <concept>
    <code value="DE274"/>
    <display value="Vaginal discharge"/>
    <definition value="Client's comorbidities or coinfections or symptoms of these include vaginal discharge"/>
  </concept>
  <concept>
    <code value="DE275"/>
    <display value="Malaria"/>
    <definition value="Client's comorbidities or coinfections or symptoms of these include malaria"/>
  </concept>
  <concept>
    <code value="DE276"/>
    <display value="Chronic obstructive pulmonary disease"/>
    <definition value="Client's comorbidities or coinfections or symptoms of these include chronic obstructive pulmonary disease"/>
  </concept>
  <concept>
    <code value="DE277"/>
    <display value="Hypertension"/>
    <definition value="Client's comorbidities or coinfections or symptoms of these include hypertension"/>
  </concept>
  <concept>
    <code value="DE278"/>
    <display value="Diabetes"/>
    <definition value="Client's comorbidities or coinfections or symptoms of these include diabetes"/>
  </concept>
  <concept>
    <code value="DE279"/>
    <display value="Gestational diabetes"/>
    <definition value="Client's comorbidities or coinfections or symptoms of these include gestational diabetes"/>
  </concept>
  <concept>
    <code value="DE280"/>
    <display value="Mental health disorders"/>
    <definition value="Client's comorbidities or coinfections or symptoms of these include mental health disorders (including depression, dementia, encephalitis, seizures)"/>
  </concept>
  <concept>
    <code value="DE281"/>
    <display value="Diarrhoea or abdominal pain"/>
    <definition value="Client's comorbidities or coinfections or symptoms of these include diarrhoea or abdominal pain"/>
  </concept>
  <concept>
    <code value="DE282"/>
    <display value="Presumptive TB"/>
    <definition value="Client's comorbidities or coinfections or symptoms of these include presumptive TB"/>
  </concept>
  <concept>
    <code value="DE283"/>
    <display value="Severe or complicated malnutrition"/>
    <definition value="Client's comorbidities or coinfections or symptoms of these include severe or complicated malnutrition"/>
  </concept>
  <concept>
    <code value="DE284"/>
    <display value="Poor growth or development"/>
    <definition value="Client's comorbidities or coinfections or symptoms of these include poor growth or development"/>
  </concept>
  <concept>
    <code value="DE285"/>
    <display value="Oedema"/>
    <definition value="Client's comorbidities or coinfections or symptoms of these include oedema"/>
  </concept>
  <concept>
    <code value="DE286"/>
    <display value="Previously treated for TB"/>
    <definition value="Client has previously been treated for tuberculosis (TB)"/>
  </concept>
  <concept>
    <code value="DE287"/>
    <display value="Other"/>
    <definition value="Other comorbidities or coinfection signs or symptoms"/>
  </concept>
  <concept>
    <code value="DE288"/>
    <display value="Other (specify)"/>
    <definition value="Other comorbidities or coinfection signs or symptoms (specify)"/>
  </concept>
  <concept>
    <code value="DE289"/>
    <display value="WHO HIV clinical stage condition or symptom"/>
    <definition value="New or recurrent clinical events used to categorize HIV disease severity based at baseline and follow up"/>
  </concept>
  <concept>
    <code value="DE290"/>
    <display value="Asymptomatic"/>
    <definition value="No HIV-related symptoms reported and no clinical signs on examination"/>
  </concept>
  <concept>
    <code value="DE291"/>
    <display value="Persistent generalized lymphadenopathy"/>
    <definition value="Persistent enlarged lymph nodes &gt;1 cm at two or more non-contiguous sites (excluding inguinal) without known cause"/>
  </concept>
  <concept>
    <code value="DE292"/>
    <display value="Moderate unexplained weight loss"/>
    <definition value="Moderate unexplained weight loss (&lt;10% of presumed or measured body weight)"/>
  </concept>
  <concept>
    <code value="DE293"/>
    <display value="Recurrent respiratory tract infections"/>
    <definition value="Client's symptoms include recurrent respiratory tract infections including sinusitis, tonsillitis, otitis media or pharyngitis"/>
  </concept>
  <concept>
    <code value="DE294"/>
    <display value="Unexplained persistent hepatosplenomegaly"/>
    <definition value="Client's symptoms include unexplained persistent hepatosplenomegaly"/>
  </concept>
  <concept>
    <code value="DE295"/>
    <display value="Herpes zoster"/>
    <definition value="Client's symptoms include herpes zoster"/>
  </concept>
  <concept>
    <code value="DE296"/>
    <display value="Angular cheilitis"/>
    <definition value="Client's symptoms include angular cheilitis"/>
  </concept>
  <concept>
    <code value="DE297"/>
    <display value="Linear gingival erythema"/>
    <definition value="Client's symptoms include linear gingival erythema"/>
  </concept>
  <concept>
    <code value="DE298"/>
    <display value="Recurrent oral ulceration"/>
    <definition value="Client's symptoms include recurrent oral ulceration"/>
  </concept>
  <concept>
    <code value="DE299"/>
    <display value="Papular pruritic eruption"/>
    <definition value="Client's symptoms include papular pruritic eruption"/>
  </concept>
  <concept>
    <code value="DE300"/>
    <display value="Fungal nail infections"/>
    <definition value="Client's symptoms include fungal nail infections"/>
  </concept>
  <concept>
    <code value="DE301"/>
    <display value="Seborrhoeic dermatitis"/>
    <definition value="Client's symptoms include seborrhoeic dermatitis"/>
  </concept>
  <concept>
    <code value="DE302"/>
    <display value="Extensive wart virus infection"/>
    <definition value="Client's symptoms include extensive wart virus infection"/>
  </concept>
  <concept>
    <code value="DE303"/>
    <display value="Extensive molluscum contagiosum"/>
    <definition value="Client's symptoms include extensive molluscum contagiosum"/>
  </concept>
  <concept>
    <code value="DE304"/>
    <display value="Unexplained persistent parotid enlargement"/>
    <definition value="Client's symptoms include unexplained persistent parotid enlargement"/>
  </concept>
  <concept>
    <code value="DE305"/>
    <display value="Unexplained severe weight loss in adults"/>
    <definition value="Unexplained severe weight loss (&gt;10% of presumed or measured body weight)"/>
  </concept>
  <concept>
    <code value="DE306"/>
    <display value="Unexplained moderate malnutrition not adequately responding to standard therapy"/>
    <definition value="Defined as weight-for-height &lt; - 2 z-score or mid-upper arm circumference 115 mm to &lt;125 mm. For children younger than five years of age: stunting is defined as severe acute malnutrition - either weight for height &lt; -3 z-score or mid-upper arm circumference &lt;115 mm or the presence of oedema."/>
  </concept>
  <concept>
    <code value="DE307"/>
    <display value="Unexplained chronic diarrhoea for longer than 1 month"/>
    <definition value="Client's symptoms include unexplained chronic diarrhoea for longer than 1 month"/>
  </concept>
  <concept>
    <code value="DE308"/>
    <display value="Unexplained persistent diarrhoea (14 days or more)"/>
    <definition value="Client's symptoms include unexplained persistent diarrhoea (14 days or more)"/>
  </concept>
  <concept>
    <code value="DE309"/>
    <display value="Unexplained persistent fever (above 37.5 C, intermittent or constant, for longer than one 1 month)"/>
    <definition value="Client's symptoms include unexplained persistent fever (above 37.5 C, intermittent or constant, for longer than one 1 month)"/>
  </concept>
  <concept>
    <code value="DE310"/>
    <display value="Persistent oral candidiasis"/>
    <definition value="Client's symptoms include persistent oral candidiasis"/>
  </concept>
  <concept>
    <code value="DE311"/>
    <display value="Oral hairy leukoplakia"/>
    <definition value="Client has fine white small linear or corrugated lesions on lateral borders of the tongue that do not scrape off"/>
  </concept>
  <concept>
    <code value="DE312"/>
    <display value="Pulmonary TB"/>
    <definition value="Client's symptoms include pulmonary TB"/>
  </concept>
  <concept>
    <code value="DE313"/>
    <display value="Lymph node TB"/>
    <definition value="Client's symptoms include lymph node TB"/>
  </concept>
  <concept>
    <code value="DE314"/>
    <display value="Severe bacterial infections (such as pneumonia, empyema, pyomyositis, bone or joint infection, meningitis, bacteraemia)"/>
    <definition value="Client's symptoms include severe bacterial infections (such as pneumonia, empyema, pyomyositis, bone or joint infection, meningitis, bacteraemia)"/>
  </concept>
  <concept>
    <code value="DE315"/>
    <display value="Severe recurrent bacterial pneumonia"/>
    <definition value="Client's symptoms include severe recurrent bacterial pneumonia"/>
  </concept>
  <concept>
    <code value="DE316"/>
    <display value="Acute necrotizing ulcerative stomatitis"/>
    <definition value="Client's symptoms include acute necrotizing ulcerative stomatitis"/>
  </concept>
  <concept>
    <code value="DE317"/>
    <display value="Acute necrotizing ulcerative gingivitis"/>
    <definition value="Client's symptoms include acute necrotizing ulcerative gingivitis"/>
  </concept>
  <concept>
    <code value="DE318"/>
    <display value="Acute necrotizing ulcerative periodontitis"/>
    <definition value="Client's symptoms include acute necrotizing ulcerative periodontitis"/>
  </concept>
  <concept>
    <code value="DE319"/>
    <display value="Unexplained anaemia (&lt;8 g/dL)"/>
    <definition value="Client's symptoms include unexplained anaemia (&lt;8 g/dL)"/>
  </concept>
  <concept>
    <code value="DE320"/>
    <display value="Neutropaenia (&lt;0.5 x 10^9/L)"/>
    <definition value="Client's symptoms include neutropaenia (&lt;0.5 x 10^9/L)"/>
  </concept>
  <concept>
    <code value="DE321"/>
    <display value="Chronic thrombocytopaenia (&lt;50 x 10^9/L)"/>
    <definition value="Client's symptoms include chronic thrombocytopaenia (&lt;50 x 10^9/L)"/>
  </concept>
  <concept>
    <code value="DE322"/>
    <display value="Symptomatic lymphoid interstitial pneumonitis"/>
    <definition value="Client's symptoms include symptomatic lymphoid interstitial pneumonitis"/>
  </concept>
  <concept>
    <code value="DE323"/>
    <display value="Chronic HIV-associated lung disease, including bronchiectasis"/>
    <definition value="Client's symptoms include chronic HIV-associated lung disease, including bronchiectasis"/>
  </concept>
  <concept>
    <code value="DE324"/>
    <display value="HIV wasting syndrome"/>
    <definition value="Unexplained involuntary weight loss (&gt;10% baseline body weight), with obvious wasting or body mass index &lt;18.5; PLUS EITHER unexplained chronic reported for longer than one month; OR reports of fever or night sweats for more than one month without other cause and lack of response to antibiotics or antimalarial agents; malaria must be excluded in malarious areas."/>
  </concept>
  <concept>
    <code value="DE325"/>
    <display value="Unexplained severe wasting not responding to standard therapy"/>
    <definition value="Client has unexplained severe wasting not responding to standard therapy . For under 5 years old, defined as weight-for-height &lt; -3 z-score"/>
  </concept>
  <concept>
    <code value="DE326"/>
    <display value="Unexplained stunting not responding to standard therapy"/>
    <definition value="Client has unexplained stunting not responding to standard therapy . For under 5 years old, defined as length-for- age/height-for-age &lt; -2 z-score"/>
  </concept>
  <concept>
    <code value="DE327"/>
    <display value="Unexplained severe malnutrition not responding to standard therapy"/>
    <definition value="Client has unexplained severe malnutrition not responding to standard therapy . For under 5 years old, weight for height &lt; -3 z-score or mid-upper arm circumference &lt;115 mm or the presence of oedema"/>
  </concept>
  <concept>
    <code value="DE328"/>
    <display value="Pneumocystis (jirovecii) pneumonia"/>
    <definition value="Client's symptoms include pneumocystis (jirovecii) pneumonia"/>
  </concept>
  <concept>
    <code value="DE329"/>
    <display value="Recurrent severe bacterial pneumonia"/>
    <definition value="Client's symptoms include recurrent severe bacterial pneumonia"/>
  </concept>
  <concept>
    <code value="DE330"/>
    <display value="Recurrent severe bacterial infections (such as empyema, pyomyositis, bone or joint infection, meningitis, but excluding pneumonia)"/>
    <definition value="Client's symptoms include recurrent severe bacterial infections (such as empyema, pyomyositis, bone or joint infection, meningitis, but excluding pneumonia)"/>
  </concept>
  <concept>
    <code value="DE331"/>
    <display value="Empyema"/>
    <definition value="Client's symptoms include recurrent empyema"/>
  </concept>
  <concept>
    <code value="DE332"/>
    <display value="Pyomyositis"/>
    <definition value="Client's symptoms include recurrent pyomyositis"/>
  </concept>
  <concept>
    <code value="DE333"/>
    <display value="Bone or joint infection"/>
    <definition value="Client's symptoms include recurrent bone or joint infections"/>
  </concept>
  <concept>
    <code value="DE334"/>
    <display value="Meningitis"/>
    <definition value="Client's symptoms include recurrent meningitis"/>
  </concept>
  <concept>
    <code value="DE335"/>
    <display value="Chronic herpes simplex infection (orolabial or cutaneous of more than 1 month duration or visceral at any site)"/>
    <definition value="Client's symptoms include chronic herpes simplex infection (orolabial or cutaneous of more than 1 month duration or visceral at any site)"/>
  </concept>
  <concept>
    <code value="DE336"/>
    <display value="Chronic herpes simplex infection (orolabial, genital or anorectal of more than 1 month in duration or visceral at any site)"/>
    <definition value="Client's symptoms include chronic herpes simplex infection (orolabial, genital or anorectal of more than one month in duration or visceral at any site)"/>
  </concept>
  <concept>
    <code value="DE337"/>
    <display value="Oesophageal candidiasis (or candidiasis of trachea, bronchi or lungs)"/>
    <definition value="Client's symptoms include oesophageal candidiasis (or candidiasis of trachea, bronchi or lungs)"/>
  </concept>
  <concept>
    <code value="DE338"/>
    <display value="Extrapulmonary TB"/>
    <definition value="Client's symptoms include extrapulmonary tuberculosis"/>
  </concept>
  <concept>
    <code value="DE339"/>
    <display value="Kaposi sarcoma"/>
    <definition value="Client's symptoms include Kaposi sarcoma"/>
  </concept>
  <concept>
    <code value="DE340"/>
    <display value="Cytomegalovirus infection (retinitis or infection of other organs)"/>
    <definition value="Client's symptoms include cytomegalovirus infection (retinitis or infection of other organs)"/>
  </concept>
  <concept>
    <code value="DE341"/>
    <display value="Central nervous system toxoplasmosis"/>
    <definition value="Client's symptoms include central nervous system toxoplasmosis"/>
  </concept>
  <concept>
    <code value="DE342"/>
    <display value="HIV encephalopathy"/>
    <definition value="Client's symptoms include HIV encephalopathy"/>
  </concept>
  <concept>
    <code value="DE343"/>
    <display value="Extrapulmonary cryptococcosis, including meningitis"/>
    <definition value="Client's symptoms include extrapulmonary cryptococcosis, including meningitis"/>
  </concept>
  <concept>
    <code value="DE344"/>
    <display value="Disseminated nontuberculous mycobacterial infection"/>
    <definition value="Client's symptoms include disseminated nontuberculous mycobacterial infection"/>
  </concept>
  <concept>
    <code value="DE345"/>
    <display value="Progressive multifocal leukoencephalopathy"/>
    <definition value="Client's symptoms include progressive multifocal leukoencephalopathy"/>
  </concept>
  <concept>
    <code value="DE346"/>
    <display value="Chronic cryptosporidiosis"/>
    <definition value="Client's symptoms include chronic cryptosporidiosis"/>
  </concept>
  <concept>
    <code value="DE347"/>
    <display value="Chronic cryptosporidiosis (with diarrhoea)"/>
    <definition value="Client's symptoms include chronic cryptosporidiosis (with diarrhoea)"/>
  </concept>
  <concept>
    <code value="DE348"/>
    <display value="Chronic isosporiasis"/>
    <definition value="Client's symptoms include chronic isosporiasis"/>
  </concept>
  <concept>
    <code value="DE349"/>
    <display value="Disseminated mycosis (extrapulmonary histoplasmosis, coccidioidomycosis)"/>
    <definition value="Client's symptoms include disseminated mycosis (extrapulmonary histoplasmosis, coccidioidomycosis)"/>
  </concept>
  <concept>
    <code value="DE350"/>
    <display value="Disseminated endemic mycosis (extrapulmonary histoplasmosis, coccidioidomycosis, penicilliosis)"/>
    <definition value="Client's symptoms include disseminated endemic mycosis (extrapulmonary histoplasmosis, coccidioidomycosis, penicilliosis)"/>
  </concept>
  <concept>
    <code value="DE351"/>
    <display value="Cerebral lymphoma"/>
    <definition value="Client's symptoms include cerebral lymphoma"/>
  </concept>
  <concept>
    <code value="DE352"/>
    <display value="B-cell non-Hodgkin lymphoma"/>
    <definition value="Client's symptoms include b-cell non-Hodgkin lymphoma"/>
  </concept>
  <concept>
    <code value="DE353"/>
    <display value="HIV-associated nephropathy or cardiomyopathy"/>
    <definition value="Client's symptoms include HIV- associated nephropathy or cardiomyopathy"/>
  </concept>
  <concept>
    <code value="DE354"/>
    <display value="Recurrent septicaemia (including nontyphoidal Salmonella)"/>
    <definition value="Client's symptoms include recurrent bacteraemia (septicaemia) (including nontyphoidal salmonella)"/>
  </concept>
  <concept>
    <code value="DE355"/>
    <display value="Invasive cervical carcinoma"/>
    <definition value="Client's symptoms include invasive cervical carcinoma"/>
  </concept>
  <concept>
    <code value="DE356"/>
    <display value="Atypical disseminated leishmaniasis"/>
    <definition value="Client's symptoms include atypical disseminated leishmaniasis"/>
  </concept>
  <concept>
    <code value="DE357"/>
    <display value="Neutropenia"/>
    <definition value="Client's symptoms include neutropenia, an abnormally low count of a type of white blood cell (neutrophils)"/>
  </concept>
  <concept>
    <code value="DE358"/>
    <display value="Clinical stage at start of ART"/>
    <definition value="WHO clinical stage of client based on signs and symptoms at start of ART"/>
  </concept>
  <concept>
    <code value="DE359"/>
    <display value="WHO clinical stage 1"/>
    <definition value="Client is assessed to be at a clinical stage of 1 at the time of starting ART, based on clinical assessment and diagnostics"/>
  </concept>
  <concept>
    <code value="DE360"/>
    <display value="WHO clinical stage 2"/>
    <definition value="Client is assessed to be at a clinical stage of 2 at the time of starting ART, based on clinical assessment and diagnostics"/>
  </concept>
  <concept>
    <code value="DE361"/>
    <display value="WHO clinical stage 3"/>
    <definition value="Client is assessed to be at a clinical stage of 3 at the time of starting ART, based on clinical assessment and diagnostics"/>
  </concept>
  <concept>
    <code value="DE362"/>
    <display value="WHO clinical stage 4"/>
    <definition value="Client is assessed to be at a clinical stage of 4 at the time of starting ART, based on clinical assessment and diagnostics"/>
  </concept>
  <concept>
    <code value="DE363"/>
    <display value="Date of clinical status change"/>
    <definition value="Date on which the client's WHO HIV clinical stage changed, including the date when the client's stage is first determined"/>
  </concept>
  <concept>
    <code value="DE364"/>
    <display value="CD4 count"/>
    <definition value="CD4 cell count in cells/mm^3"/>
  </concept>
  <concept>
    <code value="DE365"/>
    <display value="CD4 cell percentage"/>
    <definition value="CD4 cell percentage"/>
  </concept>
  <concept>
    <code value="DE366"/>
    <display value="Date of CD4 count test"/>
    <definition value="Date and time when CD4 count test was conducted"/>
  </concept>
  <concept>
    <code value="DE367"/>
    <display value="Baseline CD4 count"/>
    <definition value="CD4 result from first CD4 test performed (such as at treatment initiation), also may be called CD4 at ART initiation or at ART start"/>
  </concept>
  <concept>
    <code value="DE368"/>
    <display value="Date of baseline CD4 count test"/>
    <definition value="Date and time when baseline CD4 count test was conducted"/>
  </concept>
  <concept>
    <code value="DE369"/>
    <display value="Late ART initiation"/>
    <definition value="Client had late ART initiation. That is, the client's first CD4 count from baseline CD4 test performed (such as at treatment initiation) was a count of &lt;200 cells/mm3"/>
  </concept>
  <concept>
    <code value="DE370"/>
    <display value="Reasons for delayed ART initiation"/>
    <definition value="Reason why ART was not initiated at diagnosis or within 7 days of diagnosis"/>
  </concept>
  <concept>
    <code value="DE371"/>
    <display value="Patient self-reported as not ready/willing"/>
    <definition value="Client did not initiate ART at diagnosis or within 7 days of diagnosis because client self-reported as not ready/willing"/>
  </concept>
  <concept>
    <code value="DE372"/>
    <display value="Not completed education, support and preparation for ART"/>
    <definition value="Client did not initiate ART at diagnosis or within 7 days of diagnosis because client had not completed education, support and preparation for ART"/>
  </concept>
  <concept>
    <code value="DE373"/>
    <display value="Fear of disclosure"/>
    <definition value="Client did not initiate ART at diagnosis or within 7 days of diagnosis because of client's fear of disclosure"/>
  </concept>
  <concept>
    <code value="DE374"/>
    <display value="Patient lacks finances"/>
    <definition value="Client did not initiate ART at diagnosis or within 7 days of diagnosis because client lacks finances"/>
  </concept>
  <concept>
    <code value="DE375"/>
    <display value="Initiated on TB treatment"/>
    <definition value="Client did not initiate ART at diagnosis or within 7 days of diagnosis because client initiated on TB treatment"/>
  </concept>
  <concept>
    <code value="DE376"/>
    <display value="Patient initiated on treatment for TB meningitis"/>
    <definition value="Client did not initiate ART at diagnosis or within 7 days of diagnosis because client initiated on treatment for TB meningitis"/>
  </concept>
  <concept>
    <code value="DE377"/>
    <display value="Patient diagnosed with cryptococcal meningitis"/>
    <definition value="Client did not initiate ART at diagnosis or within 7 days of diagnosis because client diagnosed with cryptococcal meningitis"/>
  </concept>
  <concept>
    <code value="DE378"/>
    <display value="Patient diagnosed with histoplasmosis"/>
    <definition value="Client did not initiate ART at diagnosis or within 7 days of diagnosis because client diagnosed with histoplasmosis"/>
  </concept>
  <concept>
    <code value="DE379"/>
    <display value="Patient critically/severely ill"/>
    <definition value="Client did not initiate ART at diagnosis or within 7 days of diagnosis because client critically/severely ill"/>
  </concept>
  <concept>
    <code value="DE380"/>
    <display value="Other"/>
    <definition value="Client did not initiate ART at diagnosis or within 7 days of diagnosis because of other reason"/>
  </concept>
  <concept>
    <code value="DE381"/>
    <display value="Other (specify)"/>
    <definition value="Client did not initiate ART at diagnosis or within 7 days of diagnosis because of other reason (specify)"/>
  </concept>
  <concept>
    <code value="DE382"/>
    <display value="ART initiated within 7 days of diagnosis"/>
    <definition value="Client initiated ART within 7 days of diagnosis"/>
  </concept>
  <concept>
    <code value="DE383"/>
    <display value="Time to start ART"/>
    <definition value="Time from HIV diagnosis to when client started ART"/>
  </concept>
  <concept>
    <code value="DE384"/>
    <display value="Within 7 days of HIV diagnosis"/>
    <definition value="Client started ART within 7 days"/>
  </concept>
  <concept>
    <code value="DE385"/>
    <display value="Within 30 days of HIV diagnosis"/>
    <definition value="Client started ART within 30 days of ART initiation (but over 7 days)"/>
  </concept>
  <concept>
    <code value="DE386"/>
    <display value="Within 90 days of HIV diagnosis"/>
    <definition value="Client started ART within 90 days of ART initiation (but over 30 days)"/>
  </concept>
  <concept>
    <code value="DE387"/>
    <display value="Viral load test result"/>
    <definition value="Result from the viral load test in number of copies/mL"/>
  </concept>
  <concept>
    <code value="DE388"/>
    <display value="Virally suppressed"/>
    <definition value="The client is virally suppressed for HIV, based on the client's most recent viral load test result being less than 1000 copies/mL"/>
  </concept>
  <concept>
    <code value="DE389"/>
    <display value="Date viral load test results received"/>
    <definition value="Date the viral load test result was received from the lab or completed in the facility"/>
  </concept>
  <concept>
    <code value="DE390"/>
    <display value="Viral load suppression date"/>
    <definition value="Date on which the client tested as becoming virally suppressed, as indicated by a viral load test result under 1000 copies/mL"/>
  </concept>
  <concept>
    <code value="DE391"/>
    <display value="Reason for HIV viral load test"/>
    <definition value="Whether the viral load is being tested for routine monitoring on a set schedule or for targeted monitoring for suspected treatment failure"/>
  </concept>
  <concept>
    <code value="DE392"/>
    <display value="Routine viral load test"/>
    <definition value="Routine refers to viral load tests obtained at standard intervals following ART initiation to monitor viral load response to ART"/>
  </concept>
  <concept>
    <code value="DE393"/>
    <display value="Targeted viral load monitoring"/>
    <definition value="Targeted refers to viral load tests obtained based on a specific clinical indication (such as concern about disease progression or failure to respond to ART)"/>
  </concept>
  <concept>
    <code value="DE394"/>
    <display value="Initial viral load test"/>
    <definition value="The first viral load test of the client"/>
  </concept>
  <concept>
    <code value="DE395"/>
    <display value="Follow-up viral load test after receiving enhanced adherence counselling"/>
    <definition value="A follow-up viral load test within 3-6 months after enhanced adherence counselling after client received a high viral load test result"/>
  </concept>
  <concept>
    <code value="DE396"/>
    <display value="Hepatitis B test required"/>
    <definition value="Hepatitis B test is required"/>
  </concept>
  <concept>
    <code value="DE397"/>
    <display value="Hepatitis C test recommended"/>
    <definition value="Hepatitis C test is recommended or should be considered"/>
  </concept>
  <concept>
    <code value="DE398"/>
    <display value="Syphilis test required"/>
    <definition value="Syphilis test is required"/>
  </concept>
  <concept>
    <code value="DE399"/>
    <display value="Monitoring examinations"/>
    <definition value="Name of examinations, test and results for any relevant investigations carried out for client"/>
  </concept>
  <concept>
    <code value="DE400"/>
    <display value="Haemoglobin (Hb)"/>
    <definition value="Provider ordered a Haemoglobin (Hb) test, number in g/dL test"/>
  </concept>
  <concept>
    <code value="DE401"/>
    <display value="Pregnancy test"/>
    <definition value="Provider ordered a pregnancy test for client"/>
  </concept>
  <concept>
    <code value="DE402"/>
    <display value="Syphilis test"/>
    <definition value="Provider ordered a syphilis test"/>
  </concept>
  <concept>
    <code value="DE403"/>
    <display value="Chest X-ray (CXR)"/>
    <definition value="Provider ordered a chest X-ray (CXR)"/>
  </concept>
  <concept>
    <code value="DE404"/>
    <display value="Sputum or culture for TB"/>
    <definition value="Provider ordered sputum or culture for TB"/>
  </concept>
  <concept>
    <code value="DE405"/>
    <display value="HBsAg test (HBV)"/>
    <definition value="Provider ordered an HBsAg test (HBV) test"/>
  </concept>
  <concept>
    <code value="DE406"/>
    <display value="HIV viral load test ordered"/>
    <definition value="Provider ordered an HIV viral load test"/>
  </concept>
  <concept>
    <code value="DE407"/>
    <display value="HIV viral load test scheduled"/>
    <definition value="Scheduled an HIV viral load test with client"/>
  </concept>
  <concept>
    <code value="DE408"/>
    <display value="CD4 count ordered"/>
    <definition value="Provider ordered a CD4 cell count"/>
  </concept>
  <concept>
    <code value="DE409"/>
    <display value="CD4 count test scheduled"/>
    <definition value="Scheduled a CD4 test with client"/>
  </concept>
  <concept>
    <code value="DE410"/>
    <display value="Cryptococcal antigen test"/>
    <definition value="Provider ordered a cryptococcal antigen test"/>
  </concept>
  <concept>
    <code value="DE411"/>
    <display value="Histoplasmosis antigen test"/>
    <definition value="Provider ordered a histoplasmosis antigen test"/>
  </concept>
  <concept>
    <code value="DE412"/>
    <display value="Cervical cancer screening scheduled"/>
    <definition value="Scheduled cervical cancer screening with client"/>
  </concept>
  <concept>
    <code value="DE413"/>
    <display value="Date of scheduled monitoring examination"/>
    <definition value="Date of scheduled monitoring examination"/>
  </concept>
  <concept>
    <code value="DE414"/>
    <display value="Hepatitis C test ordered"/>
    <definition value="Hepatitis C test has been ordered"/>
  </concept>
  <concept>
    <code value="DE415"/>
    <display value="Syphilis test ordered"/>
    <definition value="Syphilis test has been ordered"/>
  </concept>
  <concept>
    <code value="DE416"/>
    <display value="Received viral load test results"/>
    <definition value="Client received results from viral load test"/>
  </concept>
  <concept>
    <code value="DE417"/>
    <display value="Date viral load test results received by client"/>
    <definition value="The date on which the client received results from a viral load test"/>
  </concept>
  <concept>
    <code value="DE418"/>
    <display value="Reason for ARV drug regimen substitution"/>
    <definition value="Reason why a substitution was made to the antiretroviral (ARV) drug regimen"/>
  </concept>
  <concept>
    <code value="DE419"/>
    <display value="Toxicity/side effects"/>
    <definition value="A substitution was made to the regimen because of toxicity/side effects"/>
  </concept>
  <concept>
    <code value="DE420"/>
    <display value="Drug-drug interaction"/>
    <definition value="A substitution was made to the regimen because of a drug-drug interaction"/>
  </concept>
  <concept>
    <code value="DE421"/>
    <display value="Pregnancy"/>
    <definition value="A substitution was made to the regimen because of pregnancy"/>
  </concept>
  <concept>
    <code value="DE422"/>
    <display value="New TB"/>
    <definition value="A substitution was made to the regimen because of new tuberculosis (TB)"/>
  </concept>
  <concept>
    <code value="DE423"/>
    <display value="New drug available"/>
    <definition value="A substitution was made to the regimen because a new drug was available"/>
  </concept>
  <concept>
    <code value="DE424"/>
    <display value="Drug out of stock"/>
    <definition value="A substitution was made to the regimen because drug was out of stock"/>
  </concept>
  <concept>
    <code value="DE425"/>
    <display value="Other reason for regimen substitution"/>
    <definition value="A substitution was made for another reason"/>
  </concept>
  <concept>
    <code value="DE426"/>
    <display value="Other reason for regimen substitution (specify)"/>
    <definition value="A substitution was made for another reason (specify)"/>
  </concept>
  <concept>
    <code value="DE427"/>
    <display value="Switch to second-line ART regimen recommended"/>
    <definition value="A switch to second-line ART regimen is recommended"/>
  </concept>
  <concept>
    <code value="DE428"/>
    <display value="Switch to third-line ART regimen recommended"/>
    <definition value="A switch to third-line ART regimen is recommended"/>
  </concept>
  <concept>
    <code value="DE429"/>
    <display value="Regimen switch made"/>
    <definition value="Provider has made a regimen switch"/>
  </concept>
  <concept>
    <code value="DE430"/>
    <display value="Reason for regimen switch"/>
    <definition value="Reason why a switch to a second- or third-line regimen was made"/>
  </concept>
  <concept>
    <code value="DE431"/>
    <display value="Clinical treatment failure"/>
    <definition value="A switch was made to the regimen because of clinical treatment failure"/>
  </concept>
  <concept>
    <code value="DE432"/>
    <display value="Immunological failure"/>
    <definition value="A switch was made to the regimen because of immunological failure"/>
  </concept>
  <concept>
    <code value="DE433"/>
    <display value="Virological failure"/>
    <definition value="A switch was made to the regimen because of virological failure"/>
  </concept>
  <concept>
    <code value="DE434"/>
    <display value="Other"/>
    <definition value="A switch was made to the regimen for another reason"/>
  </concept>
  <concept>
    <code value="DE435"/>
    <display value="Other (specify)"/>
    <definition value="A switch was made to the regimen for another reason (specify)"/>
  </concept>
  <concept>
    <code value="DE436"/>
    <display value="Regimen substitution recommended"/>
    <definition value="A drug substitution is recommended"/>
  </concept>
  <concept>
    <code value="DE437"/>
    <display value="Dose adjustment recommended"/>
    <definition value="A dosage change is recommended"/>
  </concept>
  <concept>
    <code value="DE438"/>
    <display value="Regimen substitution made"/>
    <definition value="Provider has made a regimen substitution"/>
  </concept>
  <concept>
    <code value="DE439"/>
    <display value="Co-trimoxazole prophylaxis start date"/>
    <definition value="Date co-trimoxazole prophylaxis prescribed to client"/>
  </concept>
  <concept>
    <code value="DE440"/>
    <display value="Co-trimoxazole prophylaxis completion date"/>
    <definition value="Completion date of co-trimoxazole prophylaxis prescribed to client"/>
  </concept>
  <concept>
    <code value="DE441"/>
    <display value="Co-trimoxazole prophylaxis dosage"/>
    <definition value="Dose of co-trimoxazole prophylaxis prescribed to client"/>
  </concept>
  <concept>
    <code value="DE442"/>
    <display value="Co-trimoxazole prophylaxis number of days prescribed"/>
    <definition value="Number of days of co-trimoxazole prophylaxis prescribed to client"/>
  </concept>
  <concept>
    <code value="DE443"/>
    <display value="Suspicion of treatment failure or interruption"/>
    <definition value="Client has been on ART, but has stopped taking it or a treatment failure is suspected"/>
  </concept>
  <concept>
    <code value="DE444"/>
    <display value="ART regimen prescribed"/>
    <definition value="INCLUDE VALUE SETS OF REGIMENS"/>
  </concept>
  <concept>
    <code value="DE445"/>
    <display value="Antiretroviral toxicity"/>
    <definition value="Client is experiencing antiretroviral drug (ARV) toxicity"/>
  </concept>
  <concept>
    <code value="DE446"/>
    <display value="Coinfection status at ART start"/>
    <definition value="Clients status of coinfections at the time when ART was initiated"/>
  </concept>
  <concept>
    <code value="DE447"/>
    <display value="Hepatitis B"/>
    <definition value="Client was hepatitis B positive at the start of ART"/>
  </concept>
  <concept>
    <code value="DE448"/>
    <display value="Hepatitis C"/>
    <definition value="Client was hepatitis C positive at the start of ART"/>
  </concept>
  <concept>
    <code value="DE449"/>
    <display value="Pregnant and breastfeeding status at ART start"/>
    <definition value="ART status of women to prevent mother-to-child transmission"/>
  </concept>
  <concept>
    <code value="DE450"/>
    <display value="Pregnant at ART start"/>
    <definition value="Client was pregnant when ART was initiated"/>
  </concept>
  <concept>
    <code value="DE451"/>
    <display value="Postpartum at ART start"/>
    <definition value="Client was postpartum when ART was initiated"/>
  </concept>
  <concept>
    <code value="DE452"/>
    <display value="ART start at labour and delivery"/>
    <definition value="Client initiated ART at labour and delivery"/>
  </concept>
  <concept>
    <code value="DE453"/>
    <display value="Breastfeeding at ART start"/>
    <definition value="Client was breastfeeding when ART was initiated"/>
  </concept>
  <concept>
    <code value="DE454"/>
    <display value="Delivery date of infant"/>
    <definition value="Date of delivery/birth of infant if breastfeeding at ART start"/>
  </concept>
  <concept>
    <code value="DE455"/>
    <display value="Serodiscordant partner at ART start"/>
    <definition value="Client living with HIV was in an ongoing sexual relationship with an HIV-negative partner when ART was started"/>
  </concept>
  <concept>
    <code value="DE456"/>
    <display value="Regimen start date"/>
    <definition value="The date on which the client started taking the current ART regimen"/>
  </concept>
  <concept>
    <code value="DE457"/>
    <display value="Medications prescribed"/>
    <definition value="Name or regimen code of all other medications prescribed during the visit"/>
  </concept>
  <concept>
    <code value="DE458"/>
    <display value="Date medications prescribed"/>
    <definition value="Date the medications were prescribed"/>
  </concept>
  <concept>
    <code value="DE459"/>
    <display value="Dose of medications prescribed"/>
    <definition value="Number of doses (quantity taken at a single point in time) of drugs prescribed/dispensed"/>
  </concept>
  <concept>
    <code value="DE460"/>
    <display value="Number of days medications prescribed"/>
    <definition value="Number of days supply of each medication or regimen prescribed during the visit"/>
  </concept>
  <concept>
    <code value="DE461"/>
    <display value="Medications dispensed"/>
    <definition value="Any other medications that were dispensed to client, including preventive treatment"/>
  </concept>
  <concept>
    <code value="DE462"/>
    <display value="Number of days of medications dispensed"/>
    <definition value="Number of days supply of each medication or regimen dispensed during the visit"/>
  </concept>
  <concept>
    <code value="DE463"/>
    <display value="Dosage"/>
    <definition value="Prescribed dosage of the medication"/>
  </concept>
  <concept>
    <code value="DE464"/>
    <display value="Frequency"/>
    <definition value="Prescribed frequency for taking the medication"/>
  </concept>
  <concept>
    <code value="DE465"/>
    <display value="Adherence counselling provided"/>
    <definition value="Counselling was carried out during visit"/>
  </concept>
  <concept>
    <code value="DE466"/>
    <display value="Type of treatment-limiting toxicity"/>
    <definition value="Type of treatment-limiting toxicity experienced by client. Treatment-limiting toxicity is defined as a serious adverse drug reaction that results in drug discontinuation or substitution. In addition, any reaction that leads to treatment interruption or requires changing the drug or regimen because of an adverse drug reaction is also considered a serious adverse drug reaction."/>
  </concept>
  <concept>
    <code value="DE467"/>
    <display value="Gastrointestinal"/>
    <definition value="Treatment-limiting toxicity due to GI issues (nausea, diarrhoea, abdominal pain, vomiting)"/>
  </concept>
  <concept>
    <code value="DE468"/>
    <display value="Skin issues"/>
    <definition value="Treatment-limiting toxicity due to skin issues (rash, hypersensitivity reaction)"/>
  </concept>
  <concept>
    <code value="DE469"/>
    <display value="Peripheral neuropathy"/>
    <definition value="Treatment-limiting toxicity due to peripheral neuropathy (burning/numbness/ tingling)"/>
  </concept>
  <concept>
    <code value="DE470"/>
    <display value="Central nervous system symptoms"/>
    <definition value="Treatment-limiting toxicity due to central nervous system symptoms (dizzy, anxiety, nightmare, depression, seizures)"/>
  </concept>
  <concept>
    <code value="DE471"/>
    <display value="Weight gain"/>
    <definition value="Treatment-limiting toxicity due to weight gain"/>
  </concept>
  <concept>
    <code value="DE472"/>
    <display value="Hepatic dysfunction"/>
    <definition value="Treatment-limiting toxicity due to hepatic dysfunction (jaundice)"/>
  </concept>
  <concept>
    <code value="DE473"/>
    <display value="Haematological disorders"/>
    <definition value="Treatment-limiting toxicity due to haematological (anaemia, neutropenia) disorders"/>
  </concept>
  <concept>
    <code value="DE474"/>
    <display value="Fatigue"/>
    <definition value="Treatment-limiting toxicity due to fatigue"/>
  </concept>
  <concept>
    <code value="DE475"/>
    <display value="Headache"/>
    <definition value="Treatment-limiting toxicity due to headache"/>
  </concept>
  <concept>
    <code value="DE476"/>
    <display value="Bone dysfunction"/>
    <definition value="Treatment-limiting toxicity due to bone dysfunction (fractures, osteopenia)"/>
  </concept>
  <concept>
    <code value="DE477"/>
    <display value="Metabolic symptoms"/>
    <definition value="Treatment-limiting toxicity due to metabolic symptoms (body fat changes, hyperglycaemia, dyslipidaemia)"/>
  </concept>
  <concept>
    <code value="DE478"/>
    <display value="Kidney dysfunction"/>
    <definition value="Treatment-limiting toxicity due to kidney dysfunction (nephrolithiasis, renal insufficiency)"/>
  </concept>
  <concept>
    <code value="DE479"/>
    <display value="Unexpected adverse drug reaction"/>
    <definition value="Client experienced an unexpected adverse drug reaction"/>
  </concept>
  <concept>
    <code value="DE480"/>
    <display value="Unexpected adverse drug reaction (specify)"/>
    <definition value="Specify the type of unexpected adverse drug reaction the client experienced"/>
  </concept>
  <concept>
    <code value="DE481"/>
    <display value="Date(s) of substitution within first-line regimen"/>
    <definition value="Date on which ARV drug regimen (one or more drugs) for client was changed within the first-line regimen (substitution)"/>
  </concept>
  <concept>
    <code value="DE482"/>
    <display value="Reason(s) for substitution within first-line regimen"/>
    <definition value="Reason(s) why one ore more drugs in client's first-line ARV drug regimen was changed (substituted)"/>
  </concept>
  <concept>
    <code value="DE483"/>
    <display value="New antiretroviral regimen after substitution within first-line regimen"/>
    <definition value="New antiretroviral (ARV) drugs after client changed regimen within the first-line regimen"/>
  </concept>
  <concept>
    <code value="DE484"/>
    <display value="Date of switch to second-line regimen"/>
    <definition value="Date client was changed from a first-line to second-line ARV drug regimen (switch)"/>
  </concept>
  <concept>
    <code value="DE485"/>
    <display value="New regimen after switch to second-line regimen"/>
    <definition value="New ART regimen after switch to second-line ART regimen"/>
  </concept>
  <concept>
    <code value="DE486"/>
    <display value="Reason for switch to second-line regimen"/>
    <definition value="Reason why client was switched from first- to second-line ARV drug regimen (see &quot;Reason for regimen switch&quot; for levels)"/>
  </concept>
  <concept>
    <code value="DE487"/>
    <display value="Date(s) of substitution within second-line regimen"/>
    <definition value="Date on which ARV drug regimen for client was changed within the second-line regimen (substitution)"/>
  </concept>
  <concept>
    <code value="DE488"/>
    <display value="Reason(s) for substitution within second-line regimen"/>
    <definition value="Reason(s) why client changed drug regimen (within the second-line)"/>
  </concept>
  <concept>
    <code value="DE489"/>
    <display value="New regimen(s) after substitution within second-line regimen"/>
    <definition value="New ARV drugs after client changed regimen within the second- line regimen"/>
  </concept>
  <concept>
    <code value="DE490"/>
    <display value="Date of switch to third-line regimen"/>
    <definition value="Date client was changed from a second- to third-line ARV drug regimen (switch)"/>
  </concept>
  <concept>
    <code value="DE491"/>
    <display value="New regimen after switch to third-line regimen"/>
    <definition value="New ART regimen after switch to third-line ART regimen"/>
  </concept>
  <concept>
    <code value="DE492"/>
    <display value="Reason for switch to third-line regimen"/>
    <definition value="Reason why client was switched from second- to third-line ARV drug regimen (see &quot;Reason for regimen switch&quot; for levels)"/>
  </concept>
  <concept>
    <code value="DE493"/>
    <display value="Date(s) of substitution within third-line regimen"/>
    <definition value="Date on which ARV drug regimen for client was changed within the third-line (substitution)"/>
  </concept>
  <concept>
    <code value="DE494"/>
    <display value="Reason(s) for substitution within third-line regimen"/>
    <definition value="Reason(s) why client changed drug regimen (within the third-line)"/>
  </concept>
  <concept>
    <code value="DE495"/>
    <display value="New regimen(s) after substitution within third-line regimen"/>
    <definition value="New ARV drugs after client changed regimen within the third-line regimen"/>
  </concept>
  <concept>
    <code value="DE496"/>
    <display value="Enhanced adherence counselling provided"/>
    <definition value="Enhanced adherence counselling was provided to the client during the visit"/>
  </concept>
  <concept>
    <code value="DE497"/>
    <display value="First enhanced adherence counselling session completed"/>
    <definition value="A first enhanced adherence counselling was provided to the client during the visit"/>
  </concept>
  <concept>
    <code value="DE498"/>
    <display value="Date of first enhanced adherence counselling session completed"/>
    <definition value="The date on which the first enhanced adherence counselling was provided to the client"/>
  </concept>
  <concept>
    <code value="DE499"/>
    <display value="Second enhanced adherence counselling session completed"/>
    <definition value="A second enhanced adherence counselling was provided to the client during the visit"/>
  </concept>
  <concept>
    <code value="DE500"/>
    <display value="Date of second enhanced adherence counselling session completed"/>
    <definition value="The date on which the second enhanced adherence counselling was provided to the client"/>
  </concept>
  <concept>
    <code value="DE501"/>
    <display value="Third enhanced adherence counselling session completed"/>
    <definition value="A third enhanced adherence counselling was provided to the client during the visit"/>
  </concept>
  <concept>
    <code value="DE502"/>
    <display value="Date of third enhanced adherence counselling session completed"/>
    <definition value="The date on which the third enhanced adherence counselling was provided to the client"/>
  </concept>
  <concept>
    <code value="DE503"/>
    <display value="Name of treatment supporter"/>
    <definition value="Full name of person providing support to client for adherence, care, treatment and other needs (e.g. ARV pick-up if ill)"/>
  </concept>
  <concept>
    <code value="DE504"/>
    <display value="Address of treatment supporter"/>
    <definition value="Full address or description of home of treatment supporter"/>
  </concept>
  <concept>
    <code value="DE505"/>
    <display value="Telephone number of treatment supporter"/>
    <definition value="Telephone number if available, or else telephone number of neighbour/friend"/>
  </concept>
  <concept>
    <code value="DE506"/>
    <display value="Home-based care provider"/>
    <definition value="Name of individual or organization that provides home-based care to client"/>
  </concept>
  <concept>
    <code value="DE507"/>
    <display value="Counselling provided on diagnoses"/>
    <definition value="Counselling provided on diagnoses"/>
  </concept>
  <concept>
    <code value="DE508"/>
    <display value="Hepatitis B positive counselling conducted"/>
    <definition value="Whether counselling was provided to a client who has been diagnosed with hepatitis B"/>
  </concept>
  <concept>
    <code value="DE509"/>
    <display value="Hepatitis C positive counselling conducted"/>
    <definition value="Whether counselling was provided to a client who has been diagnosed with hepatitis C"/>
  </concept>
  <concept>
    <code value="DE510"/>
    <display value="Syphilis counselling and treatment"/>
    <definition value="Whether counselling and treatment was provided to a client who has been diagnosed with syphilis"/>
  </concept>
  <concept>
    <code value="DE511"/>
    <display value="Syphilis counselling, treatment and further testing"/>
    <definition value="Whether counselling and treatment was provided to a client who has been diagnosed with syphilis. Additional testing (RPR test) recommended."/>
  </concept>
  <concept>
    <code value="DE512"/>
    <display value="Accepted partner services"/>
    <definition value="Client accepted offer for partner services"/>
  </concept>
  <concept>
    <code value="DE513"/>
    <display value="HIV testing for partners and biological children"/>
    <definition value="Offer voluntary testing for all partners and biological children of positive cases (includes partner services and index case testing), as well as partners and social contacts of people from key populations, where appropriate"/>
  </concept>
  <concept>
    <code value="DE514"/>
    <display value="HIV status of family member"/>
    <definition value="HIV status of each family member at time of patient's enrolment, including partner (for mothers)"/>
  </concept>
  <concept>
    <code value="DE515"/>
    <display value="Unique ID of family member"/>
    <definition value="Unique ID number of each family member if enrolled in HIV care according to national guidelines (see unique ID number)"/>
  </concept>
  <concept>
    <code value="DE516"/>
    <display value="Date of death of family member"/>
    <definition value="Date of death for each family member as appropriate"/>
  </concept>
  <concept>
    <code value="DE517"/>
    <display value="Offered voluntary partner services"/>
    <definition value="Whether the client was offered voluntary partner services or family services"/>
  </concept>
  <concept>
    <code value="DE518"/>
    <display value="Provided support for disclosure and partner services"/>
    <definition value="Offer or refer for support for disclosure and partner services"/>
  </concept>
  <concept>
    <code value="DE519"/>
    <display value="Other support services"/>
    <definition value="Offer or refer for other support services"/>
  </concept>
  <concept>
    <code value="DE520"/>
    <display value="Mental health services"/>
    <definition value="Offer or refer for mental health services"/>
  </concept>
  <concept>
    <code value="DE521"/>
    <display value="Psychosocial counselling, support and treatment adherence counselling"/>
    <definition value="Offer or refer for psychosocial counselling, support and treatment adherence counselling"/>
  </concept>
  <concept>
    <code value="DE522"/>
    <display value="Legal and social services"/>
    <definition value="Offer or refer for legal and social services"/>
  </concept>
  <concept>
    <code value="DE523"/>
    <display value="Services for responding to violence against women"/>
    <definition value="Offer or refer for services for responding to violence against women, including first-line support and psychosocial support, post-rape care and other support services including shelters, legal services and women and child protection services"/>
  </concept>
  <concept>
    <code value="DE524"/>
    <display value="Date/time of follow-up appointment"/>
    <definition value="Date the client is to return for monitoring, re-supply or any other reason"/>
  </concept>
  <concept>
    <code value="DE525"/>
    <display value="Type of follow-up appointment"/>
    <definition value="Whether the visit will be clinical only, ARV drug pick-up or other. Client may have multiple follow-ups scheduled."/>
  </concept>
  <concept>
    <code value="DE526"/>
    <display value="Clinical visit"/>
    <definition value="Appointment for clinical care by a provider"/>
  </concept>
  <concept>
    <code value="DE527"/>
    <display value="Antiretroviral drug pick up"/>
    <definition value="Appointment for a drug pick up"/>
  </concept>
  <concept>
    <code value="DE528"/>
    <display value="Post-treatment follow-up visit for cervical precancer lesions or invasive cervical cancer"/>
    <definition value="Appointment for a post-treatment follow-up visit for cervical precancer lesions or invasive cervical cancer"/>
  </concept>
  <concept>
    <code value="DE529"/>
    <display value="Other"/>
    <definition value="Other reason for the follow-up appointment"/>
  </concept>
  <concept>
    <code value="DE530"/>
    <display value="Other (specify)"/>
    <definition value="Other reason for the follow-up appointment (specify)"/>
  </concept>
  <concept>
    <code value="DE531"/>
    <display value="Follow-up test recommended date"/>
    <definition value="A test or screening recommended for the client's care plan at a future date"/>
  </concept>
  <concept>
    <code value="DE532"/>
    <display value="Reason blood pressure reading not done"/>
    <definition value="Reason why test was not performed"/>
  </concept>
  <concept>
    <code value="DE533"/>
    <display value="BP cuff (sphygmomanometer) not available"/>
    <definition value="Blood pressure cuff is not available"/>
  </concept>
  <concept>
    <code value="DE534"/>
    <display value="BP cuff (sphygmomanometer) is broken"/>
    <definition value="Blood pressure cuff is broken"/>
  </concept>
  <concept>
    <code value="DE535"/>
    <display value="Other"/>
    <definition value="Other reason blood pressure can not be taken"/>
  </concept>
  <concept>
    <code value="DE536"/>
    <display value="Other (specify)"/>
    <definition value="Other reason blood pressure can not be taken (specify)"/>
  </concept>
  <concept>
    <code value="DE537"/>
    <display value="Current medications"/>
    <definition value="List of all of the medications the client is currently taking"/>
  </concept>
  <concept>
    <code value="DE538"/>
    <display value="No medications"/>
    <definition value="The client is currently not on any medications"/>
  </concept>
  <concept>
    <code value="DE539"/>
    <display value="Don't know of any current medications"/>
    <definition value="The client does not know if she is on any medications"/>
  </concept>
  <concept>
    <code value="DE540"/>
    <display value="Analgesic"/>
    <definition value="Analgesic medication (painkiller)"/>
  </concept>
  <concept>
    <code value="DE541"/>
    <display value="Antacids"/>
    <definition value="Antacids"/>
  </concept>
  <concept>
    <code value="DE542"/>
    <display value="Antibiotics (broad-spectrum)"/>
    <definition value="Client is currently taking broad-spectrum antibiotics"/>
  </concept>
  <concept>
    <code value="DE543"/>
    <display value="Anticonvulsive"/>
    <definition value="Anticonvulsive medication"/>
  </concept>
  <concept>
    <code value="DE544"/>
    <display value="Antidiabetic"/>
    <definition value="Antidiabetic medication"/>
  </concept>
  <concept>
    <code value="DE545"/>
    <display value="Antifungals"/>
    <definition value="Client is currently taking antifungals"/>
  </concept>
  <concept>
    <code value="DE546"/>
    <display value="Antihelmintic"/>
    <definition value="Antihelmintic or antiparasitic medication"/>
  </concept>
  <concept>
    <code value="DE547"/>
    <display value="Antihypertensive"/>
    <definition value="Antihypertensive medication"/>
  </concept>
  <concept>
    <code value="DE548"/>
    <display value="Antimalarials"/>
    <definition value="Antimalarial medication"/>
  </concept>
  <concept>
    <code value="DE549"/>
    <display value="Antiretrovirals (ARVs)"/>
    <definition value="Antiretrovirals (ARVs)"/>
  </concept>
  <concept>
    <code value="DE550"/>
    <display value="Antiparasitics"/>
    <definition value="Client is currently taking antiparasitics"/>
  </concept>
  <concept>
    <code value="DE551"/>
    <display value="Antivirals"/>
    <definition value="Antiviral medication"/>
  </concept>
  <concept>
    <code value="DE552"/>
    <display value="Buprenorphine"/>
    <definition value="Opioid substitution to treat opioid dependence"/>
  </concept>
  <concept>
    <code value="DE553"/>
    <display value="Co-trimoxazole preventive therapy (CPT)"/>
    <definition value="Combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections"/>
  </concept>
  <concept>
    <code value="DE554"/>
    <display value="Hormonal family planning method"/>
    <definition value="Hormonal family planning method"/>
  </concept>
  <concept>
    <code value="DE555"/>
    <display value="Methadone"/>
    <definition value="Opioid substitution to treat opioid dependence"/>
  </concept>
  <concept>
    <code value="DE556"/>
    <display value="PrEP to prevent HIV"/>
    <definition value="Pre-exposure prophylaxis (PrEP) medication for preventing the acquisition of HIV"/>
  </concept>
  <concept>
    <code value="DE557"/>
    <display value="Other antibiotics"/>
    <definition value="Other antibiotics not listed above"/>
  </concept>
  <concept>
    <code value="DE558"/>
    <display value="Other medications"/>
    <definition value="Other medications or supplements that are not listed above"/>
  </concept>
  <concept>
    <code value="DE559"/>
    <display value="Other medications (specify)"/>
    <definition value="Other medications or supplements that are not listed above (specify)"/>
  </concept>
  <concept>
    <code value="DE560"/>
    <display value="Allergies"/>
    <definition value="Does the client have any allergies?"/>
  </concept>
  <concept>
    <code value="DE561"/>
    <display value="No known allergies"/>
    <definition value="Client does not have any known allergies"/>
  </concept>
  <concept>
    <code value="DE562"/>
    <display value="Don't know of any allergies"/>
    <definition value="Client does not know whether or not she has allergies"/>
  </concept>
  <concept>
    <code value="DE563"/>
    <display value="Albendazole"/>
    <definition value="Allergy to albendazole"/>
  </concept>
  <concept>
    <code value="DE564"/>
    <display value="Malaria medication (sulfadoxine-pyrimethamine)"/>
    <definition value="Allergy to malaria medication (sulfadoxine-pyrimethamine)"/>
  </concept>
  <concept>
    <code value="DE565"/>
    <display value="Penicillin"/>
    <definition value="Allergy to penicillin"/>
  </concept>
  <concept>
    <code value="DE566"/>
    <display value="Tenofovir disoproxil fumarate (TDF)"/>
    <definition value="Allergy to pre-exposure prophylaxis (PrEP) tenofovir disoproxil fumarate (TDF)"/>
  </concept>
  <concept>
    <code value="DE567"/>
    <display value="Other allergies"/>
    <definition value="Client has other allergies not listed here"/>
  </concept>
  <concept>
    <code value="DE568"/>
    <display value="Other allergies (specify)"/>
    <definition value="Client has other allergies not listed here (specify)"/>
  </concept>
  <concept>
    <code value="DE569"/>
    <display value="Family planning method used"/>
    <definition value="Method the client reports currently using at intake"/>
  </concept>
  <concept>
    <code value="DE570"/>
    <display value="Copper-bearing intrauterine device (Cu-IUD)"/>
    <definition value="A copper-bearing intrauterine device is being used as a family planning method"/>
  </concept>
  <concept>
    <code value="DE571"/>
    <display value="Levonorgestrel intrauterine device (LNG-IUD)"/>
    <definition value="A levonorgestrel intrauterine device (hormone-releasing intrauterine contraceptive device) is being used as a family planning method"/>
  </concept>
  <concept>
    <code value="DE572"/>
    <display value="Etonogestrel (ETG) one-rod implant"/>
    <definition value="An etonogestrel one-rod implant is being used"/>
  </concept>
  <concept>
    <code value="DE573"/>
    <display value="Levonorgestrel (LNG) two-rod implant"/>
    <definition value="A levonorgestrel two-rod implant is being used as a family planning method"/>
  </concept>
  <concept>
    <code value="DE574"/>
    <display value="DMPA-IM"/>
    <definition value="Injectable depot medroxyprogesterone acetate (DMPA), administered intramuscularly, is being used as a family planning method"/>
  </concept>
  <concept>
    <code value="DE575"/>
    <display value="DMPA-SC"/>
    <definition value="Injectable depot medroxyprogesterone acetate (DMPA), administered subcutaneously is being used"/>
  </concept>
  <concept>
    <code value="DE576"/>
    <display value="NET-EN norethisterone enanthate"/>
    <definition value="Injectable norethisterone enanthate (NET-EN) is being used as a family planning method"/>
  </concept>
  <concept>
    <code value="DE577"/>
    <display value="Progestogen-only pills (POP)"/>
    <definition value="Progestogen-only pills (POP) are being used as a family planning method"/>
  </concept>
  <concept>
    <code value="DE578"/>
    <display value="Combined oral contraceptives (COCs)"/>
    <definition value="Combined oral contraceptives (COCs) pills are being used as a family planning method"/>
  </concept>
  <concept>
    <code value="DE579"/>
    <display value="Combined contraceptive patch"/>
    <definition value="Transdermal combined contraceptive patch is being used as a family planning method"/>
  </concept>
  <concept>
    <code value="DE580"/>
    <display value="Combined contraceptive vaginal ring (CVR)"/>
    <definition value="Combined contraceptive vaginal ring (CVR) is being used as a family planning method"/>
  </concept>
  <concept>
    <code value="DE581"/>
    <display value="Progesterone-releasing vaginal ring (PVR)"/>
    <definition value="Progesterone-releasing vaginal ring (PVR) is being used as a family planning method"/>
  </concept>
  <concept>
    <code value="DE582"/>
    <display value="Lactational amenorrhea method (LAM)"/>
    <definition value="Lactational amenorrhea method (LAM) is being used as a family planning method"/>
  </concept>
  <concept>
    <code value="DE583"/>
    <display value="Emergency contraceptive pills (ECPs)"/>
    <definition value="Client uses emergency contraceptive pills (ECPs)"/>
  </concept>
  <concept>
    <code value="DE584"/>
    <display value="Fertility awareness-based methods (FAB)"/>
    <definition value="Client uses fertility awareness-based methods (FAB)"/>
  </concept>
  <concept>
    <code value="DE585"/>
    <display value="Male condoms"/>
    <definition value="Male condoms are being used as a family planning method"/>
  </concept>
  <concept>
    <code value="DE586"/>
    <display value="Female condoms"/>
    <definition value="Female condoms are being used as a family planning method"/>
  </concept>
  <concept>
    <code value="DE587"/>
    <display value="Withdrawal"/>
    <definition value="Client uses withdrawal method"/>
  </concept>
  <concept>
    <code value="DE588"/>
    <display value="Female relying on male method"/>
    <definition value="The female client is relying on her male partner for contraceptive methods (e.g. male condoms, male sterilization, withdrawal)"/>
  </concept>
  <concept>
    <code value="DE589"/>
    <display value="Male relying on female method"/>
    <definition value="The male client is relying on his female partner for contraceptive methods"/>
  </concept>
  <concept>
    <code value="DE590"/>
    <display value="Male sterilization"/>
    <definition value="Male surgical sterilization (a vasectomy) is the family planning method used"/>
  </concept>
  <concept>
    <code value="DE591"/>
    <display value="Female sterilization"/>
    <definition value="Female surgical sterilization procedure is the family planning method used"/>
  </concept>
  <concept>
    <code value="DE592"/>
    <display value="No method"/>
    <definition value="Client is not using any family planning methods"/>
  </concept>
  <concept>
    <code value="DE593"/>
    <display value="Medication status"/>
    <definition value="Current state of the client's taking of the medication"/>
  </concept>
  <concept>
    <code value="DE594"/>
    <display value="Currently taking"/>
    <definition value="The medication is still being taken (active)"/>
  </concept>
  <concept>
    <code value="DE595"/>
    <display value="Completed"/>
    <definition value="The medication is no longer being taken"/>
  </concept>
  <concept>
    <code value="DE596"/>
    <display value="Entered in error"/>
    <definition value="Entered in error"/>
  </concept>
  <concept>
    <code value="DE597"/>
    <display value="Intended"/>
    <definition value="The medication may be taken at some time in the future"/>
  </concept>
  <concept>
    <code value="DE598"/>
    <display value="Stopped"/>
    <definition value="Actions implied by the statement have been permanently halted, before all of them occurred. This should not be used if the statement was entered in error."/>
  </concept>
  <concept>
    <code value="DE599"/>
    <display value="On hold"/>
    <definition value="The client has temporarily stopped taking the medication, but is expected to continue again later. May also be called &quot;suspended&quot;."/>
  </concept>
  <concept>
    <code value="DE600"/>
    <display value="Unknown"/>
    <definition value="The state of the medication use is not currently known"/>
  </concept>
  <concept>
    <code value="DE601"/>
    <display value="Did not take"/>
    <definition value="The client did not take the medication"/>
  </concept>
  <concept>
    <code value="DE602"/>
    <display value="Hepatitis B negative counselling conducted"/>
    <definition value="Hepatitis B negative counselling conducted"/>
  </concept>
  <concept>
    <code value="DE603"/>
    <display value="Vaccine brand"/>
    <definition value="The brand or trade name used to refer to the vaccine received"/>
  </concept>
  <concept>
    <code value="DE604"/>
    <display value="Vaccine type"/>
    <definition value="Type of vaccine received (such as IPV, OPV)"/>
  </concept>
  <concept>
    <code value="DE605"/>
    <display value="Date and time of vaccination"/>
    <definition value="Represents the visit/encounter date, which is the date and time when the vaccine was administered to the client"/>
  </concept>
  <concept>
    <code value="DE606"/>
    <display value="Vaccination location"/>
    <definition value="The service delivery location where the vaccine adminstration occurred"/>
  </concept>
  <concept>
    <code value="DE607"/>
    <display value="Dose number"/>
    <definition value="Vaccine dose number within series"/>
  </concept>
  <concept>
    <code value="DE608"/>
    <display value="Dose quantity"/>
    <definition value="The quantity of vaccine product that was administered"/>
  </concept>
  <concept>
    <code value="DE609"/>
    <display value="Total doses in series"/>
    <definition value="The recommended number of vaccine doses for immunity according to national protocol"/>
  </concept>
  <concept>
    <code value="DE610"/>
    <display value="Disease targeted"/>
    <definition value="Vaccine preventable disease being targeted by vaccine administered"/>
  </concept>
  <concept>
    <code value="DE611"/>
    <display value="Hepatitis A"/>
    <definition value="The client is receiving vaccination to prevent against hepatitis A"/>
  </concept>
  <concept>
    <code value="DE612"/>
    <display value="Hepatitis B"/>
    <definition value="The client is receiving vaccination to prevent against hepatitis B"/>
  </concept>
  <concept>
    <code value="DE613"/>
    <display value="Tetanus"/>
    <definition value="The client is receiving vaccination to prevent against tetanus"/>
  </concept>
  <concept>
    <code value="DE614"/>
    <display value="COVID-19"/>
    <definition value="The client is receiving vaccination to prevent against COVID-19 due to SARS-CoV-2"/>
  </concept>
  <concept>
    <code value="DE615"/>
    <display value="Influenza due to influenza B virus"/>
    <definition value="The client is receiving vaccination to prevent against influenza due to influenza B virus"/>
  </concept>
  <concept>
    <code value="DE616"/>
    <display value="Tuberculosis"/>
    <definition value="The client is receiving vaccination to prevent against tuberculosis (e.g. BCG vaccine)"/>
  </concept>
  <concept>
    <code value="DE617"/>
    <display value="Acute poliomyelitis"/>
    <definition value="The client is receiving vaccination to prevent against acute poliomyelitis (polio)"/>
  </concept>
  <concept>
    <code value="DE618"/>
    <display value="Measles"/>
    <definition value="The client is receiving vaccination to prevent against measles"/>
  </concept>
  <concept>
    <code value="DE619"/>
    <display value="Diptheria"/>
    <definition value="The client is receiving vaccination to prevent against diptheria"/>
  </concept>
  <concept>
    <code value="DE620"/>
    <display value="Rabies"/>
    <definition value="The client is receiving vaccination to prevent against rabies"/>
  </concept>
  <concept>
    <code value="DE621"/>
    <display value="Cholera"/>
    <definition value="The client is receiving vaccination to prevent against cholera"/>
  </concept>
  <concept>
    <code value="DE622"/>
    <display value="Mumps"/>
    <definition value="The client is receiving vaccination to prevent against mumps"/>
  </concept>
  <concept>
    <code value="DE623"/>
    <display value="HPV infection"/>
    <definition value="The client is receiving vaccination to prevent against human papilloma virus (HPV) infection"/>
  </concept>
  <concept>
    <code value="DE624"/>
    <display value="Haemophilus influenzae type B"/>
    <definition value="The client is receiving vaccination to prevent against Haemophilus influenzae type B (Hib)"/>
  </concept>
  <concept>
    <code value="DE625"/>
    <display value="Varicella"/>
    <definition value="The client is receiving vaccination to prevent against varicella"/>
  </concept>
  <concept>
    <code value="DE626"/>
    <display value="Dengue"/>
    <definition value="The client is receiving vaccination to prevent against dengue"/>
  </concept>
  <concept>
    <code value="DE627"/>
    <display value="Yellow fever"/>
    <definition value="The client is receiving vaccination to prevent against yellow fever"/>
  </concept>
  <concept>
    <code value="DE628"/>
    <display value="Japanese Encephalitis"/>
    <definition value="The client is receiving vaccination to prevent against Japanese encephalitis"/>
  </concept>
  <concept>
    <code value="DE629"/>
    <display value="Rubella"/>
    <definition value="The client is receiving vaccination to prevent against rubella"/>
  </concept>
  <concept>
    <code value="DE630"/>
    <display value="Pertussis"/>
    <definition value="The client is receiving vaccination to prevent against pertussis"/>
  </concept>
  <concept>
    <code value="DE631"/>
    <display value="Enteritis due to rotavirus"/>
    <definition value="The client is receiving vaccination to prevent against enteritis due to rotavirus"/>
  </concept>
  <concept>
    <code value="DE632"/>
    <display value="Pneumococcal disease"/>
    <definition value="The client is receiving vaccination to prevent against pneumococcal disease"/>
  </concept>
  <concept>
    <code value="DE633"/>
    <display value="Meningococcal disease"/>
    <definition value="The client is receiving vaccination to prevent against meningococcal disease"/>
  </concept>
  <concept>
    <code value="DE634"/>
    <display value="Tick-borne encephalitis"/>
    <definition value="The client is receiving vaccination to prevent against tick-borne encephalitis"/>
  </concept>
  <concept>
    <code value="DE635"/>
    <display value="Typhoid"/>
    <definition value="The client is receiving vaccination to prevent against typhoid"/>
  </concept>
  <concept>
    <code value="DE636"/>
    <display value="Reason immunization was not provided"/>
    <definition value="Reason the vaccine dose was not given"/>
  </concept>
  <concept>
    <code value="DE637"/>
    <display value="Stock-out"/>
    <definition value="Stock-out of vaccine"/>
  </concept>
  <concept>
    <code value="DE638"/>
    <display value="Client is ill"/>
    <definition value="Client is ill"/>
  </concept>
  <concept>
    <code value="DE639"/>
    <display value="Client refused"/>
    <definition value="Client refused vaccine"/>
  </concept>
  <concept>
    <code value="DE640"/>
    <display value="Allergy to vaccine"/>
    <definition value="Client has an allergy to the vaccine"/>
  </concept>
  <concept>
    <code value="DE641"/>
    <display value="Other reason immunization not provided"/>
    <definition value="Other reason why the immunization was not provided"/>
  </concept>
  <concept>
    <code value="DE642"/>
    <display value="Other reason immunization not provided (specify)"/>
    <definition value="Other reason why the immunization was not provided (specify)"/>
  </concept>
  <concept>
    <code value="DE643"/>
    <display value="Malaria prophylaxis"/>
    <definition value="Whether malaria prophylaxis was given"/>
  </concept>
  <concept>
    <code value="DE644"/>
    <display value="IPTp-SP dose number provided"/>
    <definition value="IPTp-SP dose number that was provided"/>
  </concept>
  <concept>
    <code value="DE645"/>
    <display value="Date IPTp-SP dose provided"/>
    <definition value="Date on which the IPTp-SP dose was provided"/>
  </concept>
  <concept>
    <code value="DE646"/>
    <display value="Reason malaria prophylaxis not provided"/>
    <definition value="Reason why the treatment was not given"/>
  </concept>
  <concept>
    <code value="DE647"/>
    <display value="Client was referred"/>
    <definition value="Client was referred to another provider/facility"/>
  </concept>
  <concept>
    <code value="DE648"/>
    <display value="Stock out"/>
    <definition value="There was a stock out of malaria prophylaxis"/>
  </concept>
  <concept>
    <code value="DE649"/>
    <display value="Expired"/>
    <definition value="Malaria prophylaxis in stock was expired"/>
  </concept>
  <concept>
    <code value="DE650"/>
    <display value="Other reason not provided"/>
    <definition value="Other reason why the prophylaxis was not provided"/>
  </concept>
  <concept>
    <code value="DE651"/>
    <display value="Other reason not provided (specify)"/>
    <definition value="Other reason why the prophylaxis was not provided"/>
  </concept>
  <concept>
    <code value="DE652"/>
    <display value="&gt;28 days since last missed appointment"/>
    <definition value="More than 28 days have passed since client's last missed appointment"/>
  </concept>
  <concept>
    <code value="DE653"/>
    <display value="AIDS-related death"/>
    <definition value="Death of client was AIDS-related"/>
  </concept>
  <concept>
    <code value="DE654"/>
    <display value="Date of first AIDS diagnosis"/>
    <definition value="Date of client's first AIDS diagnosis"/>
  </concept>
  <concept>
    <code value="DE655"/>
    <display value="Age at final HPV vaccination dose received"/>
    <definition value="Client's age at date received final HPV vaccination dose"/>
  </concept>
  <concept>
    <code value="DE656"/>
    <display value="Date of cervical cancer screening test"/>
    <definition value="Date of cervical cancer screening test"/>
  </concept>
  <concept>
    <code value="DE657"/>
    <display value="Lifetime screening test number"/>
    <definition value="Client's lifetime number of screenings for cervical cancer"/>
  </concept>
  <concept>
    <code value="DE658"/>
    <display value="Cervical cancer primary screening test type"/>
    <definition value="Type of cervical cancer screening test used in primary screening"/>
  </concept>
  <concept>
    <code value="DE659"/>
    <display value="HPV-DNA"/>
    <definition value="Screened for cervical cancer using HPV-DNA test"/>
  </concept>
  <concept>
    <code value="DE660"/>
    <display value="VIA"/>
    <definition value="Screened for cervical cancer using visual inspection with acetic acid (VIA)"/>
  </concept>
  <concept>
    <code value="DE661"/>
    <display value="Cervical cytology"/>
    <definition value="Screened for cervical cancer using cervical cytology"/>
  </concept>
  <concept>
    <code value="DE662"/>
    <display value="Other"/>
    <definition value="Screened for cervical cancer using other method"/>
  </concept>
  <concept>
    <code value="DE663"/>
    <display value="Other (specify)"/>
    <definition value="Screened for cervical cancer using other method (specify)"/>
  </concept>
  <concept>
    <code value="DE664"/>
    <display value="HPV-DNA cervical cancer screening test result"/>
    <definition value="HPV-DNA cervical cancer screening test result"/>
  </concept>
  <concept>
    <code value="DE665"/>
    <display value="Negative"/>
    <definition value="HPV-DNA screening test was negative"/>
  </concept>
  <concept>
    <code value="DE666"/>
    <display value="Positive"/>
    <definition value="HPV-DNA screening test was positive"/>
  </concept>
  <concept>
    <code value="DE667"/>
    <display value="Invalid"/>
    <definition value="HPV-DNA screening test was invalid"/>
  </concept>
  <concept>
    <code value="DE668"/>
    <display value="VIA cervical cancer screening test result"/>
    <definition value="Screening test result for VIA"/>
  </concept>
  <concept>
    <code value="DE669"/>
    <display value="Negative"/>
    <definition value="Screening result is negative"/>
  </concept>
  <concept>
    <code value="DE670"/>
    <display value="Positive"/>
    <definition value="Screening result is positive"/>
  </concept>
  <concept>
    <code value="DE671"/>
    <display value="Suspected cancer"/>
    <definition value="Screening result is suspected cancer"/>
  </concept>
  <concept>
    <code value="DE672"/>
    <display value="Invalid"/>
    <definition value="Screening result is invalid"/>
  </concept>
  <concept>
    <code value="DE673"/>
    <display value="Cervical cytology screening test result"/>
    <definition value="Screening result for cervical cytology"/>
  </concept>
  <concept>
    <code value="DE674"/>
    <display value="NILM"/>
    <definition value="Negative for Intraepithelial Lesion Malignancy (NILM)"/>
  </concept>
  <concept>
    <code value="DE675"/>
    <display value="ASCUS"/>
    <definition value="Atypical squamous cells of undetermined significance (ASCUS)"/>
  </concept>
  <concept>
    <code value="DE676"/>
    <display value="LSIL"/>
    <definition value="Low grade squamous intraepithelial lesion (LSIL)"/>
  </concept>
  <concept>
    <code value="DE677"/>
    <display value="HSIL"/>
    <definition value="High grade squamous intraepithelial lesion (HSIL)"/>
  </concept>
  <concept>
    <code value="DE678"/>
    <display value="Cancer"/>
    <definition value="Result was positive for cancer"/>
  </concept>
  <concept>
    <code value="DE679"/>
    <display value="Invalid/inadequate"/>
    <definition value="Screening result was invalid or inadequate"/>
  </concept>
  <concept>
    <code value="DE680"/>
    <display value="Cervical cancer triage test date"/>
    <definition value="Date of triage test for cervical cancer"/>
  </concept>
  <concept>
    <code value="DE681"/>
    <display value="Cervical cancer triage test type"/>
    <definition value="Type of triage test for cervical cancer"/>
  </concept>
  <concept>
    <code value="DE682"/>
    <display value="VIA"/>
    <definition value="Triage test for cervical cancer using visual inspection with acetic acid (VIA)"/>
  </concept>
  <concept>
    <code value="DE683"/>
    <display value="Colposcopy"/>
    <definition value="Triage test for cervical cancer using colposcopy"/>
  </concept>
  <concept>
    <code value="DE684"/>
    <display value="Cervical cytology"/>
    <definition value="Triage test for cervical cancer using cervical cytology"/>
  </concept>
  <concept>
    <code value="DE685"/>
    <display value="HPV16/18"/>
    <definition value="Triage test for cervical cancer using test for HPV16/18"/>
  </concept>
  <concept>
    <code value="DE686"/>
    <display value="Other"/>
    <definition value="Triage test for cervical cancer using another test"/>
  </concept>
  <concept>
    <code value="DE687"/>
    <display value="Other (specify)"/>
    <definition value="Triage test for cervical cancer using another test (specify)"/>
  </concept>
  <concept>
    <code value="DE688"/>
    <display value="HPV16/18 test result"/>
    <definition value="Test result from HPV16/18 test"/>
  </concept>
  <concept>
    <code value="DE689"/>
    <display value="Positive"/>
    <definition value="Test is positive for HPV16/18"/>
  </concept>
  <concept>
    <code value="DE690"/>
    <display value="Negative"/>
    <definition value="Test is negative for HPV16/18"/>
  </concept>
  <concept>
    <code value="DE691"/>
    <display value="Cervical cancer colposcopy result"/>
    <definition value="Result of cervical cancer colposcopy"/>
  </concept>
  <concept>
    <code value="DE692"/>
    <display value="Normal colposcopic findings"/>
    <definition value="Colposcopy has normal colposcopic findings"/>
  </concept>
  <concept>
    <code value="DE693"/>
    <display value="Abnormal colposcopic findings"/>
    <definition value="Colposcopy has abnormal colposcopic findings"/>
  </concept>
  <concept>
    <code value="DE694"/>
    <display value="Suspicious for invasive cervical cancer"/>
    <definition value="Colposcopy is suspicious for invasive cervical cancer"/>
  </concept>
  <concept>
    <code value="DE695"/>
    <display value="Miscellaneous findings"/>
    <definition value="Colposcopy has miscellaneous findings"/>
  </concept>
  <concept>
    <code value="DE696"/>
    <display value="Inadequate"/>
    <definition value="Colposcopy exam is inadequate"/>
  </concept>
  <concept>
    <code value="DE697"/>
    <display value="Cervical cancer histopathology result"/>
    <definition value="Result of cervical cancer histopathology"/>
  </concept>
  <concept>
    <code value="DE698"/>
    <display value="Normal"/>
    <definition value="Result of cervical cancer histopathology was normal"/>
  </concept>
  <concept>
    <code value="DE699"/>
    <display value="LSIL (inclusive of LSIL-CIN1)"/>
    <definition value="Result of cervical cancer histopathology was low-grade squamous intraepithelial lesion (LSIL)"/>
  </concept>
  <concept>
    <code value="DE700"/>
    <display value="HSIL (inclusive of HSIL-CIN2 or HSIL-CIN3)"/>
    <definition value="Result of cervical cancer histopathology was high-grade squamous intraepithelial lesion (HSIL)"/>
  </concept>
  <concept>
    <code value="DE701"/>
    <display value="Invasive cervical cancer"/>
    <definition value="Result of cervical cancer histopathology is invasive cervical cancer"/>
  </concept>
  <concept>
    <code value="DE702"/>
    <display value="Date of additional cervical cancer triage test"/>
    <definition value="Date of tertiary cervical cancer screening test"/>
  </concept>
  <concept>
    <code value="DE703"/>
    <display value="Additional cervical cancer triage test type (specify)"/>
    <definition value="Additional cervical cancer triage test type (specify)"/>
  </concept>
  <concept>
    <code value="DE704"/>
    <display value="Additional cervical cancer triage test result (specify)"/>
    <definition value="Additional cervical cancer triage test result (specify)"/>
  </concept>
  <concept>
    <code value="DE705"/>
    <display value="Date of diagnosis of cervical precancer lesions or invasive cervical cancer"/>
    <definition value="Date of diagnosis of cervical precancer lesions or invasive cervical cancer"/>
  </concept>
  <concept>
    <code value="DE706"/>
    <display value="Cervical cancer screening outcome"/>
    <definition value="Client's screening outcome for cervical cancer"/>
  </concept>
  <concept>
    <code value="DE707"/>
    <display value="Positive for cervical precancer lesions"/>
    <definition value="Screening outcome for cervical precancer lesions is positive"/>
  </concept>
  <concept>
    <code value="DE708"/>
    <display value="Negative for cervical precancer lesions"/>
    <definition value="Screening outcome for cervical precancer lesions is negative"/>
  </concept>
  <concept>
    <code value="DE709"/>
    <display value="Cervical cancer diagnosis"/>
    <definition value="Type of cervical cancer diagnosis"/>
  </concept>
  <concept>
    <code value="DE710"/>
    <display value="Cervical precancer lesions"/>
    <definition value="Client is diagnosed with cervical precancer lesions"/>
  </concept>
  <concept>
    <code value="DE711"/>
    <display value="Invasive cervical cancer"/>
    <definition value="Client is diagnosed with invasive cervical cancer disease"/>
  </concept>
  <concept>
    <code value="DE712"/>
    <display value="Cervical cancer stage at diagnosis"/>
    <definition value="Cervical cancer stage at diagnosis of cervical cancer"/>
  </concept>
  <concept>
    <code value="DE713"/>
    <display value="Stage 0"/>
    <definition value="Stage 0 cervical cancer at diagnosis of cervical cancer"/>
  </concept>
  <concept>
    <code value="DE714"/>
    <display value="Stage I"/>
    <definition value="Stage I cervical cancer at diagnosis of cervical cancer"/>
  </concept>
  <concept>
    <code value="DE715"/>
    <display value="Stage II"/>
    <definition value="Stage II cervical cancer at diagnosis of cervical cancer"/>
  </concept>
  <concept>
    <code value="DE716"/>
    <display value="Stage III"/>
    <definition value="Stage III cervical cancer at diagnosis of cervical cancer"/>
  </concept>
  <concept>
    <code value="DE717"/>
    <display value="Stage IV"/>
    <definition value="Stage IV cervical cancer at diagnosis of cervical cancer"/>
  </concept>
  <concept>
    <code value="DE718"/>
    <display value="Date of treatment for cervical precancer lesions"/>
    <definition value="Date of treatment for cervical precancer lesions"/>
  </concept>
  <concept>
    <code value="DE719"/>
    <display value="Treatment method for cervical precancer lesions"/>
    <definition value="Treatment method for cervical precancer lesions"/>
  </concept>
  <concept>
    <code value="DE720"/>
    <display value="Cryotherapy"/>
    <definition value="Treatment for cervical precancer lesions is cryotherapy"/>
  </concept>
  <concept>
    <code value="DE721"/>
    <display value="Thermal ablation"/>
    <definition value="Treatment for cervical precancer lesions is Thermal ablation"/>
  </concept>
  <concept>
    <code value="DE722"/>
    <display value="Laser ablation"/>
    <definition value="Treatment for cervical precancer lesions is Laser ablation"/>
  </concept>
  <concept>
    <code value="DE723"/>
    <display value="CKC"/>
    <definition value="Treatment for cervical precancer lesions is Cold knife conization (CKC)"/>
  </concept>
  <concept>
    <code value="DE724"/>
    <display value="Laser cone biopsy"/>
    <definition value="Treatment for cervical precancer lesions is Laser cone biopsy"/>
  </concept>
  <concept>
    <code value="DE725"/>
    <display value="LLETZ/LEEP"/>
    <definition value="Treatment for cervical precancer lesions is large loop excision of the transformation zone (LLETZ)/loop electrosurgical excision procedure (LEEP)"/>
  </concept>
  <concept>
    <code value="DE726"/>
    <display value="Other"/>
    <definition value="Treatment for cervical precancer lesions is not listed"/>
  </concept>
  <concept>
    <code value="DE727"/>
    <display value="Other (specify)"/>
    <definition value="Treatment for cervical precancer lesions is not listed (specify)"/>
  </concept>
  <concept>
    <code value="DE728"/>
    <display value="Date of follow-up for treatment for cervical precancer lesions"/>
    <definition value="Date of follow-up for treatment for cervical precancer lesions"/>
  </concept>
  <concept>
    <code value="DE729"/>
    <display value="Date of start of invasive cancer treatment"/>
    <definition value="Date of start of invasive cancer treatment"/>
  </concept>
  <concept>
    <code value="DE730"/>
    <display value="Invasive cervical cancer treatment episode"/>
    <definition value="Client's lifetime number of treatments for invasive cervical cancer"/>
  </concept>
  <concept>
    <code value="DE731"/>
    <display value="Invasive cervical cancer treatment method"/>
    <definition value="Invasive cervical cancer treatment method"/>
  </concept>
  <concept>
    <code value="DE732"/>
    <display value="Conization"/>
    <definition value="Invasive cervical cancer treatment method is a conization"/>
  </concept>
  <concept>
    <code value="DE733"/>
    <display value="Trachelectomy"/>
    <definition value="Invasive cervical cancer treatment method is a trachelectomy"/>
  </concept>
  <concept>
    <code value="DE734"/>
    <display value="Hysterectomy"/>
    <definition value="Invasive cervical cancer treatment method is a hysterectomy"/>
  </concept>
  <concept>
    <code value="DE735"/>
    <display value="Management of invasive cervical cancer"/>
    <definition value="Invasive cervical cancer treatment method is management of invasive cervical cancer"/>
  </concept>
  <concept>
    <code value="DE736"/>
    <display value="Radiotherapy"/>
    <definition value="Invasive cervical cancer treatment method is a radiotherapy"/>
  </concept>
  <concept>
    <code value="DE737"/>
    <display value="Chemotherapy"/>
    <definition value="Invasive cervical cancer treatment method is a chemotherapy"/>
  </concept>
  <concept>
    <code value="DE738"/>
    <display value="Chemoradiation"/>
    <definition value="Invasive cervical cancer treatment method is a chemoradiation"/>
  </concept>
  <concept>
    <code value="DE739"/>
    <display value="Other"/>
    <definition value="Invasive cervical cancer treatment method is a not in list"/>
  </concept>
  <concept>
    <code value="DE740"/>
    <display value="Other (specify)"/>
    <definition value="Invasive cervical cancer treatment method is a not in list (specify)"/>
  </concept>
  <concept>
    <code value="DE741"/>
    <display value="Treatment outcome"/>
    <definition value="Treatment outcome from cervical pre-cancerous lesion treatment or invasive cancer treatment (specify)"/>
  </concept>
  <concept>
    <code value="DE742"/>
    <display value="Secondary/other cancers diagnosed"/>
    <definition value="Secondary and other cancers that client is diagnosed with (specify)"/>
  </concept>
  <concept>
    <code value="DE743"/>
    <display value="Cancers at other sites (HPV- and non-HPV related)"/>
    <definition value="Cancers at other sites that client has (specify)"/>
  </concept>
  <concept>
    <code value="DE744"/>
    <display value="Date of death"/>
    <definition value="If deceased, the date that the client died"/>
  </concept>
  <concept>
    <code value="DE745"/>
    <display value="Cervical cancer screening interval amongst WLHIV"/>
    <definition value="Country-specific interval between cancer screenings amongst women living with HIV (typically 3 or 5 years)"/>
  </concept>
  <concept>
    <code value="DE746"/>
    <display value="Entry point for facility-level testing"/>
    <definition value="Specific point where testing is happening at a facility"/>
  </concept>
  <concept>
    <code value="DE747"/>
    <display value="Provider-initiated tested in a clinic or emergency facility"/>
    <definition value="The client tested though provider-initiated HIV testing &amp; counselling, which could be at an emergency facility"/>
  </concept>
  <concept>
    <code value="DE748"/>
    <display value="Antenatal care clinic"/>
    <definition value="The client tested at an antenatal care clinic, including labour and delivery"/>
  </concept>
  <concept>
    <code value="DE749"/>
    <display value="Voluntary counselling and testing (within a health facility setting)"/>
    <definition value="The client tested through voluntary counselling and testing (within a health facility setting)"/>
  </concept>
  <concept>
    <code value="DE750"/>
    <display value="Family planning clinic"/>
    <definition value="The client tested at a family planning clinic"/>
  </concept>
  <concept>
    <code value="DE751"/>
    <display value="Other facility-level testing"/>
    <definition value="The client tested at another type of facility"/>
  </concept>
  <concept>
    <code value="DE752"/>
    <display value="Tuberculosis (TB) clinic"/>
    <definition value="The client tested at a TB clinic"/>
  </concept>
  <concept>
    <code value="DE753"/>
    <display value="Offer other clinical services"/>
    <definition value="Other clinical services offered or referrals given to the client"/>
  </concept>
  <concept>
    <code value="DE754"/>
    <display value="Assessment and provision of vaccinations"/>
    <definition value="Assessment and provision of vaccinations, such as for people from Key population member type, pregnant women and infants; and, where appropriate, tetanus vaccination for adolescent boys and men receiving VMMC"/>
  </concept>
  <concept>
    <code value="DE755"/>
    <display value="Hepatitis B (HBV) and hepatitis C virus (HCV) testing and treatment"/>
    <definition value="Offer or refer for HBV and/or HCV testing and treatment"/>
  </concept>
  <concept>
    <code value="DE756"/>
    <display value="Co-trimoxazole chemoprophylaxis to prevent pneumocystis carinii pneumonia"/>
    <definition value="Offer or refer for co-trimoxazole chemoprophylaxis to prevent pneumocystis carinii pneumonia"/>
  </concept>
  <concept>
    <code value="DE757"/>
    <display value="Intensified TB case finding and linkage to TB treatment"/>
    <definition value="Offer or refer for intensified TB case finding and linkage to TB treatment"/>
  </concept>
  <concept>
    <code value="DE758"/>
    <display value="Provision of isoniazid preventive therapy if person does not have TB"/>
    <definition value="Offer or refer for provision of isoniazid preventive therapy if person does not have TB"/>
  </concept>
  <concept>
    <code value="DE759"/>
    <display value="Malaria prevention (such as bed nets and prophylaxis), depending on epidemiology"/>
    <definition value="Offer or refer for malaria prevention (such as bed nets and prophylaxis), depending on epidemiology"/>
  </concept>
  <concept>
    <code value="DE760"/>
    <display value="Eligible for DSD ART"/>
    <definition value="Client is eligible for differentiated service delivery (DSD) for ART"/>
  </concept>
  <concept>
    <code value="DE761"/>
    <display value="Date DSD ART eligibility assessed"/>
    <definition value="Date client was assessed for eligibility for differentiated service delivery (DSD) for ART"/>
  </concept>
  <concept>
    <code value="DE762"/>
    <display value="Currently enrolled in DSD ART model"/>
    <definition value="Client currently enrolled in differentiated service delivery (DSD) ART model"/>
  </concept>
  <concept>
    <code value="DE763"/>
    <display value="DSD ART start date"/>
    <definition value="Date client started on differentiated service delivery (DSD) for ART"/>
  </concept>
  <concept>
    <code value="DE764"/>
    <display value="DSD ART model(s)"/>
    <definition value="Type of DSD ART model client is enrolled in (country-specific)"/>
  </concept>
  <concept>
    <code value="DE765"/>
    <display value="Fast track ART refill"/>
    <definition value="Client is enrolled in fast track ART refill (DSD ART model)"/>
  </concept>
  <concept>
    <code value="DE766"/>
    <display value="Facility adherence club"/>
    <definition value="Client is enrolled in facility adherence club (DSD ART model)"/>
  </concept>
  <concept>
    <code value="DE767"/>
    <display value="Community ART distribution point"/>
    <definition value="Client is enrolled in community ART distribution point (DSD ART model)"/>
  </concept>
  <concept>
    <code value="DE768"/>
    <display value="CHW/peer educator community ART group"/>
    <definition value="Client is enrolled in community health worker/peer educator community ART group (DSD ART model)"/>
  </concept>
  <concept>
    <code value="DE769"/>
    <display value="Patient/client community ART group"/>
    <definition value="Client is enrolled in patient/client community ART group (DSD ART model)"/>
  </concept>
  <concept>
    <code value="DE770"/>
    <display value="Other DSD ART model"/>
    <definition value="Client is enrolled in another DSD ART model"/>
  </concept>
  <concept>
    <code value="DE771"/>
    <display value="Other DSD ART model (specify)"/>
    <definition value="Client is enrolled in another DSD ART model (specify)"/>
  </concept>
  <concept>
    <code value="DE772"/>
    <display value="Partner testing offered"/>
    <definition value="Whether client was offered partner testing"/>
  </concept>
  <concept>
    <code value="DE773"/>
    <display value="Partner testing accepted"/>
    <definition value="Whether partner testing was accepted"/>
  </concept>
  <concept>
    <code value="DE774"/>
    <display value="Date partner contacted for index testing"/>
    <definition value="Date on which client's partner was contacted for index testing"/>
  </concept>
  <concept>
    <code value="DE775"/>
    <display value="Date partner tested for HIV"/>
    <definition value="Date on which client's partner was tested for HIV"/>
  </concept>
  <concept>
    <code value="DE776"/>
    <display value="Date of next scheduled follow-up appointment"/>
    <definition value="Date of client's next scheduled follow-up appointment"/>
  </concept>
  <concept>
    <code value="DE777"/>
    <display value="Type of next follow-up appointment"/>
    <definition value="Type of client's next follow-up appointment (specify)"/>
  </concept>
  <concept>
    <code value="DE778"/>
    <display value="Syndrome/STI diagnosed"/>
    <definition value="Syndrome or STI for which client is diagnosed"/>
  </concept>
  <concept>
    <code value="DE779"/>
    <display value="Urethral discharge syndrome"/>
    <definition value="Client diagnosed with urethral discharge syndrome"/>
  </concept>
  <concept>
    <code value="DE780"/>
    <display value="Vaginal discharge syndrome"/>
    <definition value="Client diagnosed with vaginal discharge syndrome"/>
  </concept>
  <concept>
    <code value="DE781"/>
    <display value="Lower Abdominal pain "/>
    <definition value="Client diagnosed with lower abdominal pain"/>
  </concept>
  <concept>
    <code value="DE782"/>
    <display value="Genital ulcer disease syndrome"/>
    <definition value="Client diagnosed with genital ulcer disease syndrome"/>
  </concept>
  <concept>
    <code value="DE783"/>
    <display value="Anorectal discharge"/>
    <definition value="Client diagnosed with anorectal discharge"/>
  </concept>
  <concept>
    <code value="DE784"/>
    <display value="Sent for testing"/>
    <definition value="Specimen sent for testing"/>
  </concept>
  <concept>
    <code value="DE785"/>
    <display value="Other"/>
    <definition value="Other syndrome/STI diagnosed"/>
  </concept>
  <concept>
    <code value="DE786"/>
    <display value="Other (specify)"/>
    <definition value="Other syndrome/STI diagnosed (specify)"/>
  </concept>
  <concept>
    <code value="DE787"/>
    <display value="Any STI syndrome diagnosed"/>
    <definition value="Was the client diagnosed with any of the five STI syndromes during this visit?"/>
  </concept>
  <concept>
    <code value="DE788"/>
    <display value="Date of STI test"/>
    <definition value="Date on which the STI test was conducted"/>
  </concept>
  <concept>
    <code value="DE789"/>
    <display value="STI tested for"/>
    <definition value="STI for which the client was tested"/>
  </concept>
  <concept>
    <code value="DE790"/>
    <display value="Neisseria gonorrhoeae"/>
    <definition value="Client tested for Neisseria gonorrhoeae"/>
  </concept>
  <concept>
    <code value="DE791"/>
    <display value="Chlamydia trachomatis"/>
    <definition value="Client tested for Chlamydia trachomatis"/>
  </concept>
  <concept>
    <code value="DE792"/>
    <display value="Trichomonas vaginalis"/>
    <definition value="Client tested for Trichomonas vaginalis"/>
  </concept>
  <concept>
    <code value="DE793"/>
    <display value="Syphilis (Treponema pallidum)"/>
    <definition value="Client tested for Syphilis (treponema pallidum)"/>
  </concept>
  <concept>
    <code value="DE794"/>
    <display value="Herpes simplex virus (HSV1, HSV2)"/>
    <definition value="Client tested for herpes simplex virus (HSV1, HSV2)"/>
  </concept>
  <concept>
    <code value="DE795"/>
    <display value="Mycoplasma genitalium"/>
    <definition value="Client tested for Mycoplasma genitalium"/>
  </concept>
  <concept>
    <code value="DE796"/>
    <display value="Mpox"/>
    <definition value="Client tested for Mpox"/>
  </concept>
  <concept>
    <code value="DE797"/>
    <display value="Hepatitis B"/>
    <definition value="Client tested for Hepatitis B"/>
  </concept>
  <concept>
    <code value="DE798"/>
    <display value="Hepatitis C"/>
    <definition value="Client tested for Hepatitis C"/>
  </concept>
  <concept>
    <code value="DE799"/>
    <display value="Other"/>
    <definition value="Client tested for other STI"/>
  </concept>
  <concept>
    <code value="DE800"/>
    <display value="Other (specify)"/>
    <definition value="Client tested for other STI (specify)"/>
  </concept>
  <concept>
    <code value="DE801"/>
    <display value="Syphilis test date"/>
    <definition value="Date of syphilis test"/>
  </concept>
  <concept>
    <code value="DE802"/>
    <display value="Syphilis test result"/>
    <definition value="Result from syphilis test"/>
  </concept>
  <concept>
    <code value="DE803"/>
    <display value="Positive"/>
    <definition value="Test result is positive for syphilis"/>
  </concept>
  <concept>
    <code value="DE804"/>
    <display value="Negative"/>
    <definition value="Test result is negative for syphilis"/>
  </concept>
  <concept>
    <code value="DE805"/>
    <display value="Inconclusive"/>
    <definition value="Test result is inconclusive"/>
  </concept>
  <concept>
    <code value="DE806"/>
    <display value="Syphilis treatment start date"/>
    <definition value="Date of initiation of syphilis treatment"/>
  </concept>
  <concept>
    <code value="DE807"/>
    <display value="Gonorrhoea test date"/>
    <definition value="Date of Gonorrhoea test"/>
  </concept>
  <concept>
    <code value="DE808"/>
    <display value="Gonorrhoea test result"/>
    <definition value="Result from Gonorrhoea test"/>
  </concept>
  <concept>
    <code value="DE809"/>
    <display value="Positive"/>
    <definition value="Test result is positive for Neisseria gonorrhoeae"/>
  </concept>
  <concept>
    <code value="DE810"/>
    <display value="Negative"/>
    <definition value="Test result is negative for Neisseria gonorrhoeae"/>
  </concept>
  <concept>
    <code value="DE811"/>
    <display value="Inconclusive"/>
    <definition value="Test result is inconclusive"/>
  </concept>
  <concept>
    <code value="DE812"/>
    <display value="Gonorrhoea treatment start date"/>
    <definition value="Date of initiation of Gonorrhoea treatment"/>
  </concept>
  <concept>
    <code value="DE813"/>
    <display value="Type of specimen"/>
    <definition value="Type of specimen to be collected"/>
  </concept>
  <concept>
    <code value="DE814"/>
    <display value="Blood"/>
    <definition value="Blood specimen to be collected"/>
  </concept>
  <concept>
    <code value="DE815"/>
    <display value="Urine"/>
    <definition value="Urine specimen to be collected"/>
  </concept>
  <concept>
    <code value="DE816"/>
    <display value="Cervical or vaginal swab"/>
    <definition value="Cervical or vaginal swab to be collected"/>
  </concept>
  <concept>
    <code value="DE817"/>
    <display value="Urethral or penile swab"/>
    <definition value="Urethral or penile swab to be collected"/>
  </concept>
  <concept>
    <code value="DE818"/>
    <display value="Rectal swab"/>
    <definition value="Rectal swab to be collected"/>
  </concept>
  <concept>
    <code value="DE819"/>
    <display value="Other"/>
    <definition value="Other specimen type to be collected"/>
  </concept>
  <concept>
    <code value="DE820"/>
    <display value="Other type of specimen (specify)"/>
    <definition value="Other specimen type to be collected (specify)"/>
  </concept>
  <concept>
    <code value="DE821"/>
    <display value="Syphilis test type"/>
    <definition value="Type of diagnostic test used for syphilis (Treponema pallidum)"/>
  </concept>
  <concept>
    <code value="DE822"/>
    <display value="Treponemal"/>
    <definition value="Treponemal test used "/>
  </concept>
  <concept>
    <code value="DE823"/>
    <display value="Non-treponemal"/>
    <definition value="Non-treponemal test used"/>
  </concept>
  <concept>
    <code value="DE824"/>
    <display value="POC Test"/>
    <definition value="Point-of-care (POC) test used"/>
  </concept>
  <concept>
    <code value="DE825"/>
    <display value="NAAT"/>
    <definition value="Nucleic Acid Amplification Test (NAAT) used"/>
  </concept>
  <concept>
    <code value="DE826"/>
    <display value="Other"/>
    <definition value="Other test used"/>
  </concept>
  <concept>
    <code value="DE827"/>
    <display value="Other syphilis test type (specify)"/>
    <definition value="Other test used (specify)"/>
  </concept>
  <concept>
    <code value="DE828"/>
    <display value="Neisseria gonorrhoeae test type"/>
    <definition value="Type of diagnostic test used for Neisseria gonorrhoeae"/>
  </concept>
  <concept>
    <code value="DE829"/>
    <display value="NAAT"/>
    <definition value="Nucleic Acid Amplification Test (NAAT) used"/>
  </concept>
  <concept>
    <code value="DE830"/>
    <display value="POC Test"/>
    <definition value="Point-of-care (POC) test used"/>
  </concept>
  <concept>
    <code value="DE831"/>
    <display value="Culture"/>
    <definition value="Culture test used"/>
  </concept>
  <concept>
    <code value="DE832"/>
    <display value="Microscopy"/>
    <definition value="Microscopy test used"/>
  </concept>
  <concept>
    <code value="DE833"/>
    <display value="Other"/>
    <definition value="Other type of test used"/>
  </concept>
  <concept>
    <code value="DE834"/>
    <display value="Other (specify)"/>
    <definition value="Other type of test used (specify)"/>
  </concept>
  <concept>
    <code value="DE835"/>
    <display value="POC Test for Neisseria gonorrhoeae (specify)"/>
    <definition value="Point-of-care (POC) test used for Neisseria gonorrhoeae (specify)"/>
  </concept>
  <concept>
    <code value="DE836"/>
    <display value="Chlamydia trachomatis test type"/>
    <definition value="Type of diagnostic test used for Chlamydia trachomatis"/>
  </concept>
  <concept>
    <code value="DE837"/>
    <display value="NAAT"/>
    <definition value="Nucleic Acid Amplification Test (NAAT) used"/>
  </concept>
  <concept>
    <code value="DE838"/>
    <display value="POC Test"/>
    <definition value="Point-of-care (POC) test used"/>
  </concept>
  <concept>
    <code value="DE839"/>
    <display value="Culture"/>
    <definition value="Culture test used"/>
  </concept>
  <concept>
    <code value="DE840"/>
    <display value="ELISA"/>
    <definition value="ELISA test used"/>
  </concept>
  <concept>
    <code value="DE841"/>
    <display value="Microscopy"/>
    <definition value="Microscopy test used"/>
  </concept>
  <concept>
    <code value="DE842"/>
    <display value="Other"/>
    <definition value="Other type of test used"/>
  </concept>
  <concept>
    <code value="DE843"/>
    <display value="Other test for Chlamydia (specify)"/>
    <definition value="Other type of test used for Chlaymdia (specify)"/>
  </concept>
  <concept>
    <code value="DE844"/>
    <display value="POC Test type for Chlamydia test (specify)"/>
    <definition value="Point-of-care (POC) test used for Chlamydia (specify)"/>
  </concept>
  <concept>
    <code value="DE845"/>
    <display value="Trichomonas vaginalis test type"/>
    <definition value="Type of diagnostic test used for Trichomonas vaginalis"/>
  </concept>
  <concept>
    <code value="DE846"/>
    <display value="NAAT"/>
    <definition value="Nucleic Acid Amplification Test (NAAT) used"/>
  </concept>
  <concept>
    <code value="DE847"/>
    <display value="POC Test"/>
    <definition value="Point-of-care (POC) test used"/>
  </concept>
  <concept>
    <code value="DE848"/>
    <display value="Culture"/>
    <definition value="Culture test used"/>
  </concept>
  <concept>
    <code value="DE849"/>
    <display value="Microscopy"/>
    <definition value="Microscopy test used"/>
  </concept>
  <concept>
    <code value="DE850"/>
    <display value="Other"/>
    <definition value="Other type of test used"/>
  </concept>
  <concept>
    <code value="DE851"/>
    <display value="Other (specify)"/>
    <definition value="Other type of test used (specify)"/>
  </concept>
  <concept>
    <code value="DE852"/>
    <display value="POC Test type for Trichomonas vaginalis test (specify)"/>
    <definition value="Point-of-care (POC) test used (specify)"/>
  </concept>
  <concept>
    <code value="DE853"/>
    <display value="Herpes simplex virus (HSV) test type"/>
    <definition value="Type of diagnostic test used for Herpes simplex virus (HSV)"/>
  </concept>
  <concept>
    <code value="DE854"/>
    <display value="NAAT"/>
    <definition value="Nucleic Acid Amplification Test (NAAT) used"/>
  </concept>
  <concept>
    <code value="DE855"/>
    <display value="Antibody test "/>
    <definition value="Antibody test used"/>
  </concept>
  <concept>
    <code value="DE856"/>
    <display value="Other"/>
    <definition value="Other type of test used"/>
  </concept>
  <concept>
    <code value="DE857"/>
    <display value="Other (specify)"/>
    <definition value="Other type of test used for Herpes simplex virus (HSV) test (specify)"/>
  </concept>
  <concept>
    <code value="DE858"/>
    <display value="Mycoplasma genitalium test type"/>
    <definition value="Type of diagnostic test used for Mycoplasma genitalium"/>
  </concept>
  <concept>
    <code value="DE859"/>
    <display value="NAAT"/>
    <definition value="Nucleic Acid Amplification Test (NAAT) used"/>
  </concept>
  <concept>
    <code value="DE860"/>
    <display value="Microscopy "/>
    <definition value="Microscopy test used"/>
  </concept>
  <concept>
    <code value="DE861"/>
    <display value="Other"/>
    <definition value="Other type of test used"/>
  </concept>
  <concept>
    <code value="DE862"/>
    <display value="Other (specify)"/>
    <definition value="Other type of test used for Mycoplasma genitalium test (specify)"/>
  </concept>
  <concept>
    <code value="DE863"/>
    <display value="Test type for other STI tested for (specify)"/>
    <definition value="Test type used for the other specified STI"/>
  </concept>
  <concept>
    <code value="DE864"/>
    <display value="STI test result"/>
    <definition value="Result from STI test"/>
  </concept>
  <concept>
    <code value="DE865"/>
    <display value="Positive"/>
    <definition value="Test result is positive"/>
  </concept>
  <concept>
    <code value="DE866"/>
    <display value="Negative"/>
    <definition value="Test result is negative"/>
  </concept>
  <concept>
    <code value="DE867"/>
    <display value="Inconclusive"/>
    <definition value="Test result is inconclusive"/>
  </concept>
  <concept>
    <code value="DE868"/>
    <display value="Date of STI confirmatory test"/>
    <definition value="Date of STI confirmatory test"/>
  </concept>
  <concept>
    <code value="DE869"/>
    <display value="Confirmatory syphilis test type"/>
    <definition value="Type of test ued for confirmatory syphilis test"/>
  </concept>
  <concept>
    <code value="DE870"/>
    <display value="Treponemal"/>
    <definition value="Treponemal test used "/>
  </concept>
  <concept>
    <code value="DE871"/>
    <display value="Non-treponemal"/>
    <definition value="Non-treponemal test used"/>
  </concept>
  <concept>
    <code value="DE872"/>
    <display value="POC Test"/>
    <definition value="Point-of-care (POC) test used"/>
  </concept>
  <concept>
    <code value="DE873"/>
    <display value="NAAT"/>
    <definition value="Nucleic Acid Amplification Test (NAAT) used"/>
  </concept>
  <concept>
    <code value="DE874"/>
    <display value="Other"/>
    <definition value="Other test used"/>
  </concept>
  <concept>
    <code value="DE875"/>
    <display value="Other (specify)"/>
    <definition value="Other test used for confirmatory syphilis test (specify)"/>
  </concept>
  <concept>
    <code value="DE876"/>
    <display value="Confirmatory test type for other STI (specify)"/>
    <definition value="Confirmatory test type for other STI"/>
  </concept>
  <concept>
    <code value="DE877"/>
    <display value="Confirmatory STI test result"/>
    <definition value="Result from confirmatory STI test"/>
  </concept>
  <concept>
    <code value="DE878"/>
    <display value="Positive"/>
    <definition value="Test result is positive"/>
  </concept>
  <concept>
    <code value="DE879"/>
    <display value="Negative"/>
    <definition value="Test result is negative"/>
  </concept>
  <concept>
    <code value="DE880"/>
    <display value="Inconclusive"/>
    <definition value="Test result is inconclusive"/>
  </concept>
  <concept>
    <code value="DE881"/>
    <display value="Date STI treatment prescribed "/>
    <definition value="Date STI treatment was prescribed to the client"/>
  </concept>
  <concept>
    <code value="DE882"/>
    <display value="Date STI treatment dispensed"/>
    <definition value="Date STI treatment dispensed to the client"/>
  </concept>
  <concept>
    <code value="DE883"/>
    <display value="STI treatment dispensed (specify)"/>
    <definition value="STI treatment dispensed to the client"/>
  </concept>
  <concept>
    <code value="DE884"/>
    <display value="Mid-upper arm circumference (MUAC)"/>
    <definition value="Client's mid-upper arm circumference (MUAC)"/>
  </concept>
  <concept>
    <code value="DE885"/>
    <display value="Date of start of fluconazole prophylaxis"/>
    <definition value="Date of client's start of fluconazole prophylaxis"/>
  </concept>
  <concept>
    <code value="DE886"/>
    <display value="Fluconazole prophylaxis"/>
    <definition value="Client provided with fluconazole prophylaxis"/>
  </concept>
  <concept>
    <code value="DE887"/>
    <display value="Date started cryptococcal meningitis treatment induction regimen"/>
    <definition value="Date client started cryptococcal meningitis treatment induction regimen"/>
  </concept>
  <concept>
    <code value="DE888"/>
    <display value="Date completed cryptococcal meningitis treatment induction regimen"/>
    <definition value="Date client completed cryptococcal meningitis treatment induction regimen"/>
  </concept>
  <concept>
    <code value="DE889"/>
    <display value="Date started cryptococcal meningitis treatment maintenance regimen"/>
    <definition value="Date client started cryptococcal meningitis treatment maintenance regimen"/>
  </concept>
  <concept>
    <code value="DE890"/>
    <display value="Date completed cryptococcal meningitis treatment maintenance regimen"/>
    <definition value="Date client completed cryptococcal meningitis treatment maintenance regimen"/>
  </concept>
  <concept>
    <code value="DE891"/>
    <display value="Date started cryptococcal meningitis treatment consolidation regimen"/>
    <definition value="Date client started cryptococcal meningitis treatment consolidation regimen"/>
  </concept>
  <concept>
    <code value="DE892"/>
    <display value="Date completed cryptococcal meningitis treatment consolidation regimen"/>
    <definition value="Date client completed cryptococcal meningitis treatment consolidation regimen"/>
  </concept>
  <concept>
    <code value="DE893"/>
    <display value="Staging of liver disease"/>
    <definition value="Staging of liver disease in client"/>
  </concept>
  <concept>
    <code value="DE894"/>
    <display value="F0-4, fibrosis staging"/>
    <definition value="Fibrosis staging of liver disease"/>
  </concept>
  <concept>
    <code value="DE895"/>
    <display value="F4 or cirrhosis, presence of cirrhosis"/>
    <definition value="Presence of cirrhosis"/>
  </concept>
  <concept>
    <code value="DE896"/>
    <display value="Advanced HIV disease"/>
    <definition value="Client has Advanced HIV disease (AHD)"/>
  </concept>
  <concept>
    <code value="DE897"/>
    <display value="WHO functional status"/>
    <definition value="Functional status of people with advanced HIV disease"/>
  </concept>
  <concept>
    <code value="DE898"/>
    <display value="Working, able to perform usual work inside and outside the home"/>
    <definition value="Client is able to perform usual work inside and outside the home (working)"/>
  </concept>
  <concept>
    <code value="DE899"/>
    <display value="Ambulatory, able to perform activity of daily living (ADL), not able to work"/>
    <definition value="Client is able to perform activity of daily living (ADL), not able to work (ambulatory)"/>
  </concept>
  <concept>
    <code value="DE900"/>
    <display value="Bedridden not able to perform ADL"/>
    <definition value="Client is dedridden not able to perform ADL"/>
  </concept>
  <concept>
    <code value="DE901"/>
    <display value="Tailored adherence counselling for advanced HIV disease"/>
    <definition value="Client provided with tailored adherence counselling for advanced HIV disease"/>
  </concept>
  <concept>
    <code value="DE902"/>
    <display value="Date(s) of tracing interventions"/>
    <definition value="Date tracing interventions to support reengagement into HIV care conducted"/>
  </concept>
  <concept>
    <code value="DE903"/>
    <display value="Medication/drug"/>
    <definition value="Current or considered medication/drug, for the purpose of determining drug interactions"/>
  </concept>
  <concept>
    <code value="DE904"/>
    <display value="Rifampicin"/>
    <definition value="Rifampicin currently being taken by, or considered for, client"/>
  </concept>
  <concept>
    <code value="DE905"/>
    <display value="Halofantrine"/>
    <definition value="Halofantrine currently being taken by, or considered for, client"/>
  </concept>
  <concept>
    <code value="DE906"/>
    <display value="Lovastatin"/>
    <definition value="Lovastatin currently being taken by, or considered for, client"/>
  </concept>
  <concept>
    <code value="DE907"/>
    <display value="Simvastatin"/>
    <definition value="Simvastatin currently being taken by, or considered for, client"/>
  </concept>
  <concept>
    <code value="DE908"/>
    <display value="Hormonal contraception"/>
    <definition value="Hormonal contraception currently being taken by, or considered for, client"/>
  </concept>
  <concept>
    <code value="DE909"/>
    <display value="Metformin"/>
    <definition value="Metformin currently being taken by, or considered for, client"/>
  </concept>
  <concept>
    <code value="DE910"/>
    <display value="Astemizole"/>
    <definition value="Astemizole currently being taken by, or considered for, client"/>
  </concept>
  <concept>
    <code value="DE911"/>
    <display value="Terfenadine"/>
    <definition value="Terfenadine currently being taken by, or considered for, client"/>
  </concept>
  <concept>
    <code value="DE912"/>
    <display value="TDF"/>
    <definition value="TDF currently being taken by, or considered for, client"/>
  </concept>
  <concept>
    <code value="DE913"/>
    <display value="Simeprevir"/>
    <definition value="Simeprevir currently being taken by, or considered for, client"/>
  </concept>
  <concept>
    <code value="DE914"/>
    <display value="Ombitasvir + paritaprevir/ritonavir + dasabuvir"/>
    <definition value="Ombitasvir + paritaprevir/ritonavir + dasabuvir currently being taken by, or considered for, client"/>
  </concept>
  <concept>
    <code value="DE915"/>
    <display value="Methadone"/>
    <definition value="Methadone currently being taken by, or considered for, client"/>
  </concept>
  <concept>
    <code value="DE916"/>
    <display value="Buprenorphine"/>
    <definition value="Buprenorphine currently being taken by, or considered for, client"/>
  </concept>
  <concept>
    <code value="DE917"/>
    <display value="Dofetilide"/>
    <definition value="Dofetilide currently being taken by, or considered for, client"/>
  </concept>
  <concept>
    <code value="DE918"/>
    <display value="Carbamazepine"/>
    <definition value="Carbamazepine currently being taken by, or considered for, client"/>
  </concept>
  <concept>
    <code value="DE919"/>
    <display value="Phenobarbital"/>
    <definition value="Phenobarbital currently being taken by, or considered for, client"/>
  </concept>
  <concept>
    <code value="DE920"/>
    <display value="Phenytoin"/>
    <definition value="Phenytoin currently being taken by, or considered for, client"/>
  </concept>
  <concept>
    <code value="DE921"/>
    <display value="Polyvalent cation products containing Mg, Al, Fe, Ca and Zn"/>
    <definition value="Polyvalent cation products containing Mg, Al, Fe, Ca and Zn currently being taken by, or considered for, client"/>
  </concept>
  <concept>
    <code value="DE922"/>
    <display value="Amodiaquine"/>
    <definition value="Amodiaquine currently being taken by, or considered for, client"/>
  </concept>
  <concept>
    <code value="DE923"/>
    <display value="Cisapride"/>
    <definition value="Cisapride currently being taken by, or considered for, client"/>
  </concept>
  <concept>
    <code value="DE924"/>
    <display value="Ergotamine"/>
    <definition value="Ergotamine currently being taken by, or considered for, client"/>
  </concept>
  <concept>
    <code value="DE925"/>
    <display value="Dihydroergotamine"/>
    <definition value="Dihydroergotamine currently being taken by, or considered for, client"/>
  </concept>
  <concept>
    <code value="DE926"/>
    <display value="Midazolam"/>
    <definition value="Midazolam currently being taken by, or considered for, client"/>
  </concept>
  <concept>
    <code value="DE927"/>
    <display value="Triazolam"/>
    <definition value="Triazolam currently being taken by, or considered for, client"/>
  </concept>
  <concept>
    <code value="DE928"/>
    <display value="Estrogen-based hormonal contraception"/>
    <definition value="Estrogen-based hormonal contraception currently being taken by, or considered for, client"/>
  </concept>
  <concept>
    <code value="DE929"/>
    <display value="Ribavirin"/>
    <definition value="Ribavirin currently being taken by, or considered for, client"/>
  </concept>
  <concept>
    <code value="DE930"/>
    <display value="Peginterferon alfa-2a"/>
    <definition value="Peginterferon alfa-2a currently being taken by, or considered for, client"/>
  </concept>
  <concept>
    <code value="DE931"/>
    <display value="Other"/>
    <definition value="Other medication currently being taken by, or considered for, client"/>
  </concept>
  <concept>
    <code value="DE932"/>
    <display value="Other (specify)"/>
    <definition value="Other medication currently being taken by, or considered for, client (specify)"/>
  </concept>
  <concept>
    <code value="DE933"/>
    <display value="Medication change recommended"/>
    <definition value="A medication change is recommended for the client based upon current or considered medications"/>
  </concept>
  <concept>
    <code value="DE934"/>
    <display value="WHO HIV clinical stage condition or symptom"/>
    <definition value="New or recurrent clinical events used to categorize HIV disease severity based at baseline and follow up"/>
  </concept>
  <concept>
    <code value="DE935"/>
    <display value="Pulmonary TB"/>
    <definition value="Client's symptoms include pulmonary TB"/>
  </concept>
  <concept>
    <code value="DE936"/>
    <display value="Lymph node TB"/>
    <definition value="Client's symptoms include lymph node TB"/>
  </concept>
  <concept>
    <code value="DE937"/>
    <display value="Extrapulmonary TB"/>
    <definition value="Client's symptoms include extrapulmonary tuberculosis (TB)"/>
  </concept>
  <concept>
    <code value="DE938"/>
    <display value="TB disease"/>
    <definition value="Whether the client has tuberculosis (TB) disease. Sometimes known as active TB"/>
  </concept>
  <concept>
    <code value="DE939"/>
    <display value="TB diagnosis result"/>
    <definition value="Final result of the TB investigation (bacteriological and/or clinical)"/>
  </concept>
  <concept>
    <code value="DE940"/>
    <display value="Diagnosed TB"/>
    <definition value="Client is diagnosed with TB disease"/>
  </concept>
  <concept>
    <code value="DE941"/>
    <display value="TB excluded"/>
    <definition value="Client is not diagnosed with TB"/>
  </concept>
  <concept>
    <code value="DE942"/>
    <display value="Method of TB diagnosis"/>
    <definition value="Method used to set the TB diagnosis"/>
  </concept>
  <concept>
    <code value="DE943"/>
    <display value="Bacteriologically confirmed"/>
    <definition value="A person from whom a biological specimen is positive by smear microscopy, culture or a WHO-recommended rapid diagnostic"/>
  </concept>
  <concept>
    <code value="DE944"/>
    <display value="Clinically diagnosed"/>
    <definition value="A person who does not fulfil the criteria for bacteriological confirmation but has been diagnosed with TB disease by a medical practitioner who has decided to give the person a full course of TB treatment"/>
  </concept>
  <concept>
    <code value="DE945"/>
    <display value="Presumptive TB"/>
    <definition value="Client has signs or symptoms of tuberculosis (TB) without laboratory confirmation"/>
  </concept>
  <concept>
    <code value="DE946"/>
    <display value="Presumptive TB registration date"/>
    <definition value="Date client is registered as having signs or symptoms of tuberculosis (TB) without laboratory confirmation"/>
  </concept>
  <concept>
    <code value="DE947"/>
    <display value="TB treatment history"/>
    <definition value="History of previous TB treatment"/>
  </concept>
  <concept>
    <code value="DE948"/>
    <display value="New"/>
    <definition value="A person with TB disease who has never been treated for TB before or has only previously ever taken TB drugs for less than 1 month"/>
  </concept>
  <concept>
    <code value="DE949"/>
    <display value="Recurrent"/>
    <definition value="A person with TB disease who was previously treated for TB, was declared cured or treatment completed at the end of their most recent course of TB treatment and is now diagnosed with a new episode of TB."/>
  </concept>
  <concept>
    <code value="DE950"/>
    <display value="Re-registered"/>
    <definition value="A person with TB disease who had been notified previously as a TB case, but was not declared cured or treatment completed, and is now being registered for a new course of TB treatment. "/>
  </concept>
  <concept>
    <code value="DE951"/>
    <display value="Unknown"/>
    <definition value="A person with TB disease who has undocumented history of TB treatment"/>
  </concept>
  <concept>
    <code value="DE952"/>
    <display value="Date of TB diagnosis"/>
    <definition value="The date when the diagnosis was established"/>
  </concept>
  <concept>
    <code value="DE953"/>
    <display value="Currently on TB preventive treatment (TPT)"/>
    <definition value="Client is currently taking TPT"/>
  </concept>
  <concept>
    <code value="DE954"/>
    <display value="TB preventive treatment (TPT) start date"/>
    <definition value="The date on which the client began taking TPT"/>
  </concept>
  <concept>
    <code value="DE955"/>
    <display value="TB preventive treatment (TPT) completion date"/>
    <definition value="The date on which the client completed TPT"/>
  </concept>
  <concept>
    <code value="DE956"/>
    <display value="TB screening algorithm"/>
    <definition value="Screening algorithm selected for screening activities"/>
  </concept>
  <concept>
    <code value="DE957"/>
    <display value="Screening with cough"/>
    <definition value="Client screened for TB based on cough symptom"/>
  </concept>
  <concept>
    <code value="DE958"/>
    <display value="Screening with any TB symptom"/>
    <definition value="Client screened for TB based on any TB symptom"/>
  </concept>
  <concept>
    <code value="DE959"/>
    <display value="W4SS single screening algorithm"/>
    <definition value="Client screened for TB based on the WHO-recommended four-symptom screen"/>
  </concept>
  <concept>
    <code value="DE960"/>
    <display value="CRP single screening algorithm"/>
    <definition value="Client screened for TB based on C-reactive protein (CRP) testing"/>
  </concept>
  <concept>
    <code value="DE961"/>
    <display value="CXR single screening algorithm"/>
    <definition value="Client screened for TB with a chest radiography (CXR)"/>
  </concept>
  <concept>
    <code value="DE962"/>
    <display value="Parallel screening algorithm with W4SS and CRP"/>
    <definition value="Client screened for TB using parallel screening with WHO-recommended four-symptom screen and C-reactive protein (CRP) testing"/>
  </concept>
  <concept>
    <code value="DE963"/>
    <display value="Sequential positive screening algorithm with W4SS and CRP"/>
    <definition value="Client screened for TB using sequential positive screening with WHO-recommended four-symptom screen and C-reactive protein (CRP) testing."/>
  </concept>
  <concept>
    <code value="DE964"/>
    <display value="Sequential negative screening algorithm with W4SS and CRP"/>
    <definition value="Client screened for TB using sequential negative screening with WHO-recommended four-symptom screen and C-reactive protein (CRP) testing"/>
  </concept>
  <concept>
    <code value="DE965"/>
    <display value="Parallel screening algorithm with W4SS and CXR"/>
    <definition value="Client screened for TB using the parallel screening algorithm with W4SS and CXR"/>
  </concept>
  <concept>
    <code value="DE966"/>
    <display value="Sequential positive screening algorithm with W4SS and CXR"/>
    <definition value="Client screened for TB using sequential positive screening with WHO-recommended four-symptom screen and chest radiography"/>
  </concept>
  <concept>
    <code value="DE967"/>
    <display value="Sequential negative screening algorithm with W4SS and CXR"/>
    <definition value="Client screened for TB using sequential negative screening with WHO-recommended four-symptom screen and chest radiography"/>
  </concept>
  <concept>
    <code value="DE968"/>
    <display value="Screening with mWRD"/>
    <definition value="Client screened for TB with a molecular WHO-recommended rapid diagnostic test (mWRD), such as an Xpert MTB/RIF test to detect Mycobacterium tuberculosis (MTB)"/>
  </concept>
  <concept>
    <code value="DE969"/>
    <display value="Clinical assessment"/>
    <definition value="Client screened for with a clinical evaluation for tuberculosis (TB) based on national guidelines. Clinical assessment may be used as an eligibility evaluation for testing with LF-LAM or for empiric TB treatment."/>
  </concept>
  <concept>
    <code value="DE970"/>
    <display value="Other TB screening algorithm"/>
    <definition value="Client screened for tuberculosis (TB) with a different screening method not listed"/>
  </concept>
  <concept>
    <code value="DE971"/>
    <display value="Other TB screening algorithm (specify)"/>
    <definition value="Client screened for tuberculosis (TB) with a different screening method not listed (specify)"/>
  </concept>
  <concept>
    <code value="DE972"/>
    <display value="TB screening conducted"/>
    <definition value="A screening for tuberculosis (TB) was performed"/>
  </concept>
  <concept>
    <code value="DE973"/>
    <display value="Symptoms of TB"/>
    <definition value="Symptoms that may indicate TB disease in clients living with HIV, based on a clinical algorithm"/>
  </concept>
  <concept>
    <code value="DE974"/>
    <display value="Current cough"/>
    <definition value="Client has a cough regardless of duration"/>
  </concept>
  <concept>
    <code value="DE975"/>
    <display value="Prolonged cough (&gt;=2w)"/>
    <definition value="Client has a prolonged cough of 2 weeks or more"/>
  </concept>
  <concept>
    <code value="DE976"/>
    <display value="Fever of 39 °C or greater"/>
    <definition value="Client has a fever with a measured temperature of 102.2 °F/39 °C or greater"/>
  </concept>
  <concept>
    <code value="DE977"/>
    <display value="Weight loss (reported)"/>
    <definition value="Unexplained weight loss"/>
  </concept>
  <concept>
    <code value="DE978"/>
    <display value="Night sweats"/>
    <definition value="Client reports experiencing night sweats"/>
  </concept>
  <concept>
    <code value="DE979"/>
    <display value="Poor weight gain"/>
    <definition value="Client reports poor weight gain of child or infant or growth curve flattening or weight for age &lt;-2 Z-scores."/>
  </concept>
  <concept>
    <code value="DE980"/>
    <display value="Reduced playfulness"/>
    <definition value="Client reports reduced playfulness of child"/>
  </concept>
  <concept>
    <code value="DE981"/>
    <display value="Chest pain"/>
    <definition value="Client reports chest pain"/>
  </concept>
  <concept>
    <code value="DE982"/>
    <display value="Haemoptysis"/>
    <definition value="Client reports experiencing haemoptysis"/>
  </concept>
  <concept>
    <code value="DE983"/>
    <display value="Lethargy"/>
    <definition value="Client reports lethargy"/>
  </concept>
  <concept>
    <code value="DE984"/>
    <display value="None"/>
    <definition value="No symptoms of TB identified"/>
  </concept>
  <concept>
    <code value="DE985"/>
    <display value="History of contact with a person with TB"/>
    <definition value="Client had a history of a contact with a person with TB"/>
  </concept>
  <concept>
    <code value="DE986"/>
    <display value="TB screening result"/>
    <definition value="Record the result of the tuberculosis (TB) screening"/>
  </concept>
  <concept>
    <code value="DE987"/>
    <display value="Screen positive for TB"/>
    <definition value="Screening result was positive for tuberculosis (TB)"/>
  </concept>
  <concept>
    <code value="DE988"/>
    <display value="Screen negative for TB"/>
    <definition value="Screening result was negative for tuberculosis (TB)"/>
  </concept>
  <concept>
    <code value="DE989"/>
    <display value="Inconclusive"/>
    <definition value="Screening result was inconclusive for tuberculosis (TB)"/>
  </concept>
  <concept>
    <code value="DE990"/>
    <display value="TB screening date"/>
    <definition value="Date the TB screening was conducted"/>
  </concept>
  <concept>
    <code value="DE991"/>
    <display value="TB screening result date"/>
    <definition value="The date when the result of TB screening is available"/>
  </concept>
  <concept>
    <code value="DE992"/>
    <display value="TB diagnostic test category"/>
    <definition value="The type of diagnostic test performed to detect tuberculosis (TB) disease"/>
  </concept>
  <concept>
    <code value="DE993"/>
    <display value="LF-LAM"/>
    <definition value="Client tested for tuberculosis with a lateral flow urine lipoarabinomannan assay"/>
  </concept>
  <concept>
    <code value="DE994"/>
    <display value="mWRD test for TB"/>
    <definition value="Client tested with a WHO-recommended molecular diagnostic test to detect Mycobacterium tuberculosis (MTB)"/>
  </concept>
  <concept>
    <code value="DE995"/>
    <display value="Microscopy - Sputum acid-fast bacilli (AFB)"/>
    <definition value="Client tested for tuberculosis with a sputum acid-fast bacilli (AFB)"/>
  </concept>
  <concept>
    <code value="DE996"/>
    <display value="TB Culture"/>
    <definition value="Client tested for tuberculosis (TB) with a culture"/>
  </concept>
  <concept>
    <code value="DE997"/>
    <display value="TB diagnostic test date"/>
    <definition value="The date when TB diagnostic test was performed"/>
  </concept>
  <concept>
    <code value="DE998"/>
    <display value="Test sample collection date"/>
    <definition value="The date when the test sample was collected from the client"/>
  </concept>
  <concept>
    <code value="DE999"/>
    <display value="TB diagnostic test result date"/>
    <definition value="The date when the result of the TB diagnostic test is available"/>
  </concept>
  <concept>
    <code value="DE1000"/>
    <display value="TB treatment started"/>
    <definition value="Indicates if TB treatment was started"/>
  </concept>
  <concept>
    <code value="DE1001"/>
    <display value="TB treatment start date"/>
    <definition value="The date on which the client start or restarted tuberculosis (TB) treatment"/>
  </concept>
  <concept>
    <code value="DE1002"/>
    <display value="TB treatment outcome"/>
    <definition value="Indicates patient's TB treatment outcome"/>
  </concept>
  <concept>
    <code value="DE1003"/>
    <display value="Treatment failed"/>
    <definition value="The treatment regimen terminated or permanently changed to a new regimen or treatment strategy. Reasons for the change include:&#xA;- no clinical response or no bacteriological response, or both (see note;&#xA;- adverse drug reaction; or&#xA;- evidence of additional drug-resistance to medicines in the regimen."/>
  </concept>
  <concept>
    <code value="DE1004"/>
    <display value="Cured"/>
    <definition value="Client with pulmonary TB with bacteriologically confirmed TB at the beginning of treatment who completed treatment as recommended by the national policy, with evidence of bacteriological response and no evidence of failure."/>
  </concept>
  <concept>
    <code value="DE1005"/>
    <display value="Treatment completed"/>
    <definition value="Patient completed treatment as recommended by the national policy but the outcome does not meet the definition for cure or treatment failure"/>
  </concept>
  <concept>
    <code value="DE1006"/>
    <display value="Died"/>
    <definition value="Client died before starting treatment or during the course of treatment"/>
  </concept>
  <concept>
    <code value="DE1007"/>
    <display value="Lost to follow-up"/>
    <definition value="Client was lost to follow-up"/>
  </concept>
  <concept>
    <code value="DE1008"/>
    <display value="Not evaluated"/>
    <definition value="No treatment outcome was assigned. This includes cases 'transferred out' to another treatment unit and whose treatment outcome is unknown; however, it excludes those lost to follow-up."/>
  </concept>
  <concept>
    <code value="DE1009"/>
    <display value="TB treatment completion date"/>
    <definition value="Date client completes TB treatment"/>
  </concept>
  <concept>
    <code value="DE1010"/>
    <display value="TB treatment regimen composition"/>
    <definition value="TB drugs currently being taken by the client"/>
  </concept>
  <concept>
    <code value="DE1011"/>
    <display value="Isoniazid"/>
    <definition value="Client is currently taking isoniazid"/>
  </concept>
  <concept>
    <code value="DE1012"/>
    <display value="Rifampicin"/>
    <definition value="Client is currently taking rifampicin"/>
  </concept>
  <concept>
    <code value="DE1013"/>
    <display value="Rifabutin"/>
    <definition value="Client is currently taking rifabutin"/>
  </concept>
  <concept>
    <code value="DE1014"/>
    <display value="Ethambutol"/>
    <definition value="Client is currently taking ethambutol"/>
  </concept>
  <concept>
    <code value="DE1015"/>
    <display value="Levofloxacin"/>
    <definition value="Client is currently taking levofloxacin"/>
  </concept>
  <concept>
    <code value="DE1016"/>
    <display value="Pyrazinamide"/>
    <definition value="Client is currently taking pyrazinamide, a first-line anti-tuberculosis drug"/>
  </concept>
  <concept>
    <code value="DE1017"/>
    <display value="Eligible for TB preventive treatment"/>
    <definition value="Client is eligible for tuberculosis preventive treatment (TPT)"/>
  </concept>
  <concept>
    <code value="DE1018"/>
    <display value="Date when eligibility for TB preventive treatment (TPT) was determined"/>
    <definition value="Date when a determination of the client's eligibility for TPT was made"/>
  </concept>
  <concept>
    <code value="DE1019"/>
    <display value="TB status at ART start"/>
    <definition value="Client's tuberculosis (TB) status when antiretroviral therapy (ART) is started"/>
  </concept>
  <concept>
    <code value="DE1020"/>
    <display value="Symptomatic for TB"/>
    <definition value="Signs or symptoms of tuberculosis (TB) without laboratory confirmation"/>
  </concept>
  <concept>
    <code value="DE1021"/>
    <display value="Diagnosed TB"/>
    <definition value="Laboratory confirmed tuberculosis (TB) diagnosis"/>
  </concept>
  <concept>
    <code value="DE1022"/>
    <display value="None"/>
    <definition value="Client has no signs or symptoms of tuberculosis (TB) and is not diagnosed with tuberculosis (TB)"/>
  </concept>
  <concept>
    <code value="DE1023"/>
    <display value="TB prevention services accepted"/>
    <definition value="Indicates if the client accepts to be evaluated for TB infection and to take the treatment in case he/she is eligible"/>
  </concept>
  <concept>
    <code value="DE1024"/>
    <display value="TB meningitis"/>
    <definition value="Type of extrapulmonary TB identified for the client is TB meningitis"/>
  </concept>
  <concept>
    <code value="DE1025"/>
    <display value="C reactive protein test date"/>
    <definition value="The date on which the client has a test for C reactive protein"/>
  </concept>
  <concept>
    <code value="DE1026"/>
    <display value="C reactive protein test result"/>
    <definition value="Test result of the client's C reactive protein test result in mg/L"/>
  </concept>
  <concept>
    <code value="DE1027"/>
    <display value="C reactive protein test result date"/>
    <definition value="The date when the client's test result for C reactive protein is available"/>
  </concept>
  <concept>
    <code value="DE1028"/>
    <display value="TPT regimen type"/>
    <definition value="Type of TPT regimen the client is currently on"/>
  </concept>
  <concept>
    <code value="DE1029"/>
    <display value="3HP"/>
    <definition value="The client's current TPT regimen is 3HP"/>
  </concept>
  <concept>
    <code value="DE1030"/>
    <display value="1HP"/>
    <definition value="The client's current TPT regimen is 1HP"/>
  </concept>
  <concept>
    <code value="DE1031"/>
    <display value="6H"/>
    <definition value="The client's current TPT regimen is 6H"/>
  </concept>
  <concept>
    <code value="DE1032"/>
    <display value="Six months of levofloxacin daily"/>
    <definition value="The client's current TPT regimen is six months of levofloxacin daily"/>
  </concept>
  <concept>
    <code value="DE1033"/>
    <display value="Other TB preventive treatment (TPT) regimen"/>
    <definition value="The client's current TPT regimen is another regimen than those listed above"/>
  </concept>
  <concept>
    <code value="DE1034"/>
    <display value="TB preventive treatment (TPT) status"/>
    <definition value="Indicates the current status of TB preventive treatment (TPT)"/>
  </concept>
  <concept>
    <code value="DE1035"/>
    <display value="Not started"/>
    <definition value="The client did not start the TB preventive treatment (TPT)"/>
  </concept>
  <concept>
    <code value="DE1036"/>
    <display value="On TPT"/>
    <definition value="The client started the TB preventive treatment (TPT) and is currently taking the medication, without treatment interruptions"/>
  </concept>
  <concept>
    <code value="DE1037"/>
    <display value="On TPT with interruptions"/>
    <definition value="The client started the TB preventive treatment (TPT) and is currently taking the medication, with treatment interruptions"/>
  </concept>
  <concept>
    <code value="DE1038"/>
    <display value="On hold"/>
    <definition value="The health care worker has temporarily stopped the TB preventive treatment (TPT), but TPT is expected to continue again later. May also be called &quot;suspended&quot;."/>
  </concept>
  <concept>
    <code value="DE1039"/>
    <display value="Completed"/>
    <definition value="TB preventive treatment (TPT) was completed"/>
  </concept>
</CodeSystem>